data_1whv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1whv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.667 ' CD2' ' CD2' ' A' ' 505' ' ' TYR . 53.2 t-80 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.56 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.435 ' CD1' HD13 ' A' ' 466' ' ' ILE . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.422 ' C ' HG23 ' A' ' 464' ' ' ILE . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.422 HG23 ' C ' ' A' ' 463' ' ' ASN . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 455' ' ' TYR . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.564 HG13 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.41 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 500' ' ' GLN . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.449 ' N ' HG21 ' A' ' 499' ' ' ILE . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 506' ' ' VAL . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.667 ' CD2' ' CD2' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 502' ' ' TYR . 30.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.454 ' CG2' HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.555 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.413 ' C ' HG23 ' A' ' 464' ' ' ILE . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.413 HG23 ' C ' ' A' ' 463' ' ' ASN . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.459 HD11 ' CZ ' ' A' ' 455' ' ' TYR . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.636 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 484' ' ' VAL . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 485' ' ' GLN . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 0.8 OUTLIER -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.455 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.454 HG12 ' CG2' ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 474' ' ' ALA . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.568 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 454' ' ' LEU . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.511 ' CZ ' HD13 ' A' ' 466' ' ' ILE . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.506 ' CD1' ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.415 ' C ' HG21 ' A' ' 464' ' ' ILE . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.415 HG21 ' C ' ' A' ' 463' ' ' ASN . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 455' ' ' TYR . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.588 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.506 ' CE2' ' CD1' ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.459 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . 0.409 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 24.9 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.818 0.342 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.556 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.557 HD12 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.527 ' CD2' HD13 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.419 ' C ' HG22 ' A' ' 464' ' ' ILE . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.603 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.603 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 484' ' ' VAL . 22.9 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 481' ' ' PRO . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 501' ' ' THR . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 53.1 t-80 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 442' ' ' HIS . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 474' ' ' ALA . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.567 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.49 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 466' ' ' ILE . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.561 ' CZ ' HG12 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.419 ' C ' HG22 ' A' ' 464' ' ' ILE . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.564 HD11 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.561 HG12 ' CZ ' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.481 ' HG3' ' CD1' ' A' ' 461' ' ' PHE . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 499' ' ' ILE . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.537 HD12 ' CE1' ' A' ' 497' ' ' TYR . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.468 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 15.3 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.534 ' CE2' HG13 ' A' ' 506' ' ' VAL . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.692 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.534 HG13 ' CE2' ' A' ' 502' ' ' TYR . 10.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.337 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.489 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 63.2 t-80 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.561 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.501 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 464' ' ' ILE . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.418 HG23 ' C ' ' A' ' 463' ' ' ASN . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 455' ' ' TYR . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.575 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.575 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.518 ' OE1' ' CD2' ' A' ' 461' ' ' PHE . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 483' ' ' GLN . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 492' ' ' LYS . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 501' ' ' THR . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.489 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.555 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 49.7 t-80 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.433 ' CG2' HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.567 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 454' ' ' LEU . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.568 ' CD2' HD13 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG23 ' A' ' 464' ' ' ILE . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.42 HG23 ' C ' ' A' ' 463' ' ' ASN . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.569 HD13 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.539 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.569 ' CD2' HD13 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 491' ' ' SER . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.513 ' CE1' HD13 ' A' ' 499' ' ' ILE . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.513 HD13 ' CE1' ' A' ' 497' ' ' TYR . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.468 ' CE2' HG13 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.555 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.468 HG13 ' CE2' ' A' ' 502' ' ' TYR . 20.9 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.722 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 54.9 t-80 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 474' ' ' ALA . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 454' ' ' LEU . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.555 ' CE1' HG21 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.66 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.56 ' HB1' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.66 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.555 HG21 ' CE1' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 484' ' ' VAL . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 483' ' ' GLN . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.415 ' CE1' HD13 ' A' ' 499' ' ' ILE . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 500' ' ' GLN . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.456 ' N ' HG21 ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.47 ' CE2' HG11 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.722 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.47 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.3 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.848 0.356 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 441' ' ' LEU . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 440' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 474' ' ' ALA . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.544 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 466' ' ' ILE . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.46 ' CB ' HD11 ' A' ' 464' ' ' ILE . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.52 ' CD2' HD21 ' A' ' 478' ' ' LEU . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG21 ' A' ' 464' ' ' ILE . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 458' ' ' PHE . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.544 HD13 ' CD2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.648 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.648 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 461' ' ' PHE . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.427 ' O ' ' C ' ' A' ' 484' ' ' VAL . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 483' ' ' GLN . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.455 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.551 ' CE2' ' CG1' ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.551 ' CG1' ' CE2' ' A' ' 502' ' ' TYR . 34.5 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.491 ' CE2' HD13 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.423 ' C ' HG23 ' A' ' 464' ' ' ILE . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 463' ' ' ASN . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.443 HD11 ' CE2' ' A' ' 455' ' ' TYR . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.441 ' O ' ' C ' ' A' ' 484' ' ' VAL . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.51 ' CZ ' HG12 ' A' ' 506' ' ' VAL . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . 0.466 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 502' ' ' TYR . 12.6 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.407 ' CD2' HG11 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 466' ' ' ILE . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 460' ' ' ALA . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.502 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.633 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.633 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.401 ' HA ' ' ND2' ' A' ' 489' ' ' ASN . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 492' ' ' LYS . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.416 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 5.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 48.4 t-80 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD12 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.559 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.54 ' CD2' HD11 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.412 ' C ' HG22 ' A' ' 464' ' ' ILE . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.412 HG22 ' C ' ' A' ' 463' ' ' ASN . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.634 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.427 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.634 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.476 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.543 ' CE2' HG12 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.494 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.543 HG12 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.562 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.407 ' C ' HG21 ' A' ' 464' ' ' ILE . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.407 HG21 ' C ' ' A' ' 463' ' ' ASN . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.532 HD13 ' CD2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.635 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.458 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.409 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE1' ' A' ' 502' ' ' TYR . 19.8 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.496 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.571 HD12 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.423 ' C ' HG22 ' A' ' 464' ' ' ILE . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.423 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.566 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 470' ' ' ASP . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 484' ' ' VAL . 21.6 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 483' ' ' GLN . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . 0.415 ' HA ' ' NE2' ' A' ' 485' ' ' GLN . 7.9 tp60 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 488' ' ' VAL . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.543 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.432 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' A' ' 506' ' ' VAL . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 502' ' ' TYR . 31.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.417 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 47.9 t-80 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.46 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.486 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . 0.419 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.561 HD12 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.414 ' C ' HG21 ' A' ' 464' ' ' ILE . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.414 HG21 ' C ' ' A' ' 463' ' ' ASN . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.48 HD11 ' CE2' ' A' ' 455' ' ' TYR . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.448 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.518 ' CE1' HG11 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.518 HG11 ' CE1' ' A' ' 502' ' ' TYR . 27.5 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.849 0.356 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.402 ' CD1' HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.523 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.55 ' CD2' HD12 ' A' ' 466' ' ' ILE . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG21 ' A' ' 464' ' ' ILE . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.42 HG21 ' C ' ' A' ' 463' ' ' ASN . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.55 HD12 ' CD2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.629 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 484' ' ' VAL . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 483' ' ' GLN . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.449 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.53 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.559 ' CE2' ' HB1' ' A' ' 474' ' ' ALA . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 464' ' ' ILE . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG22 ' A' ' 464' ' ' ILE . 16.1 m-80 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 458' ' ' PHE . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.465 HD12 ' CD2' ' A' ' 455' ' ' TYR . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.619 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.559 ' HB1' ' CE2' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.619 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 477' ' ' SER . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 476' ' ' VAL . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 486' ' ' ILE . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' SER . . . . . 0.439 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.43 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . 0.439 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 501' ' ' THR . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 11.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 441' ' ' LEU . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . 0.402 ' N ' HG12 ' A' ' 440' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 466' ' ' ILE . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.406 ' CE2' ' CG2' ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG23 ' A' ' 464' ' ' ILE . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.421 HG23 ' C ' ' A' ' 463' ' ' ASN . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.516 HD13 ' CE2' ' A' ' 455' ' ' TYR . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.406 ' CG2' ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 9.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 489' ' ' ASN . 10.1 mm-40 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 485' ' ' GLN . 87.2 m-20 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . 0.542 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 501' ' ' THR . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.542 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 64.5 t-80 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . 0.547 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG23 ' A' ' 464' ' ' ILE . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.421 HG23 ' C ' ' A' ' 463' ' ' ASN . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.626 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.486 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.626 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.537 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.547 ' HG2' ' CD1' ' A' ' 461' ' ' PHE . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.565 ' CE2' HG12 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' HIS . . . . . 0.793 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 46.3 t-80 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 454' ' ' LEU . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 466' ' ' ILE . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' PHE . . . . . 0.413 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 464' ' ' ILE . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' ILE . . . . . 0.418 HG23 ' C ' ' A' ' 463' ' ' ASN . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' ILE . . . . . 0.621 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' ALA . . . . . 0.559 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' PHE . . . . . 0.621 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' VAL . . . . . 0.413 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 39.0 m-20 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' TYR . . . . . 0.439 ' CD2' HD21 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' TYR . . . . . 0.562 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' TYR . . . . . 0.793 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 95.7 p -141.27 148.59 40.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.3 p -108.07 168.69 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.87 155.12 25.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 105.69 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 p -125.34 176.75 6.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -80.16 -157.8 15.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 155.45 -95.0 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.58 14.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.669 2.246 . . . . 0.0 112.387 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.5 170.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.2 tp -101.38 140.45 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -94.36 143.93 27.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.609 0.719 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 164.22 35.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -42.15 138.54 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.547 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 31.8 mtt180 -84.61 74.87 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.97 -47.01 7.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -55.91 -31.17 62.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.667 ' CD2' ' CD2' ' A' ' 505' ' ' TYR . 53.2 t-80 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.566 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.56 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.56 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.435 ' CD1' HD13 ' A' ' 466' ' ' ILE . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.564 ' CE2' HG13 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.422 ' C ' HG23 ' A' ' 464' ' ' ILE . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.422 HG23 ' C ' ' A' ' 463' ' ' ASN . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.435 HD13 ' CD1' ' A' ' 455' ' ' TYR . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.57 HD13 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.57 ' CD2' HD13 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.564 HG13 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.41 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 500' ' ' GLN . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.449 ' N ' HG21 ' A' ' 499' ' ' ILE . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 506' ' ' VAL . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.667 ' CD2' ' CD2' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.561 HG12 ' CE1' ' A' ' 502' ' ' TYR . 30.7 m -52.39 -42.57 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -36.23 -49.63 1.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.409 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -56.86 -55.07 39.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -54.87 -61.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -123.95 144.82 49.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -139.4 109.53 6.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -68.33 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -127.31 84.19 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . 0.409 ' NE2' HG11 ' A' ' 515' ' ' VAL . 22.2 tm0? -165.24 125.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 516' ' ' LYS . 11.0 p -39.41 141.96 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.108 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.447 ' N ' HG23 ' A' ' 515' ' ' VAL . 0.0 OUTLIER -110.92 152.78 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.6 t -145.22 145.89 31.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -122.05 83.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.75 19.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 60.3 p -117.41 171.48 7.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.0 p -39.21 108.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 28.0 p -158.06 124.22 4.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 44.0 m -88.0 160.52 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.41 -123.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.7 m -73.25 122.96 22.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 45.8 t -111.75 136.69 50.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 88.96 153.13 26.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -145.64 87.08 0.17 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.535 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.08 32.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 0.0 112.318 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.32 177.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.65 65.15 3.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.89 144.09 47.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 145.73 57.58 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.689 2.259 . . . . 0.0 112.316 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.0 106.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.496 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 45.3 mtt180 60.68 37.93 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.85 -59.56 4.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.9 p-80 -42.48 -27.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.454 ' CG2' HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.555 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.555 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.413 ' C ' HG23 ' A' ' 464' ' ' ILE . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.413 HG23 ' C ' ' A' ' 463' ' ' ASN . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.459 HD11 ' CZ ' ' A' ' 455' ' ' TYR . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.636 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.57 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.636 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.433 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 484' ' ' VAL . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 485' ' ' GLN . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 0.8 OUTLIER -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.455 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.454 HG12 ' CG2' ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.496 ' CZ ' ' HD2' ' A' ' 437' ' ' ARG . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 30.9 m -51.24 -33.45 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.52 -63.13 1.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -73.95 -49.19 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -46.68 -68.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.865 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.38 116.78 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -150.49 122.01 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -144.35 -141.27 3.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -121.83 87.5 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.727 0.298 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -174.02 132.02 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.17 133.33 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -54.72 141.33 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 74.7 p -72.66 127.71 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 49.98 83.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 178.72 4.29 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 90.9 p -163.09 115.96 1.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.2 t -98.32 130.99 44.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -112.37 102.76 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.3 m -100.29 127.75 46.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -154.46 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 28.3 p -156.86 117.24 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.9 m -136.89 117.78 14.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 52.38 177.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 140.16 -80.94 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -77.44 171.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.92 111.18 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -116.46 150.76 46.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.722 . . . . 0.0 110.94 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 156.57 63.0 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -96.97 41.32 1.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.488 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 61.6 mtt-85 -64.73 78.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.54 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -42.8 -32.21 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 474' ' ' ALA . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.568 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 454' ' ' LEU . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.511 ' CZ ' HD13 ' A' ' 466' ' ' ILE . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.506 ' CD1' ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.415 ' C ' HG21 ' A' ' 464' ' ' ILE . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.415 HG21 ' C ' ' A' ' 463' ' ' ASN . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.511 HD13 ' CZ ' ' A' ' 455' ' ' TYR . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.588 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.588 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.506 ' CE2' ' CD1' ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.459 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.459 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.488 ' CZ ' ' HD2' ' A' ' 437' ' ' ARG . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . 0.409 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.408 ' O ' ' C ' ' A' ' 507' ' ' GLY . 24.9 m -50.26 -48.48 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -36.36 -56.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 509' ' ' LYS . 27.7 mmtp -68.66 -50.4 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 508' ' ' LYS . 37.4 tttt -36.47 -57.99 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -91.57 129.56 37.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 40.98 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 73.54 100.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -121.78 41.9 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -166.25 150.41 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.1 m -48.45 164.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -113.12 99.09 7.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -85.63 108.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.828 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 102.48 83.31 1.71 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.66 57.56 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 75.8 m -93.34 -51.06 5.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.5 m -101.91 96.97 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -127.42 171.11 11.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 27.6 t -96.59 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.843 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 134.72 -144.73 16.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.5 p -157.42 151.59 24.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.89 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 18.4 p -132.78 159.68 39.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -60.04 -166.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -141.78 145.64 16.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 1.48 4.4 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.59 140.08 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -47.0 159.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.78 143.61 38.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.9 Cg_endo -69.73 -175.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.239 . . . . 0.0 112.382 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 435' ' ' PRO . 7.3 mmpt? -35.91 150.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.557 ' HD3' ' CD2' ' A' ' 502' ' ' TYR . 0.0 OUTLIER -126.26 40.23 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.06 -45.89 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -54.69 -18.62 4.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.556 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.557 HD12 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.527 ' CD2' HD13 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.419 ' C ' HG22 ' A' ' 464' ' ' ILE . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.527 HD13 ' CD2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.603 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.603 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.504 HG12 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 484' ' ' VAL . 22.9 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 481' ' ' PRO . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.557 ' CD2' ' HD3' ' A' ' 437' ' ' ARG . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m -48.28 -22.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.53 -54.95 30.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -39.75 -51.76 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -55.14 -71.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -61.84 159.42 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -134.89 107.5 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 159.82 47.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -168.33 110.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -154.12 129.84 10.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.8 155.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -58.72 92.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.7 m -135.86 156.92 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -129.27 142.35 13.48 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.86 58.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.347 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.6 p -173.11 113.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 7.7 m -143.95 175.7 9.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.52 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.8 m -128.68 156.97 42.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 43.5 p -96.18 115.04 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -165.75 121.84 1.03 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 t -120.85 110.28 16.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 44.7 t -143.2 115.8 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -150.46 107.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -81.23 -91.24 0.54 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 109.59 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 29.8 mt -145.24 166.25 26.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -70.39 144.04 91.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 110.92 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 153.66 68.99 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 145.86 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.548 ' HB2' ' CD2' ' A' ' 502' ' ' TYR . 33.5 mtt180 62.83 44.46 6.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -57.27 -58.71 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -43.32 -36.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 53.1 t-80 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.461 ' CG2' HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' THR . . . . . 0.421 HG22 ' CE1' ' A' ' 442' ' ' HIS . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 474' ' ' ALA . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.567 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.49 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.564 ' CE2' HD11 ' A' ' 466' ' ' ILE . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.561 ' CZ ' HG12 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.419 ' C ' HG22 ' A' ' 464' ' ' ILE . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.419 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.564 HD11 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.561 HG12 ' CZ ' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.481 ' HG3' ' CD1' ' A' ' 461' ' ' PHE . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 499' ' ' ILE . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.537 HD12 ' CE1' ' A' ' 497' ' ' TYR . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.468 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 15.3 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.548 ' CD2' ' HB2' ' A' ' 437' ' ' ARG . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.692 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.534 HG13 ' CE2' ' A' ' 502' ' ' TYR . 10.9 m -53.7 -38.36 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -58.06 -41.13 94.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.38 -63.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -44.2 -37.88 3.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.898 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 506' ' ' VAL . 25.7 mm-40 -60.65 151.84 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -135.99 106.73 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -114.61 -142.19 7.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -166.96 121.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -171.65 134.55 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.96 144.92 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -57.53 116.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.7 t -60.76 120.73 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 98.62 157.07 29.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -47.55 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 73.1 m -114.47 140.63 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.1 p -71.09 126.09 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.539 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 8.4 t -153.42 173.52 15.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 53.7 p -140.8 169.6 17.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 133.06 159.48 9.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 22.2 t -166.15 130.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 87.6 p -103.59 100.32 10.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -69.6 140.55 33.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -146.44 173.15 26.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 112.09 2.98 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.681 2.254 . . . . 0.0 112.365 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -164.63 164.24 21.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.7 mp -79.77 103.36 9.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -96.2 151.24 38.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.619 0.724 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 160.28 50.28 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 439' ' ' HIS . 43.7 tttp -84.12 47.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.553 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 10.9 mmt180 -87.53 41.03 0.96 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -80.13 -58.67 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . 0.445 ' CE1' ' O ' ' A' ' 436' ' ' LYS . 7.1 p-80 -40.31 -39.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.489 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 63.2 t-80 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.451 ' CG2' HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.561 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.452 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.501 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.483 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 464' ' ' ILE . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.418 HG23 ' C ' ' A' ' 463' ' ' ASN . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.501 HD12 ' CE2' ' A' ' 455' ' ' TYR . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.575 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.569 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.575 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.483 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.518 ' OE1' ' CD2' ' A' ' 461' ' ' PHE . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 483' ' ' GLN . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 492' ' ' LYS . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.488 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.451 HG12 ' CG2' ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.553 ' CE2' ' HD2' ' A' ' 437' ' ' ARG . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.489 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 29.6 m -49.21 -38.46 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -52.59 -40.86 55.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -62.95 -59.67 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.469 ' HD2' ' CZ ' ' A' ' 505' ' ' TYR . 25.6 mtpt -40.87 -72.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -61.16 156.12 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -85.87 8.17 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 56.79 -95.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -173.7 110.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -150.84 128.35 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.38 162.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -95.64 94.68 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.1 t -149.22 120.93 8.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 50.65 -179.28 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.22 28.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.662 2.241 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 31.0 t -170.38 124.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.8 m -88.93 -59.21 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 91.9 p -80.23 140.48 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.382 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.5 t -163.37 177.55 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.23 163.47 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -63.6 116.63 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.5 m -89.39 102.71 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -45.67 127.71 8.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 119.74 82.78 0.77 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.505 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 143.67 51.48 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.342 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.08 144.11 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 434' ' ' GLN . 56.9 mt -51.29 173.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 433' ' ' LEU . 25.8 mp0 -35.93 144.11 0.26 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.546 0.688 . . . . 0.0 110.931 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 146.39 60.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -53.43 141.44 24.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 63.32 42.0 7.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.41 -51.74 27.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -47.36 -20.64 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.555 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 49.7 t-80 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.433 ' CG2' HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.539 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.567 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 454' ' ' LEU . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.568 ' CD2' HD13 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.542 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.49 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG23 ' A' ' 464' ' ' ILE . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.42 HG23 ' C ' ' A' ' 463' ' ' ASN . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.568 HD13 ' CD2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.569 HD13 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.539 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.569 ' CD2' HD13 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.542 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.479 ' O ' ' N ' ' A' ' 491' ' ' SER . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.513 ' CE1' HD13 ' A' ' 499' ' ' ILE . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.513 HD13 ' CE1' ' A' ' 497' ' ' TYR . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.468 ' CE2' HG13 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.555 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.468 HG13 ' CE2' ' A' ' 502' ' ' TYR . 20.9 m -61.91 -36.14 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.16 -53.46 4.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -75.35 -49.69 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.954 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -38.89 -55.29 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.8 169.15 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.43 41.16 2.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -95.37 91.77 1.39 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.537 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.25 116.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -159.78 149.35 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.0 145.97 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -109.25 160.62 15.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.4 p -162.94 145.17 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 172.29 -160.4 31.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -8.13 22.81 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.252 . . . . 0.0 112.361 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 10.8 t -40.01 121.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 2.9 t -86.13 139.09 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.2 m -102.8 149.76 24.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.8 t -171.87 133.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 160.8 156.74 8.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.2 m -87.43 173.25 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -99.06 -46.72 5.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -91.11 -122.48 2.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 145.86 -95.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 108.16 2.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.274 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -168.41 159.47 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 82.4 mt -148.53 122.82 9.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -72.06 150.32 92.43 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 172.39 12.73 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.732 2.288 . . . . 0.0 112.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -49.65 128.34 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -112.13 82.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -86.6 -52.73 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -50.71 -36.77 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.722 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 54.9 t-80 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . 0.4 ' CG2' HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.56 ' CZ ' ' HB1' ' A' ' 474' ' ' ALA . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 454' ' ' LEU . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.555 ' CE1' HG21 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.66 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.56 ' HB1' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.66 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.555 HG21 ' CE1' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 484' ' ' VAL . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 483' ' ' GLN . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.415 ' CE1' HD13 ' A' ' 499' ' ' ILE . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.456 HG21 ' N ' ' A' ' 500' ' ' GLN . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.456 ' N ' HG21 ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.47 ' CE2' HG11 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.722 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.47 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.3 m -58.27 -30.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.05 -62.78 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -50.76 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -37.88 -52.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -54.75 173.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -111.99 84.78 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -176.88 127.26 1.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -129.49 87.99 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.755 0.312 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.61 124.71 3.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.76 146.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -54.99 110.57 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.3 t -117.98 151.13 38.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -142.55 72.9 0.37 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 94.17 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.376 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 33.2 t -108.22 154.14 22.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.3 m -92.19 153.41 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.2 t -145.91 140.95 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.364 . . . . 0.0 110.925 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 50.9 m -120.93 124.45 44.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.51 23.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 58.8 m -85.92 92.96 8.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 40.9 m -52.01 176.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -163.61 -82.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.17 21.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 113.41 3.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.11 166.29 11.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 59.9 mt -59.88 86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.13 151.96 62.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -178.52 2.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -85.34 90.63 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 25.4 mtt-85 -125.82 80.49 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -92.31 -51.65 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -48.97 -37.65 20.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 441' ' ' LEU . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.456 ' N ' HG12 ' A' ' 440' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 474' ' ' ALA . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.544 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.544 ' CD2' HD13 ' A' ' 466' ' ' ILE . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.46 ' CB ' HD11 ' A' ' 464' ' ' ILE . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.52 ' CD2' HD21 ' A' ' 478' ' ' LEU . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG21 ' A' ' 464' ' ' ILE . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.46 HD11 ' CB ' ' A' ' 458' ' ' PHE . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.544 HD13 ' CD2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.648 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.648 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.456 HG22 ' CE1' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.52 HD21 ' CD2' ' A' ' 461' ' ' PHE . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.427 ' O ' ' C ' ' A' ' 484' ' ' VAL . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.427 ' C ' ' O ' ' A' ' 483' ' ' GLN . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.455 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.448 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.551 ' CE2' ' CG1' ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.551 ' CG1' ' CE2' ' A' ' 502' ' ' TYR . 34.5 m -59.17 -41.0 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -54.01 -47.14 67.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -70.04 -56.87 5.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.349 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -44.21 -48.33 9.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.28 171.89 12.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -150.01 123.2 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -60.6 -143.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -123.46 42.58 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -162.58 146.27 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 516' ' ' LYS . 11.2 p -75.42 144.19 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 515' ' ' VAL . 12.1 mmmt -44.4 135.19 4.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.2 t -160.17 140.83 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 131.45 84.99 0.31 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.51 57.65 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.8 m -140.37 113.55 8.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 522' ' ' GLY . 58.2 m -122.78 155.09 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 521' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 32.0 t -97.14 100.25 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 84.8 p -133.7 130.27 37.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -126.51 -173.39 13.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.1 t -91.37 141.14 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 110.849 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.6 p -87.88 120.88 29.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.835 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -116.46 90.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.08 83.32 1.1 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 102.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.701 2.268 . . . . 0.0 112.348 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.4 168.52 5.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.62 89.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -51.45 142.97 20.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -174.85 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.54 33.46 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.554 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 29.7 mtt180 -78.42 84.43 4.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -100.39 -45.23 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -54.36 -30.09 50.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.491 ' CE2' HD13 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.491 HD13 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.423 ' C ' HG23 ' A' ' 464' ' ' ILE . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.423 HG23 ' C ' ' A' ' 463' ' ' ASN . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.443 HD11 ' CE2' ' A' ' 455' ' ' TYR . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.455 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . . . . . . . . . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.441 ' O ' ' C ' ' A' ' 484' ' ' VAL . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.554 ' CE2' ' HD2' ' A' ' 437' ' ' ARG . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . 0.466 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 502' ' ' TYR . 12.6 m -56.05 -23.19 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -81.28 -34.76 25.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -89.65 -18.02 27.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.446 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -91.65 -33.86 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -71.36 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -158.3 113.71 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -100.94 -143.85 14.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -131.5 80.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -164.05 130.82 3.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.44 138.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -60.63 137.35 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.7 p -101.83 172.74 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -103.07 146.21 16.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 137.32 35.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 80.7 p -46.84 124.12 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 3.4 t -58.17 157.46 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.9 m -146.25 164.6 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 110.811 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.1 t -147.59 156.55 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.06 149.23 34.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 70.3 m -91.65 173.64 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 m -109.0 98.53 7.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -79.61 54.58 4.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.45 1.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 141.63 45.66 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.688 2.259 . . . . 0.0 112.338 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.421 ' O ' ' NE2' ' A' ' 434' ' ' GLN . 3.3 p30 -56.73 166.42 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.94 97.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 432' ' ' ASP . 7.3 mp0 -41.33 151.55 0.29 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.563 0.697 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -179.19 2.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.668 2.245 . . . . 0.0 112.303 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -101.33 42.37 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.548 ' CB ' ' CD2' ' A' ' 502' ' ' TYR . 24.0 mmt180 -110.29 74.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -106.11 -43.47 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -60.8 -36.82 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.407 ' CD2' HG11 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.493 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.502 ' CE2' HD12 ' A' ' 466' ' ' ILE . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 460' ' ' ALA . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . . . . . . . . . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.502 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.633 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.633 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.401 ' HA ' ' ND2' ' A' ' 489' ' ' ASN . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.401 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 492' ' ' LYS . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.416 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.548 ' CD2' ' CB ' ' A' ' 437' ' ' ARG . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 5.7 m -51.93 -26.79 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.94 -44.28 97.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.527 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -41.79 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -56.47 -58.31 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -80.97 121.99 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -81.26 42.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 72.37 125.51 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -132.18 89.7 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -168.07 125.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.57 159.28 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -102.43 102.81 13.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.2 t -59.55 137.67 57.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 121.69 85.31 0.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.9 Cg_endo -69.77 136.57 33.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 519' ' ' PRO . 53.9 p -34.66 138.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.0 p -81.46 147.05 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 20.9 m -118.47 92.15 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.4 t -138.05 143.16 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.48 -115.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.4 m -160.28 142.45 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -113.04 169.93 8.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 121.22 42.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -54.73 164.17 3.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.47 4.4 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -80.0 165.42 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.79 102.94 15.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -80.99 149.86 67.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 154.54 67.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -74.67 110.76 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.408 ' HB3' ' CD2' ' A' ' 502' ' ' TYR . 16.2 mmt85 -124.11 43.84 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.59 -60.3 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -41.47 -32.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 48.4 t-80 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD12 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.559 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.54 ' CD2' HD11 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.504 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.412 ' C ' HG22 ' A' ' 464' ' ' ILE . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.412 HG22 ' C ' ' A' ' 463' ' ' ASN . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.54 HD11 ' CD2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.634 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.427 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.634 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.504 HG21 ' CE2' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.481 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.476 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.543 ' CE2' HG12 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.494 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.543 HG12 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m -52.27 -29.75 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -43.43 -63.18 2.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -47.94 30.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.411 ' HD2' ' CE2' ' A' ' 505' ' ' TYR . 28.2 tttm -41.48 -46.35 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.21 179.06 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -144.28 110.25 5.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.14 -141.78 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -174.91 116.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.726 0.298 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -164.77 123.77 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.419 HG12 ' N ' ' A' ' 516' ' ' LYS . 93.6 t -127.13 140.68 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.419 ' N ' HG12 ' A' ' 515' ' ' VAL . 22.7 ttpp -171.42 120.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 13.3 t -88.84 92.86 9.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -126.72 88.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -174.11 0.85 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.336 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 71.7 m -106.04 116.04 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 42.1 t -101.76 165.04 11.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.5 p -53.05 152.98 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.9 p -165.02 139.76 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 149.39 159.17 8.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.4 p -148.2 137.53 22.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 t -86.41 97.62 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 50.57 -126.2 24.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 124.49 74.5 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 1.55 4.35 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -78.33 154.07 31.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 10.5 mt -106.79 147.71 29.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -119.03 150.92 49.73 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.6 Cg_endo -69.77 -174.51 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 435' ' ' PRO . 20.3 mmtt -34.93 146.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 -108.61 80.0 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.18 -55.76 3.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -43.78 -36.85 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.532 ' CD2' HD13 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.562 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.407 ' C ' HG21 ' A' ' 464' ' ' ILE . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.407 HG21 ' C ' ' A' ' 463' ' ' ASN . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.532 HD13 ' CD2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.635 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.458 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.409 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE1' ' A' ' 502' ' ' TYR . 19.8 m -65.83 -38.11 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.19 -48.01 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 0.0 OUTLIER -82.55 -48.66 10.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 11.4 tptp -35.75 -58.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 510' ' ' GLN . 11.9 pt20 -80.07 90.52 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -65.73 86.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -91.54 -134.23 6.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.459 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -125.47 45.56 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 110.885 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -160.42 156.05 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 516' ' ' LYS . 46.5 t -120.47 143.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.466 ' N ' HG11 ' A' ' 515' ' ' VAL . 18.1 pttm -38.18 126.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.9 m -101.19 131.34 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 139.18 70.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 120.25 7.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.76 2.307 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 65.7 p -137.89 111.72 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 6.0 t -44.47 148.65 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.515 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 50.0 m -119.09 167.78 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.5 t -117.18 115.92 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 132.09 69.18 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.0 t -56.29 145.14 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.845 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.3 p -88.85 84.27 6.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 54.1 -114.03 3.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.4 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.53 4.37 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -91.88 150.96 20.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.12 92.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -73.88 143.99 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.584 0.707 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 165.45 30.88 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -94.45 38.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.503 ' NH1' ' CE2' ' A' ' 502' ' ' TYR . 37.3 mtt85 -84.18 79.15 9.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.31 -46.95 7.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -54.82 -33.72 61.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.496 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.571 HD12 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.484 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.467 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.423 ' C ' HG22 ' A' ' 464' ' ' ILE . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.423 HG22 ' C ' ' A' ' 463' ' ' ASN . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.566 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 470' ' ' ASP . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.519 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.566 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.423 ' O ' ' C ' ' A' ' 484' ' ' VAL . 21.6 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 483' ' ' GLN . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . 0.415 ' HA ' ' NE2' ' A' ' 485' ' ' GLN . 7.9 tp60 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 488' ' ' VAL . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.543 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.432 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' A' ' 506' ' ' VAL . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.54 HG13 ' CE2' ' A' ' 502' ' ' TYR . 31.4 m -63.82 -38.99 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.11 -65.05 0.43 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -65.72 -42.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -46.16 -64.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.06 110.92 22.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -173.48 128.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.96 -85.13 0.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -171.92 109.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 515' ' ' VAL . 21.1 tt0 -149.04 126.36 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 514' ' ' GLN . 15.0 p -37.52 142.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -92.8 136.44 33.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -166.09 166.15 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 145.56 -162.9 28.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 2.28 3.63 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.25 . . . . 0.0 112.363 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 68.5 m -73.04 142.98 47.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.2 t -164.28 164.66 22.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 t -46.6 -58.96 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 79.8 p -56.19 156.42 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -164.81 50.37 0.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 71.9 p -166.3 161.37 16.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 56.1 p -93.81 169.12 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -111.45 42.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -135.57 -158.71 8.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.32 5.02 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 0.0 112.342 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -143.22 170.45 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 tp -104.4 93.28 4.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.71 152.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 175.91 7.52 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -92.29 42.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -112.89 52.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -90.09 -48.97 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -50.25 -27.37 5.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.417 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 47.9 t-80 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.46 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.486 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . 0.419 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.561 HD12 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.467 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.414 ' C ' HG21 ' A' ' 464' ' ' ILE . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.414 HG21 ' C ' ' A' ' 463' ' ' ASN . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.48 HD11 ' CE2' ' A' ' 455' ' ' TYR . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.637 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.568 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.637 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.467 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.448 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.448 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.518 ' CE1' HG11 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.518 HG11 ' CE1' ' A' ' 502' ' ' TYR . 27.5 m -59.09 -39.27 78.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -41.14 -58.18 2.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -47.74 -41.29 22.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -64.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.37 111.21 8.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -173.22 112.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -119.65 -107.44 2.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -121.29 40.77 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -149.23 127.94 12.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.6 176.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -79.54 111.6 15.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 1.6 t -114.38 161.89 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.81 16.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.7 Cg_endo -69.78 -49.31 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 519' ' ' PRO . 83.8 p -34.74 146.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.5 p -50.92 -179.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.1 t -103.98 137.06 42.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.2 t -151.19 175.46 12.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -128.16 176.19 18.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.5 t -126.32 85.59 2.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.9 m 50.69 42.52 27.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -177.14 -156.4 15.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 143.41 -161.59 27.66 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 432' ' ' ASP . 53.7 Cg_endo -69.77 174.46 9.48 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.677 2.252 . . . . 0.0 112.358 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 431' ' ' PRO . 30.9 t0 -36.22 125.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.6 tp -113.06 92.26 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.1 143.96 86.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.604 0.716 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 147.34 62.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 0.0 112.355 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -173.33 129.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 53.52 45.5 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.87 -54.78 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -45.13 -30.37 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.402 ' CD1' HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.497 ' CE2' ' HB3' ' A' ' 474' ' ' ALA . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.523 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.48 HD13 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.55 ' CD2' HD12 ' A' ' 466' ' ' ILE . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.472 ' CE2' HG22 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.42 ' C ' HG21 ' A' ' 464' ' ' ILE . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.42 HG21 ' C ' ' A' ' 463' ' ' ASN . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.55 HD12 ' CD2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.629 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.497 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.629 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.472 HG22 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . 0.402 HD11 ' CD1' ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.437 ' O ' ' C ' ' A' ' 484' ' ' VAL . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 483' ' ' GLN . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.449 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.523 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.53 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.53 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m -69.93 -44.02 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.23 -49.69 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.445 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.38 -52.42 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.25 -36.95 71.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -66.38 128.17 35.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -132.72 98.67 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -111.4 -133.17 6.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -170.37 112.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -155.09 134.34 12.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.29 171.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -174.14 141.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.8 m -70.48 172.96 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -82.72 141.37 21.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -42.16 3.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.262 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 43.8 p -109.11 146.58 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.0 m -125.33 -47.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 63.2 p -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 8.4 t -65.05 -45.7 84.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.95 -98.62 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 4.0 m 52.79 44.66 30.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.843 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.7 p -70.07 -44.4 69.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -108.35 -150.48 14.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 52.89 83.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 131.77 21.95 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.34 156.14 16.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.18 39.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -80.64 154.02 73.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.8 Cg_endo -69.66 153.27 69.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.354 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 435' ' ' PRO . 17.7 pttp -35.8 145.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.454 ' HB3' ' CG2' ' A' ' 440' ' ' VAL . 1.0 OUTLIER -67.63 90.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.27 -58.32 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -47.15 -34.77 6.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.454 ' CG2' ' HB3' ' A' ' 437' ' ' ARG . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.559 ' CE2' ' HB1' ' A' ' 474' ' ' ALA . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.523 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.45 ' CB ' HD12 ' A' ' 464' ' ' ILE . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG22 ' A' ' 464' ' ' ILE . 16.1 m-80 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.45 HD12 ' CB ' ' A' ' 458' ' ' PHE . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.465 HD12 ' CD2' ' A' ' 455' ' ' TYR . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.619 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.559 ' HB1' ' CE2' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.619 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 477' ' ' SER . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.428 ' N ' HG12 ' A' ' 476' ' ' VAL . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 486' ' ' ILE . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' SER . . . . . 0.439 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.43 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . 0.439 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.43 ' C ' ' O ' ' A' ' 501' ' ' THR . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 11.1 m -49.8 -42.51 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -48.32 -44.49 27.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.423 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -49.95 -58.72 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.7 -61.67 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.91 169.96 3.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -170.45 116.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -150.95 -56.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -159.24 116.84 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -173.49 136.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 516' ' ' LYS . 8.0 p -59.9 139.25 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.101 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . 0.419 ' N ' HG23 ' A' ' 515' ' ' VAL . 21.8 ttpt -121.65 149.52 43.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 m -47.04 137.65 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -156.12 70.99 0.27 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 166.1 28.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 62.4 p -94.22 -46.5 7.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.9 p -87.93 98.06 11.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.82 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -104.03 114.03 27.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 26.1 p -158.09 150.63 22.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 136.27 92.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.9 m -143.15 111.88 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 43.3 t -98.9 147.83 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -46.87 112.31 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 48.62 79.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 122.06 8.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -121.76 155.44 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.68 142.68 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -108.4 150.89 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 163.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.24 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -77.26 143.28 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.446 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 31.7 mtt-85 -106.12 78.58 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.58 -61.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -41.8 -36.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 441' ' ' LEU . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . 0.402 ' N ' HG12 ' A' ' 440' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.536 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 454' ' ' LEU . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' A' ' 466' ' ' ILE . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.406 ' CE2' ' CG2' ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG23 ' A' ' 464' ' ' ILE . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.421 HG23 ' C ' ' A' ' 463' ' ' ASN . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.516 HD13 ' CE2' ' A' ' 455' ' ' TYR . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.608 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.488 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.608 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.406 ' CG2' ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 9.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 489' ' ' ASN . 10.1 mm-40 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 485' ' ' GLN . 87.2 m-20 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . 0.542 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.446 ' CE1' ' HD2' ' A' ' 437' ' ' ARG . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.542 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m -48.58 -35.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.69 -48.18 9.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -50.28 -54.09 23.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -47.08 -63.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -55.32 176.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . 0.456 ' HE2' ' N ' ' A' ' 512' ' ' GLY . 0.0 OUTLIER -128.64 110.44 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . 0.456 ' N ' ' HE2' ' A' ' 511' ' ' LYS . . . 99.09 79.1 1.43 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 42.52 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -153.89 135.33 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.39 143.71 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -72.34 155.2 40.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -103.06 114.45 28.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 78.72 146.13 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -17.3 37.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.282 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 63.3 m -106.62 87.69 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 15.5 t -70.75 94.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.859 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.521 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.8 m -143.71 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.0 t -153.23 164.89 37.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 144.24 -174.04 24.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 48.8 m -108.29 96.74 6.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.0 t -44.79 138.6 3.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -99.37 118.64 6.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -161.8 145.88 11.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 1.1 4.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.686 2.258 . . . . 0.0 112.342 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.55 168.94 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.0 104.49 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.86 139.83 6.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 153.79 68.28 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.674 2.25 . . . . 0.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -87.34 103.63 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.455 ' HG3' ' CE2' ' A' ' 502' ' ' TYR . 2.3 mmp_? -118.14 83.11 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -110.4 -47.75 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.08 -24.1 65.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 64.5 t-80 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.568 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.563 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . 0.547 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.421 ' C ' HG23 ' A' ' 464' ' ' ILE . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.421 HG23 ' C ' ' A' ' 463' ' ' ASN . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.626 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.486 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.626 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.537 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.547 ' HG2' ' CD1' ' A' ' 461' ' ' PHE . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.565 ' CE2' HG12 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.565 HG12 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m -79.06 -32.23 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.21 -61.15 2.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 8.8 ptmt -60.83 -53.62 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 21.2 mttt -35.27 -55.4 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 126.57 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -116.8 104.86 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -135.89 -64.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -159.34 126.24 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -171.24 131.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.48 131.81 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.62 124.35 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -98.02 114.69 26.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 81.72 66.57 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.12 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 0.0 112.374 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 26.8 t -92.15 -56.71 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.3 m -46.8 119.65 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.499 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -155.09 132.67 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.9 t -58.45 -56.8 17.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.81 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 168.24 -78.92 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 46.3 t -119.28 154.69 33.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 51.5 p -80.12 114.17 18.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 65.12 119.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -67.5 125.6 23.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.459 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 1.42 4.48 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.9 155.41 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 53.3 mt -51.86 172.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -48.64 142.69 8.54 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 146.52 60.14 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.658 2.239 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -112.81 177.48 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' ARG . . . . . 0.563 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 55.1 mtt-85 60.82 47.59 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -55.08 7.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -44.98 -30.9 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' HIS . . . . . 0.793 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 46.3 t-80 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' VAL . . . . . . . . . . . . . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' PHE . . . . . 0.559 ' CE2' ' HB2' ' A' ' 474' ' ' ALA . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LEU . . . . . 0.473 HD22 ' N ' ' A' ' 454' ' ' LEU . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 466' ' ' ILE . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' PHE . . . . . 0.413 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' GLY . . . . . . . . . . . . . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.418 ' C ' HG23 ' A' ' 464' ' ' ILE . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' ILE . . . . . 0.418 HG23 ' C ' ' A' ' 463' ' ' ASN . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' ILE . . . . . 0.621 ' CD1' ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' ALA . . . . . 0.559 ' HB2' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' PHE . . . . . 0.621 ' CD2' ' CD1' ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' VAL . . . . . 0.413 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 39.0 m-20 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' TYR . . . . . 0.439 ' CD2' HD21 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ILE . . . . . . . . . . . . . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' TYR . . . . . 0.563 ' CE1' ' HD2' ' A' ' 437' ' ' ARG . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' TYR . . . . . 0.793 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' VAL . . . . . 0.562 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m -56.83 -40.44 71.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -37.01 -44.48 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 508' ' ' LYS . 2.7 mptp? -65.83 -68.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.98 -57.74 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -64.11 97.12 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -169.34 117.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -102.83 -134.68 8.44 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.467 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -120.9 84.12 2.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -173.49 124.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.52 137.87 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -81.55 127.4 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -118.9 151.83 37.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 130.47 144.96 5.63 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 114.55 3.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 2.5 t -115.86 170.41 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 1.2 t -173.76 177.45 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 478' ' ' LEU . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.705 ' CE1' ' CZ ' ' A' ' 505' ' ' TYR . 23.9 t60 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 499' ' ' ILE . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.409 HG22 ' HD2' ' A' ' 455' ' ' TYR . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 1.033 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.409 ' HD2' HG22 ' A' ' 451' ' ' THR . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.59 ' CE2' HG11 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.59 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 441' ' ' LEU . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 488' ' ' VAL . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 484' ' ' VAL . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.414 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 443' ' ' VAL . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 506' ' ' VAL . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.705 ' CZ ' ' CE1' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 502' ' ' TYR . 30.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 7.6 p80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.653 HD21 HG22 ' A' ' 484' ' ' VAL . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.4 ' CE1' HG23 ' A' ' 444' ' ' THR . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.726 HG22 HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 444' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 442' ' ' HIS . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.664 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.484 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.664 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' TRP . . . . . 0.484 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.908 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.908 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 483' ' ' GLN . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.535 ' HB2' HD13 ' A' ' 478' ' ' LEU . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.653 HG22 HD21 ' A' ' 441' ' ' LEU . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 2.4 mp0 -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 484' ' ' VAL . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.467 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.696 ' CE2' HG11 ' A' ' 506' ' ' VAL . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 503' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.696 HG11 ' CE2' ' A' ' 502' ' ' TYR . 30.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 499' ' ' ILE . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.593 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.977 HD11 ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.892 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.892 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.988 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 464' ' ' ILE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' A' ' 483' ' ' GLN . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.448 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.442 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.977 ' CE2' HD11 ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.685 HG12 HG22 ' A' ' 443' ' ' VAL . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 500' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.478 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.643 ' CE2' HG11 ' A' ' 506' ' ' VAL . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 502' ' ' TYR . 24.9 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.818 0.342 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.488 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 499' ' ' ILE . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.989 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.989 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.607 ' CE2' HG11 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.46 ' OD1' HG23 ' A' ' 472' ' ' THR . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 471' ' ' ASP . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.952 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.607 HG11 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 483' ' ' GLN . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.635 ' OE1' HD22 ' A' ' 478' ' ' LEU . 27.2 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 488' ' ' VAL . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 484' ' ' VAL . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.614 HG12 HG13 ' A' ' 443' ' ' VAL . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 501' ' ' THR . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.9 p80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.577 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 80.3 t60 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.907 ' CE1' HG11 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ASP . . . . . 0.451 ' CG ' HG23 ' A' ' 472' ' ' THR . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 472' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 471' ' ' ASP . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 1.04 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.907 HG11 ' CE1' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 483' ' ' GLN . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.798 ' HB3' HD13 ' A' ' 478' ' ' LEU . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 488' ' ' VAL . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 443' ' ' VAL . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 500' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 3.0 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.577 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 439' ' ' HIS . . . . . 0.477 ' ND1' HG23 ' A' ' 440' ' ' VAL . 5.8 p80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.337 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.477 HG23 ' ND1' ' A' ' 439' ' ' HIS . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 484' ' ' VAL . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.828 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.973 HD11 ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' ASP . . . . . 0.795 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.973 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.633 HD22 ' OE1' ' A' ' 483' ' ' GLN . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.633 ' OE1' HD22 ' A' ' 478' ' ' LEU . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.498 HG13 HD21 ' A' ' 441' ' ' LEU . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.557 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 506' ' ' VAL . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 502' ' ' TYR . 29.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.7 p80 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.736 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 56.5 t60 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.68 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.68 HG23 ' O ' ' A' ' 462' ' ' GLY . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.746 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.48 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 488' ' ' VAL . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 484' ' ' VAL . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 443' ' ' VAL . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.736 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 502' ' ' TYR . 20.9 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.7 p80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 484' ' ' VAL . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.734 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 38.2 t60 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.659 HG22 HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.458 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.831 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.802 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' TRP . . . . . 0.458 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.974 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.974 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.831 HG11 ' CE2' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 483' ' ' GLN . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.461 ' HB2' HD13 ' A' ' 478' ' ' LEU . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 441' ' ' LEU . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 484' ' ' VAL . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 457' ' ' LEU . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 443' ' ' VAL . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 500' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.734 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 502' ' ' TYR . 34.3 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.848 0.356 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 484' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 499' ' ' ILE . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 455' ' ' TYR . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 445' ' ' PHE . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.904 ' CE2' HG11 ' A' ' 476' ' ' VAL . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.845 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 462' ' ' GLY . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 1.009 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.904 HG11 ' CE2' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.583 HD22 ' OE1' ' A' ' 483' ' ' GLN . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.583 ' OE1' HD22 ' A' ' 478' ' ' LEU . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 484' ' ' VAL . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.469 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 443' ' ' VAL . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.938 ' CE2' HG11 ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.938 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.5 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 478' ' ' LEU . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 499' ' ' ILE . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 462' ' ' GLY . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.948 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 470' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.948 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 441' ' ' LEU . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.614 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 443' ' ' VAL . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.962 ' O ' HG22 ' A' ' 506' ' ' VAL . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 503' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.962 HG22 ' O ' ' A' ' 502' ' ' TYR . 12.6 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 499' ' ' ILE . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 476' ' ' VAL . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.896 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.896 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.687 HG23 HG22 ' A' ' 443' ' ' VAL . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.491 ' O ' HG22 ' A' ' 506' ' ' VAL . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 502' ' ' TYR . 5.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.8 p80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 484' ' ' VAL . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.539 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 43.5 t60 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 499' ' ' ILE . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.526 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.49 HG13 HD21 ' A' ' 441' ' ' LEU . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.484 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 443' ' ' VAL . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.874 ' CE2' HG11 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.62 HD21 HG22 ' A' ' 484' ' ' VAL . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 499' ' ' ILE . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.663 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.852 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.666 HD12 ' CE2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.895 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.852 HG21 ' CE2' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 483' ' ' GLN . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.552 ' CB ' HD13 ' A' ' 478' ' ' LEU . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 488' ' ' VAL . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 484' ' ' VAL . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 443' ' ' VAL . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.604 ' O ' HG22 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 502' ' ' TYR . 19.8 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.1 p80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 440' ' ' VAL . . . . . 0.435 HG11 ' HD1' ' A' ' 502' ' ' TYR . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 484' ' ' VAL . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.643 HG22 HG23 ' A' ' 499' ' ' ILE . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.771 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.808 HG22 ' OD1' ' A' ' 470' ' ' ASP . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' ASP . . . . . 0.808 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 483' ' ' GLN . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.612 ' CB ' HD13 ' A' ' 478' ' ' LEU . 52.3 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 490' ' ' THR . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.559 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 443' ' ' VAL . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.435 ' HD1' HG11 ' A' ' 440' ' ' VAL . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.424 HG11 ' CE2' ' A' ' 502' ' ' TYR . 31.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 478' ' ' LEU . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 499' ' ' ILE . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 1.001 ' CE2' HG11 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 1.001 HG11 ' CE2' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 441' ' ' LEU . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 484' ' ' VAL . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 441' ' ' LEU . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.462 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 443' ' ' VAL . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 502' ' ' TYR . 27.5 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.1 p80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.849 0.356 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 499' ' ' ILE . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.464 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.739 ' CE2' HG21 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' TRP . . . . . 0.464 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.905 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' PRO . . . . . 0.503 ' HA ' HG23 ' A' ' 484' ' ' VAL . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.504 ' HB2' HD13 ' A' ' 478' ' ' LEU . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 488' ' ' VAL . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.463 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.531 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.691 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.691 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 484' ' ' VAL . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' THR . . . . . 0.454 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.784 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 454' ' ' LEU . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' TRP . . . . . 0.454 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.891 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.891 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.784 HG11 ' CE1' ' A' ' 458' ' ' PHE . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.558 HD13 ' CB ' ' A' ' 483' ' ' GLN . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.558 ' CB ' HD13 ' A' ' 478' ' ' LEU . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 488' ' ' VAL . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 484' ' ' VAL . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.451 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.444 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 498' ' ' ARG . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 443' ' ' VAL . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 502' ' ' TYR . 11.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.505 HD21 HG13 ' A' ' 484' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 499' ' ' ILE . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.668 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.668 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.608 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.903 ' CE2' HG21 ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.794 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 1.003 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 1.003 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.903 HG21 ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 483' ' ' GLN . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 12.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.505 HG13 HD21 ' A' ' 441' ' ' LEU . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 9.3 mm100 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 484' ' ' VAL . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 14.6 m120 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.608 ' CE2' HD11 ' A' ' 457' ' ' LEU . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 443' ' ' VAL . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 500' ' ' GLN . . . . . 0.585 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 501' ' ' THR . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.585 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.816 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 13.5 t60 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 499' ' ' ILE . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.635 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.944 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 470' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.944 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 483' ' ' GLN . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.604 ' HB2' HD13 ' A' ' 478' ' ' LEU . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 486' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 494' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 443' ' ' VAL . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 503' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.816 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.4 p80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 478' ' ' LEU . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 442' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 83.0 t60 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 443' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 499' ' ' ILE . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 454' ' ' LEU . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' LEU . . . . . 0.8 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 455' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' PHE . . . . . 0.702 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' ALA . . . . . 0.46 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 441' ' ' LEU . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 8.3 m120 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 499' ' ' ILE . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' TYR . . . . . 0.542 ' CE2' HD11 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 491' ' ' SER . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 502' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' TYR . . . . . 0.684 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 95.7 p -141.27 148.59 40.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.3 p -108.07 168.69 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.87 155.12 25.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 105.69 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 p -125.34 176.75 6.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -80.16 -157.8 15.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 155.45 -95.0 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.58 14.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.669 2.246 . . . . 0.0 112.387 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.5 170.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.2 tp -101.38 140.45 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -94.36 143.93 27.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.609 0.719 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 164.22 35.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -42.15 138.54 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 31.8 mtt180 -84.61 74.87 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.97 -47.01 7.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -55.91 -31.17 62.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 478' ' ' LEU . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.705 ' CE1' ' CZ ' ' A' ' 505' ' ' TYR . 23.9 t60 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 499' ' ' ILE . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.409 HG22 ' HD2' ' A' ' 455' ' ' TYR . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 1.033 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.409 ' HD2' HG22 ' A' ' 451' ' ' THR . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.59 ' CE2' HG11 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.59 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 441' ' ' LEU . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 488' ' ' VAL . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 484' ' ' VAL . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.414 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 443' ' ' VAL . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.567 ' CE2' ' HD2' ' A' ' 437' ' ' ARG . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.705 ' CZ ' ' CE1' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 502' ' ' TYR . 30.7 m -52.39 -42.57 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -36.23 -49.63 1.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.417 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -56.86 -55.07 39.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -54.87 -61.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -123.95 144.82 49.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -139.4 109.53 6.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -68.33 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -127.31 84.19 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 514' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 515' ' ' VAL . 22.2 tm0? -165.24 125.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 514' ' ' GLN . 11.0 p -39.41 141.96 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.108 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 516' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 516' ' ' LYS . 0.0 OUTLIER -110.92 152.78 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.6 t -145.22 145.89 31.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -122.05 83.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.75 19.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 60.3 p -117.41 171.48 7.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.0 p -39.21 108.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 28.0 p -158.06 124.22 4.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 44.0 m -88.0 160.52 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.41 -123.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.7 m -73.25 122.96 22.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 45.8 t -111.75 136.69 50.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 88.96 153.13 26.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -145.64 87.08 0.17 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.535 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.08 32.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 0.0 112.318 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.32 177.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.65 65.15 3.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.89 144.09 47.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 145.73 57.58 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.689 2.259 . . . . 0.0 112.316 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.0 106.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.502 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 45.3 mtt180 60.68 37.93 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.85 -59.56 4.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -42.48 -27.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.653 HD21 HG22 ' A' ' 484' ' ' VAL . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.4 ' CE1' HG23 ' A' ' 444' ' ' THR . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.726 HG22 HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 444' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 442' ' ' HIS . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.664 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.484 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.664 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' TRP . . . . . 0.484 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.908 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.908 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 483' ' ' GLN . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.535 ' HB2' HD13 ' A' ' 478' ' ' LEU . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.653 HG22 HD21 ' A' ' 441' ' ' LEU . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 2.4 mp0 -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 484' ' ' VAL . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.467 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.696 ' CE2' HG11 ' A' ' 506' ' ' VAL . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.696 HG11 ' CE2' ' A' ' 502' ' ' TYR . 30.9 m -51.24 -33.45 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.52 -63.13 1.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -73.95 -49.19 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -46.68 -68.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.865 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.38 116.78 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -150.49 122.01 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -144.35 -141.27 3.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -121.83 87.5 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.727 0.298 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -174.02 132.02 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.17 133.33 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -54.72 141.33 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 74.7 p -72.66 127.71 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 49.98 83.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 178.72 4.29 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 90.9 p -163.09 115.96 1.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.2 t -98.32 130.99 44.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -112.37 102.76 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.3 m -100.29 127.75 46.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -154.46 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 28.3 p -156.86 117.24 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.9 m -136.89 117.78 14.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 52.38 177.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 140.16 -80.94 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -77.44 171.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.92 111.18 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -116.46 150.76 46.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.722 . . . . 0.0 110.94 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 156.57 63.0 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -96.97 41.32 1.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 61.6 mtt-85 -64.73 78.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.54 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -42.8 -32.21 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 499' ' ' ILE . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.593 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.977 HD11 ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.892 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.892 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.988 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 464' ' ' ILE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' A' ' 483' ' ' GLN . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.448 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.442 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.977 ' CE2' HD11 ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.685 HG12 HG22 ' A' ' 443' ' ' VAL . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 500' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.478 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.643 ' CE2' HG11 ' A' ' 506' ' ' VAL . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 502' ' ' TYR . 24.9 m -50.26 -48.48 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -36.36 -56.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 509' ' ' LYS . 27.7 mmtp -68.66 -50.4 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 508' ' ' LYS . 37.4 tttt -36.47 -57.99 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -91.57 129.56 37.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 40.98 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 73.54 100.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -121.78 41.9 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 514' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 515' ' ' VAL . 39.9 tt0 -166.25 150.41 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 514' ' ' GLN . 34.1 m -48.45 164.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -113.12 99.09 7.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -85.63 108.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.828 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 102.48 83.31 1.71 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.66 57.56 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 75.8 m -93.34 -51.06 5.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.5 m -101.91 96.97 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -127.42 171.11 11.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 27.6 t -96.59 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.843 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 134.72 -144.73 16.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.5 p -157.42 151.59 24.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.89 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 18.4 p -132.78 159.68 39.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -60.04 -166.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -141.78 145.64 16.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 1.48 4.4 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.59 140.08 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -47.0 159.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 434' ' ' GLN . 0.0 OUTLIER -121.78 143.61 38.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.9 Cg_endo -69.73 -175.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.239 . . . . 0.0 112.382 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 435' ' ' PRO . 7.3 mmpt? -35.91 150.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.569 ' HD3' ' CD2' ' A' ' 502' ' ' TYR . 0.0 OUTLIER -126.26 40.23 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.06 -45.89 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -54.69 -18.62 4.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.488 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 499' ' ' ILE . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.989 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.989 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.607 ' CE2' HG11 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.46 ' OD1' HG23 ' A' ' 472' ' ' THR . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 471' ' ' ASP . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.952 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.607 HG11 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.635 HD22 ' OE1' ' A' ' 483' ' ' GLN . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.635 ' OE1' HD22 ' A' ' 478' ' ' LEU . 27.2 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 488' ' ' VAL . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 484' ' ' VAL . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.614 HG12 HG13 ' A' ' 443' ' ' VAL . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.569 ' CD2' ' HD3' ' A' ' 437' ' ' ARG . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m -48.28 -22.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.53 -54.95 30.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -39.75 -51.76 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -55.14 -71.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -61.84 159.42 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -134.89 107.5 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 159.82 47.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -168.33 110.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -154.12 129.84 10.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.8 155.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -58.72 92.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.7 m -135.86 156.92 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -129.27 142.35 13.48 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.86 58.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.347 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.6 p -173.11 113.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 7.7 m -143.95 175.7 9.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.52 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.8 m -128.68 156.97 42.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 43.5 p -96.18 115.04 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -165.75 121.84 1.03 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 t -120.85 110.28 16.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 44.7 t -143.2 115.8 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -150.46 107.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -81.23 -91.24 0.54 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 109.59 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 29.8 mt -145.24 166.25 26.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -70.39 144.04 91.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 110.92 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 153.66 68.99 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 145.86 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.556 ' HB2' ' CD2' ' A' ' 502' ' ' TYR . 33.5 mtt180 62.83 44.46 6.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -57.27 -58.71 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -43.32 -36.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.577 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 80.3 t60 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.907 ' CE1' HG11 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ASP . . . . . 0.451 ' CG ' HG23 ' A' ' 472' ' ' THR . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 472' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 471' ' ' ASP . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 1.04 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.907 HG11 ' CE1' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 483' ' ' GLN . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.798 ' HB3' HD13 ' A' ' 478' ' ' LEU . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 488' ' ' VAL . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 443' ' ' VAL . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 500' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 3.0 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 437' ' ' ARG . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.577 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.477 ' O ' ' CG ' ' A' ' 510' ' ' GLN . 10.9 m -53.7 -38.36 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -58.06 -41.13 94.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.38 -63.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -44.2 -37.88 3.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.898 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 510' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 506' ' ' VAL . 25.7 mm-40 -60.65 151.84 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -135.99 106.73 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -114.61 -142.19 7.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -166.96 121.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -171.65 134.55 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.96 144.92 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -57.53 116.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.7 t -60.76 120.73 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 98.62 157.07 29.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -47.55 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 73.1 m -114.47 140.63 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.1 p -71.09 126.09 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.539 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 8.4 t -153.42 173.52 15.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 53.7 p -140.8 169.6 17.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 133.06 159.48 9.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 22.2 t -166.15 130.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 87.6 p -103.59 100.32 10.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -69.6 140.55 33.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -146.44 173.15 26.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 112.09 2.98 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.681 2.254 . . . . 0.0 112.365 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -164.63 164.24 21.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.7 mp -79.77 103.36 9.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -96.2 151.24 38.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.619 0.724 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 160.28 50.28 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -84.12 47.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 502' ' ' TYR . 10.9 mmt180 -87.53 41.03 0.96 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -80.13 -58.67 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.477 ' ND1' HG23 ' A' ' 440' ' ' VAL . 5.8 p80 -40.31 -39.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.477 HG23 ' ND1' ' A' ' 439' ' ' HIS . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 484' ' ' VAL . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.828 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.973 HD11 ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' ASP . . . . . 0.795 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.973 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.633 HD22 ' OE1' ' A' ' 483' ' ' GLN . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.633 ' OE1' HD22 ' A' ' 478' ' ' LEU . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.498 HG13 HD21 ' A' ' 441' ' ' LEU . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.557 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 506' ' ' VAL . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.468 ' CZ ' ' HD2' ' A' ' 509' ' ' LYS . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 502' ' ' TYR . 29.6 m -49.21 -38.46 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -52.59 -40.86 55.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -62.95 -59.67 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 505' ' ' TYR . 25.6 mtpt -40.87 -72.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -61.16 156.12 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -85.87 8.17 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 56.79 -95.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -173.7 110.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -150.84 128.35 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.38 162.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -95.64 94.68 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.1 t -149.22 120.93 8.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 50.65 -179.28 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.22 28.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.662 2.241 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 31.0 t -170.38 124.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.8 m -88.93 -59.21 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 91.9 p -80.23 140.48 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.382 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.5 t -163.37 177.55 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.23 163.47 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -63.6 116.63 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.5 m -89.39 102.71 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -45.67 127.71 8.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 119.74 82.78 0.77 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.505 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 143.67 51.48 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.342 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.08 144.11 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 434' ' ' GLN . 56.9 mt -51.29 173.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' GLN . . . . . 0.427 ' CD ' ' H ' ' A' ' 434' ' ' GLN . 25.8 mp0 -35.93 144.11 0.26 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.546 0.688 . . . . 0.0 110.931 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 146.39 60.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -53.43 141.44 24.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 63.32 42.0 7.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.41 -51.74 27.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -47.36 -20.64 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.736 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 56.5 t60 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.68 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.68 HG23 ' O ' ' A' ' 462' ' ' GLY . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.746 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.48 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 488' ' ' VAL . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 484' ' ' VAL . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 443' ' ' VAL . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.736 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 502' ' ' TYR . 20.9 m -61.91 -36.14 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.16 -53.46 4.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -75.35 -49.69 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.954 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -38.89 -55.29 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.8 169.15 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.43 41.16 2.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -95.37 91.77 1.39 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.537 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.25 116.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -159.78 149.35 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.0 145.97 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -109.25 160.62 15.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.4 p -162.94 145.17 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 172.29 -160.4 31.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -8.13 22.81 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.252 . . . . 0.0 112.361 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 10.8 t -40.01 121.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 2.9 t -86.13 139.09 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.2 m -102.8 149.76 24.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.8 t -171.87 133.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 160.8 156.74 8.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.2 m -87.43 173.25 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -99.06 -46.72 5.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -91.11 -122.48 2.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 145.86 -95.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 108.16 2.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.274 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -168.41 159.47 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 82.4 mt -148.53 122.82 9.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -72.06 150.32 92.43 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 172.39 12.73 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.732 2.288 . . . . 0.0 112.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -49.65 128.34 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.697 ' HD3' HG21 ' A' ' 440' ' ' VAL . 21.2 mtt180 -112.13 82.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -86.6 -52.73 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.494 ' CD2' HG23 ' A' ' 440' ' ' VAL . 9.0 p-80 -50.71 -36.77 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.697 HG21 ' HD3' ' A' ' 437' ' ' ARG . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 484' ' ' VAL . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.734 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 38.2 t60 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.659 HG22 HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.458 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.831 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.802 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' TRP . . . . . 0.458 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.974 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.974 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.831 HG11 ' CE2' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 483' ' ' GLN . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.461 ' HB2' HD13 ' A' ' 478' ' ' LEU . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 441' ' ' LEU . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 484' ' ' VAL . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 457' ' ' LEU . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 443' ' ' VAL . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.734 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 502' ' ' TYR . 34.3 m -58.27 -30.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.05 -62.78 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -50.76 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -37.88 -52.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -54.75 173.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -111.99 84.78 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -176.88 127.26 1.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -129.49 87.99 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.755 0.312 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.61 124.71 3.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.76 146.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -54.99 110.57 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.3 t -117.98 151.13 38.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -142.55 72.9 0.37 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 94.17 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.376 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 33.2 t -108.22 154.14 22.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.3 m -92.19 153.41 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.2 t -145.91 140.95 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.364 . . . . 0.0 110.925 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 50.9 m -120.93 124.45 44.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.51 23.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 58.8 m -85.92 92.96 8.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 40.9 m -52.01 176.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -163.61 -82.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.17 21.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 113.41 3.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.11 166.29 11.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 59.9 mt -59.88 86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.13 151.96 62.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -178.52 2.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -85.34 90.63 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 25.4 mtt-85 -125.82 80.49 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -92.31 -51.65 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.411 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.3 p-80 -48.97 -37.65 20.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 439' ' ' HIS . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 484' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 499' ' ' ILE . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 455' ' ' TYR . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 445' ' ' PHE . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.904 ' CE2' HG11 ' A' ' 476' ' ' VAL . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.845 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 462' ' ' GLY . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 1.009 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.904 HG11 ' CE2' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.583 HD22 ' OE1' ' A' ' 483' ' ' GLN . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.583 ' OE1' HD22 ' A' ' 478' ' ' LEU . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 484' ' ' VAL . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.469 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 443' ' ' VAL . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.938 ' CE2' HG11 ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.938 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.5 m -59.17 -41.0 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -54.01 -47.14 67.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -70.04 -56.87 5.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.349 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -44.21 -48.33 9.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.28 171.89 12.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -150.01 123.2 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -60.6 -143.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -123.46 42.58 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -162.58 146.27 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.42 144.19 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -44.4 135.19 4.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.2 t -160.17 140.83 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 131.45 84.99 0.31 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.51 57.65 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.8 m -140.37 113.55 8.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 522' ' ' GLY . 58.2 m -122.78 155.09 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 522' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 521' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 32.0 t -97.14 100.25 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 84.8 p -133.7 130.27 37.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -126.51 -173.39 13.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.1 t -91.37 141.14 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 110.849 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.6 p -87.88 120.88 29.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.835 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -116.46 90.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.08 83.32 1.1 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 102.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.701 2.268 . . . . 0.0 112.348 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.4 168.52 5.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.62 89.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -51.45 142.97 20.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -174.85 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.54 33.46 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.56 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 29.7 mtt180 -78.42 84.43 4.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -100.39 -45.23 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -54.36 -30.09 50.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.5 HG21 ' HD3' ' A' ' 437' ' ' ARG . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 478' ' ' LEU . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 499' ' ' ILE . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 462' ' ' GLY . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.948 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 470' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.948 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 441' ' ' LEU . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.614 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 443' ' ' VAL . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.962 ' O ' HG22 ' A' ' 506' ' ' VAL . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.962 HG22 ' O ' ' A' ' 502' ' ' TYR . 12.6 m -56.05 -23.19 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -81.28 -34.76 25.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -89.65 -18.02 27.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.456 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -91.65 -33.86 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -71.36 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -158.3 113.71 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -100.94 -143.85 14.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -131.5 80.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -164.05 130.82 3.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.44 138.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -60.63 137.35 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.7 p -101.83 172.74 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -103.07 146.21 16.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 137.32 35.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 80.7 p -46.84 124.12 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 3.4 t -58.17 157.46 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.9 m -146.25 164.6 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 110.811 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.1 t -147.59 156.55 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.06 149.23 34.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 70.3 m -91.65 173.64 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 m -109.0 98.53 7.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -79.61 54.58 4.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.45 1.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 141.63 45.66 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.688 2.259 . . . . 0.0 112.338 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.421 ' O ' ' NE2' ' A' ' 434' ' ' GLN . 3.3 p30 -56.73 166.42 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.94 97.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 432' ' ' ASP . 7.3 mp0 -41.33 151.55 0.29 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.563 0.697 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -179.19 2.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.668 2.245 . . . . 0.0 112.303 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -101.33 42.37 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.548 ' CB ' ' CD2' ' A' ' 502' ' ' TYR . 24.0 mmt180 -110.29 74.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -106.11 -43.47 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.2 p-80 -60.8 -36.82 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 439' ' ' HIS . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 499' ' ' ILE . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 476' ' ' VAL . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.896 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.896 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.687 HG23 HG22 ' A' ' 443' ' ' VAL . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.548 ' CD2' ' CB ' ' A' ' 437' ' ' ARG . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 502' ' ' TYR . 5.7 m -51.93 -26.79 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.94 -44.28 97.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.527 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -41.79 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -56.47 -58.31 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -80.97 121.99 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -81.26 42.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 72.37 125.51 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -132.18 89.7 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -168.07 125.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.57 159.28 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -102.43 102.81 13.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.2 t -59.55 137.67 57.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 121.69 85.31 0.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.9 Cg_endo -69.77 136.57 33.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 519' ' ' PRO . 53.9 p -34.66 138.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.0 p -81.46 147.05 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 20.9 m -118.47 92.15 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.4 t -138.05 143.16 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.48 -115.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.4 m -160.28 142.45 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -113.04 169.93 8.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 121.22 42.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -54.73 164.17 3.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.47 4.4 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -80.0 165.42 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.79 102.94 15.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -80.99 149.86 67.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 154.54 67.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -74.67 110.76 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 502' ' ' TYR . 16.2 mmt85 -124.11 43.84 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.59 -60.3 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -41.47 -32.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 484' ' ' VAL . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.539 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 43.5 t60 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 499' ' ' ILE . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.526 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.49 HG13 HD21 ' A' ' 441' ' ' LEU . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.484 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 443' ' ' VAL . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.874 ' CE2' HG11 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m -52.27 -29.75 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -43.43 -63.18 2.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -47.94 30.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 505' ' ' TYR . 28.2 tttm -41.48 -46.35 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.21 179.06 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -144.28 110.25 5.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.14 -141.78 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -174.91 116.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.726 0.298 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -164.77 123.77 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 93.6 t -127.13 140.68 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -171.42 120.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 13.3 t -88.84 92.86 9.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -126.72 88.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -174.11 0.85 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.336 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 71.7 m -106.04 116.04 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 42.1 t -101.76 165.04 11.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.5 p -53.05 152.98 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.9 p -165.02 139.76 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 149.39 159.17 8.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.4 p -148.2 137.53 22.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 t -86.41 97.62 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 50.57 -126.2 24.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 124.49 74.5 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 1.55 4.35 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -78.33 154.07 31.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 10.5 mt -106.79 147.71 29.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -119.03 150.92 49.73 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.6 Cg_endo -69.77 -174.51 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 435' ' ' PRO . 20.3 mmtt -34.93 146.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 -108.61 80.0 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.18 -55.76 3.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -43.78 -36.85 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.62 HD21 HG22 ' A' ' 484' ' ' VAL . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 499' ' ' ILE . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.663 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.852 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.666 HD12 ' CE2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.895 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.852 HG21 ' CE2' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 483' ' ' GLN . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.552 ' CB ' HD13 ' A' ' 478' ' ' LEU . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 488' ' ' VAL . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 484' ' ' VAL . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 443' ' ' VAL . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.604 ' O ' HG22 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 502' ' ' TYR . 19.8 m -65.83 -38.11 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.19 -48.01 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 0.0 OUTLIER -82.55 -48.66 10.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 11.4 tptp -35.75 -58.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 510' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 510' ' ' GLN . 11.9 pt20 -80.07 90.52 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -65.73 86.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -91.54 -134.23 6.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.459 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -125.47 45.56 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 110.885 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -160.42 156.05 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 46.5 t -120.47 143.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -38.18 126.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.9 m -101.19 131.34 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 139.18 70.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 120.25 7.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.76 2.307 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 65.7 p -137.89 111.72 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 6.0 t -44.47 148.65 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.515 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 50.0 m -119.09 167.78 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.5 t -117.18 115.92 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 132.09 69.18 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.0 t -56.29 145.14 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.845 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.3 p -88.85 84.27 6.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 54.1 -114.03 3.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.4 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.53 4.37 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -91.88 150.96 20.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.12 92.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -73.88 143.99 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.584 0.707 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 165.45 30.88 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -94.45 38.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.503 ' NH1' ' CE2' ' A' ' 502' ' ' TYR . 37.3 mtt85 -84.18 79.15 9.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.31 -46.95 7.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.454 ' CD2' HG23 ' A' ' 440' ' ' VAL . 5.1 p-80 -54.82 -33.72 61.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 439' ' ' HIS . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 484' ' ' VAL . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.643 HG22 HG23 ' A' ' 499' ' ' ILE . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.771 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.808 HG22 ' OD1' ' A' ' 470' ' ' ASP . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' ASP . . . . . 0.808 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 483' ' ' GLN . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.612 ' CB ' HD13 ' A' ' 478' ' ' LEU . 52.3 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 490' ' ' THR . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.559 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 443' ' ' VAL . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.503 ' CE2' ' NH1' ' A' ' 437' ' ' ARG . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 507' ' ' GLY . 31.4 m -63.82 -38.99 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.11 -65.05 0.43 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -65.72 -42.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -46.16 -64.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.06 110.92 22.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -173.48 128.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.96 -85.13 0.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -171.92 109.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 515' ' ' VAL . 21.1 tt0 -149.04 126.36 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 515' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 514' ' ' GLN . 15.0 p -37.52 142.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -92.8 136.44 33.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -166.09 166.15 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 145.56 -162.9 28.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 2.28 3.63 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.25 . . . . 0.0 112.363 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 68.5 m -73.04 142.98 47.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.2 t -164.28 164.66 22.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 t -46.6 -58.96 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 79.8 p -56.19 156.42 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -164.81 50.37 0.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 71.9 p -166.3 161.37 16.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 56.1 p -93.81 169.12 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -111.45 42.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -135.57 -158.71 8.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.32 5.02 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 0.0 112.342 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -143.22 170.45 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 tp -104.4 93.28 4.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.71 152.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 175.91 7.52 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -92.29 42.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -112.89 52.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -90.09 -48.97 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' HIS . . . . . 0.421 ' CD2' HG23 ' A' ' 440' ' ' VAL . 7.8 p-80 -50.25 -27.37 5.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 439' ' ' HIS . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 478' ' ' LEU . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 499' ' ' ILE . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 1.001 ' CE2' HG11 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 1.001 HG11 ' CE2' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 441' ' ' LEU . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 484' ' ' VAL . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 441' ' ' LEU . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.462 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 443' ' ' VAL . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 502' ' ' TYR . 27.5 m -59.09 -39.27 78.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -41.14 -58.18 2.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -47.74 -41.29 22.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -64.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -73.37 111.21 8.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -173.22 112.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -119.65 -107.44 2.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -121.29 40.77 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -149.23 127.94 12.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.6 176.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -79.54 111.6 15.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 1.6 t -114.38 161.89 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.81 16.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.7 Cg_endo -69.78 -49.31 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 519' ' ' PRO . 83.8 p -34.74 146.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.5 p -50.92 -179.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.1 t -103.98 137.06 42.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.2 t -151.19 175.46 12.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -128.16 176.19 18.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.5 t -126.32 85.59 2.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.9 m 50.69 42.52 27.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -177.14 -156.4 15.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 143.41 -161.59 27.66 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 432' ' ' ASP . 53.7 Cg_endo -69.77 174.46 9.48 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.677 2.252 . . . . 0.0 112.358 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 431' ' ' PRO . 30.9 t0 -36.22 125.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.6 tp -113.06 92.26 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.1 143.96 86.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.604 0.716 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 147.34 62.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 0.0 112.355 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -173.33 129.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 53.52 45.5 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.87 -54.78 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -45.13 -30.37 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 499' ' ' ILE . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.464 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.739 ' CE2' HG21 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' TRP . . . . . 0.464 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.905 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.503 ' HA ' HG23 ' A' ' 484' ' ' VAL . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.504 ' HB2' HD13 ' A' ' 478' ' ' LEU . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 488' ' ' VAL . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.463 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.531 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.691 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.691 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m -69.93 -44.02 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -42.23 -49.69 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.445 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.38 -52.42 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.25 -36.95 71.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -66.38 128.17 35.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -132.72 98.67 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -111.4 -133.17 6.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -170.37 112.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -155.09 134.34 12.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.29 171.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -174.14 141.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.8 m -70.48 172.96 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -82.72 141.37 21.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -42.16 3.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.262 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 43.8 p -109.11 146.58 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.0 m -125.33 -47.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 63.2 p -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 8.4 t -65.05 -45.7 84.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.95 -98.62 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 4.0 m 52.79 44.66 30.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.843 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.7 p -70.07 -44.4 69.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -108.35 -150.48 14.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 52.89 83.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 131.77 21.95 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.34 156.14 16.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.18 39.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -80.64 154.02 73.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.8 Cg_endo -69.66 153.27 69.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.354 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.73 ' HD2' ' HB2' ' A' ' 503' ' ' ALA . 17.7 pttp -35.8 145.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.458 ' HB3' ' CG2' ' A' ' 440' ' ' VAL . 1.0 OUTLIER -67.63 90.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.27 -58.32 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -47.15 -34.77 6.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 437' ' ' ARG . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 484' ' ' VAL . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' THR . . . . . 0.454 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.784 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 454' ' ' LEU . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' TRP . . . . . 0.454 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.891 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.891 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.784 HG11 ' CE1' ' A' ' 458' ' ' PHE . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.558 HD13 ' CB ' ' A' ' 483' ' ' GLN . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.558 ' CB ' HD13 ' A' ' 478' ' ' LEU . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 488' ' ' VAL . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 484' ' ' VAL . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.451 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.444 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 498' ' ' ARG . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 443' ' ' VAL . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 436' ' ' LYS . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 502' ' ' TYR . 11.1 m -49.8 -42.51 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -48.32 -44.49 27.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -49.95 -58.72 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.7 -61.67 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.91 169.96 3.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -170.45 116.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -150.95 -56.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -159.24 116.84 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -173.49 136.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.9 139.25 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.101 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -121.65 149.52 43.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 m -47.04 137.65 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -156.12 70.99 0.27 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 166.1 28.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 62.4 p -94.22 -46.5 7.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.9 p -87.93 98.06 11.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.82 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -104.03 114.03 27.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 26.1 p -158.09 150.63 22.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 136.27 92.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.9 m -143.15 111.88 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 43.3 t -98.9 147.83 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -46.87 112.31 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 48.62 79.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 122.06 8.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -121.76 155.44 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.68 142.68 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -108.4 150.89 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 163.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.24 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -77.26 143.28 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 31.7 mtt-85 -106.12 78.58 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.58 -61.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -41.8 -36.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.505 HD21 HG13 ' A' ' 484' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 499' ' ' ILE . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.668 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.668 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.608 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.903 ' CE2' HG21 ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.794 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 1.003 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 1.003 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.903 HG21 ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 483' ' ' GLN . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 12.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.505 HG13 HD21 ' A' ' 441' ' ' LEU . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' GLN . . . . . 0.422 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 9.3 mm100 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 484' ' ' VAL . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.422 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 14.6 m120 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.608 ' CE2' HD11 ' A' ' 457' ' ' LEU . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 443' ' ' VAL . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 500' ' ' GLN . . . . . 0.585 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.463 ' CE1' ' HD2' ' A' ' 437' ' ' ARG . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.585 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m -48.58 -35.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.69 -48.18 9.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -50.28 -54.09 23.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -47.08 -63.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -55.32 176.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 512' ' ' GLY . 0.0 OUTLIER -128.64 110.44 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 512' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 511' ' ' LYS . . . 99.09 79.1 1.43 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 42.52 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -153.89 135.33 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.39 143.71 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -72.34 155.2 40.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -103.06 114.45 28.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 78.72 146.13 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -17.3 37.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.282 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 63.3 m -106.62 87.69 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 15.5 t -70.75 94.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.859 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.521 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.8 m -143.71 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.0 t -153.23 164.89 37.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 144.24 -174.04 24.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 48.8 m -108.29 96.74 6.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.0 t -44.79 138.6 3.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -99.37 118.64 6.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -161.8 145.88 11.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 1.1 4.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.686 2.258 . . . . 0.0 112.342 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.55 168.94 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.0 104.49 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.86 139.83 6.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 153.79 68.28 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.674 2.25 . . . . 0.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -87.34 103.63 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 502' ' ' TYR . 2.3 mmp_? -118.14 83.11 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -110.4 -47.75 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.08 -24.1 65.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.816 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 13.5 t60 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 499' ' ' ILE . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.635 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.944 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 470' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.944 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 483' ' ' GLN . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.604 ' HB2' HD13 ' A' ' 478' ' ' LEU . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 494' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 443' ' ' VAL . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 503' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.816 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m -79.06 -32.23 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.21 -61.15 2.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 8.8 ptmt -60.83 -53.62 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 21.2 mttt -35.27 -55.4 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 126.57 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -116.8 104.86 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -135.89 -64.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -159.34 126.24 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -171.24 131.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.48 131.81 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.62 124.35 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -98.02 114.69 26.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 81.72 66.57 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.12 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 0.0 112.374 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 26.8 t -92.15 -56.71 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.3 m -46.8 119.65 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.499 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -155.09 132.67 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.9 t -58.45 -56.8 17.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.81 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 168.24 -78.92 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 46.3 t -119.28 154.69 33.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 51.5 p -80.12 114.17 18.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 65.12 119.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -67.5 125.6 23.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.459 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 1.42 4.48 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.9 155.41 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 53.3 mt -51.86 172.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -48.64 142.69 8.54 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 146.52 60.14 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.658 2.239 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -112.81 177.48 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 55.1 mtt-85 60.82 47.59 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -55.08 7.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -44.98 -30.9 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 478' ' ' LEU . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' HIS . . . . . 0.684 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 83.0 t60 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 499' ' ' ILE . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 454' ' ' LEU . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LEU . . . . . 0.8 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 455' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' PHE . . . . . 0.702 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' ALA . . . . . 0.46 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 441' ' ' LEU . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 8.3 m120 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 499' ' ' ILE . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' TYR . . . . . 0.542 ' CE2' HD11 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 491' ' ' SER . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 502' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' TYR . . . . . 0.684 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m -56.83 -40.44 71.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -37.01 -44.48 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 508' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 508' ' ' LYS . 2.7 mptp? -65.83 -68.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.98 -57.74 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -64.11 97.12 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -169.34 117.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -102.83 -134.68 8.44 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.467 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -120.9 84.12 2.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -173.49 124.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.52 137.87 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -81.55 127.4 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -118.9 151.83 37.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 130.47 144.96 5.63 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 114.55 3.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 2.5 t -115.86 170.41 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 1.2 t -173.76 177.45 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.842 0.353 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 478' ' ' LEU . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.667 ' CD2' ' CD2' ' A' ' 505' ' ' TYR . 53.2 t-80 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 499' ' ' ILE . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.409 HG22 ' HD2' ' A' ' 455' ' ' TYR . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 1.033 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.409 ' HD2' HG22 ' A' ' 451' ' ' THR . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.59 ' CE2' HG11 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.59 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 441' ' ' LEU . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 488' ' ' VAL . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 484' ' ' VAL . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.414 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 443' ' ' VAL . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 506' ' ' VAL . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.667 ' CD2' ' CD2' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 502' ' ' TYR . 30.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.404 ' CD2' HG23 ' A' ' 440' ' ' VAL . 5.9 p-80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.829 0.347 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.404 HG23 ' CD2' ' A' ' 439' ' ' HIS . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.653 HD21 HG22 ' A' ' 484' ' ' VAL . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.4 ' CE1' HG23 ' A' ' 444' ' ' THR . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.726 HG22 HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 442' ' ' HIS . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.664 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.484 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.664 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . 0.484 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.908 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.908 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 483' ' ' GLN . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.535 ' HB2' HD13 ' A' ' 478' ' ' LEU . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.653 HG22 HD21 ' A' ' 441' ' ' LEU . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 0.8 OUTLIER -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 484' ' ' VAL . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.467 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.696 ' CE2' HG11 ' A' ' 506' ' ' VAL . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.696 HG11 ' CE2' ' A' ' 502' ' ' TYR . 30.9 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.3 p-80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 439' ' ' HIS . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 499' ' ' ILE . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.593 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.977 HD11 ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.892 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.892 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.988 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 464' ' ' ILE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' A' ' 483' ' ' GLN . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.448 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.442 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.977 ' CE2' HD11 ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.685 HG12 HG22 ' A' ' 443' ' ' VAL . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.478 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.643 ' CE2' HG11 ' A' ' 506' ' ' VAL . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 502' ' ' TYR . 24.9 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.818 0.342 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.488 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 499' ' ' ILE . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.989 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.989 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.607 ' CE2' HG11 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.46 ' OD1' HG23 ' A' ' 472' ' ' THR . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 471' ' ' ASP . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.952 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.607 HG11 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.785 HD22 ' NE2' ' A' ' 483' ' ' GLN . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.785 ' NE2' HD22 ' A' ' 478' ' ' LEU . 22.9 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 488' ' ' VAL . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 484' ' ' VAL . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.614 HG12 HG13 ' A' ' 443' ' ' VAL . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.438 ' C ' ' O ' ' A' ' 501' ' ' THR . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 440' ' ' VAL . 6.7 p-80 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.846 0.355 . . . . 0.0 110.878 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 439' ' ' HIS . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 53.1 t-80 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . 0.557 HG23 ' CE1' ' A' ' 442' ' ' HIS . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.907 ' CE1' HG11 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . 0.451 ' CG ' HG23 ' A' ' 472' ' ' THR . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 471' ' ' ASP . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 1.04 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.907 HG11 ' CE1' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 483' ' ' GLN . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.798 ' HB3' HD13 ' A' ' 478' ' ' LEU . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 488' ' ' VAL . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 443' ' ' VAL . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 15.3 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.692 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.677 ' CD2' HG23 ' A' ' 440' ' ' VAL . 7.1 p-80 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.809 0.337 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.677 HG23 ' CD2' ' A' ' 439' ' ' HIS . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 484' ' ' VAL . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.489 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 63.2 t-80 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.828 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.973 HD11 ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . 0.795 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.973 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.633 HD22 ' OE1' ' A' ' 483' ' ' GLN . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.633 ' OE1' HD22 ' A' ' 478' ' ' LEU . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.498 HG13 HD21 ' A' ' 441' ' ' LEU . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.557 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 506' ' ' VAL . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.489 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 502' ' ' TYR . 29.6 m . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.472 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.0 p-80 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.854 0.359 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 439' ' ' HIS . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.555 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 49.7 t-80 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.68 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.68 HG23 ' O ' ' A' ' 462' ' ' GLY . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.746 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.48 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 488' ' ' VAL . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 484' ' ' VAL . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 443' ' ' VAL . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.555 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 502' ' ' TYR . 20.9 m . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.494 ' CD2' HG23 ' A' ' 440' ' ' VAL . 9.0 p-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.494 HG23 ' CD2' ' A' ' 439' ' ' HIS . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 484' ' ' VAL . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.722 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 54.9 t-80 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.659 HG22 HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.458 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.831 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.802 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . 0.458 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.974 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.974 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.831 HG11 ' CE2' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 483' ' ' GLN . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.461 ' HB2' HD13 ' A' ' 478' ' ' LEU . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 441' ' ' LEU . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 484' ' ' VAL . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 457' ' ' LEU . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 443' ' ' VAL . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.722 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 502' ' ' TYR . 34.3 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.411 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.3 p-80 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.848 0.356 . . . . 0.0 110.848 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 439' ' ' HIS . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 484' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 499' ' ' ILE . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 455' ' ' TYR . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 445' ' ' PHE . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.904 ' CE2' HG11 ' A' ' 476' ' ' VAL . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.845 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 462' ' ' GLY . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 1.009 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.904 HG11 ' CE2' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.583 HD22 ' OE1' ' A' ' 483' ' ' GLN . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.583 ' OE1' HD22 ' A' ' 478' ' ' LEU . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 484' ' ' VAL . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.469 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 443' ' ' VAL . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.938 ' CE2' HG11 ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.938 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.5 m . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.857 0.36 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 478' ' ' LEU . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 499' ' ' ILE . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 462' ' ' GLY . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.948 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.948 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 441' ' ' LEU . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.614 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 443' ' ' VAL . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.962 ' O ' HG22 ' A' ' 506' ' ' VAL . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.962 HG22 ' O ' ' A' ' 502' ' ' TYR . 12.6 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.2 p-80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.903 0.382 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 439' ' ' HIS . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 499' ' ' ILE . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 476' ' ' VAL . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.896 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.896 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.687 HG23 HG22 ' A' ' 443' ' ' VAL . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.491 ' O ' HG22 ' A' ' 506' ' ' VAL . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 502' ' ' TYR . 5.7 m . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.425 ' CD2' HG23 ' A' ' 440' ' ' VAL . 3.0 p-80 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.867 0.365 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 439' ' ' HIS . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 484' ' ' VAL . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 48.4 t-80 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 499' ' ' ILE . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.526 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.49 HG13 HD21 ' A' ' 441' ' ' LEU . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.484 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 443' ' ' VAL . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.874 ' CE2' HG11 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.494 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.62 HD21 HG22 ' A' ' 484' ' ' VAL . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 499' ' ' ILE . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.663 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.852 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.666 HD12 ' CE2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.895 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.852 HG21 ' CE2' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 483' ' ' GLN . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.552 ' CB ' HD13 ' A' ' 478' ' ' LEU . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 488' ' ' VAL . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 484' ' ' VAL . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 443' ' ' VAL . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.604 ' O ' HG22 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 502' ' ' TYR . 19.8 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.454 ' CD2' HG23 ' A' ' 440' ' ' VAL . 5.1 p-80 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.865 0.364 . . . . 0.0 110.858 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 439' ' ' HIS . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 484' ' ' VAL . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.643 HG22 HG23 ' A' ' 499' ' ' ILE . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.771 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.808 HG22 ' OD1' ' A' ' 470' ' ' ASP . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . 0.808 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 483' ' ' GLN . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . 0.418 ' H ' ' NE2' ' A' ' 483' ' ' GLN . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.612 ' CB ' HD13 ' A' ' 478' ' ' LEU . 21.6 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 485' ' ' GLN . 7.9 tp60 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 490' ' ' THR . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.559 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 443' ' ' VAL . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.435 ' HD1' HG11 ' A' ' 440' ' ' VAL . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.424 HG11 ' CE2' ' A' ' 502' ' ' TYR . 31.4 m . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.421 ' CD2' HG23 ' A' ' 440' ' ' VAL . 7.8 p-80 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.787 0.327 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 439' ' ' HIS . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 478' ' ' LEU . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.417 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 47.9 t-80 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 499' ' ' ILE . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 1.001 ' CE2' HG11 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 1.001 HG11 ' CE2' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 441' ' ' LEU . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 484' ' ' VAL . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 441' ' ' LEU . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.462 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 443' ' ' VAL . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 502' ' ' TYR . 27.5 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.537 ' CD2' HG23 ' A' ' 440' ' ' VAL . 3.2 p-80 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.849 0.356 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 439' ' ' HIS . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 499' ' ' ILE . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.464 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.739 ' CE2' HG21 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . 0.464 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.905 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . 0.503 ' HA ' HG23 ' A' ' 484' ' ' VAL . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.504 ' HB2' HD13 ' A' ' 478' ' ' LEU . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 488' ' ' VAL . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.463 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.531 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.691 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.691 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.402 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.3 p-80 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.784 0.326 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.402 HG23 ' CD2' ' A' ' 439' ' ' HIS . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 484' ' ' VAL . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . 0.454 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.784 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 454' ' ' LEU . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . 0.454 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.891 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.891 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.784 HG11 ' CE1' ' A' ' 458' ' ' PHE . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.558 HD13 ' CB ' ' A' ' 483' ' ' GLN . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.558 ' CB ' HD13 ' A' ' 478' ' ' LEU . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 488' ' ' VAL . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 484' ' ' VAL . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.451 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.444 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 498' ' ' ARG . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 443' ' ' VAL . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 502' ' ' TYR . 11.1 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.807 0.337 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.505 HD21 HG13 ' A' ' 484' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 499' ' ' ILE . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.668 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.668 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.608 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.903 ' CE2' HG21 ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.794 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 1.003 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 1.003 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.903 HG21 ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 483' ' ' GLN . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 9.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.505 HG13 HD21 ' A' ' 441' ' ' LEU . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 489' ' ' ASN . 10.1 mm-40 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 484' ' ' VAL . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 485' ' ' GLN . 87.2 m-20 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.608 ' CE2' HD11 ' A' ' 457' ' ' LEU . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 443' ' ' VAL . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . 0.585 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.435 ' C ' ' O ' ' A' ' 501' ' ' THR . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.585 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.815 0.34 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 64.5 t-80 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 499' ' ' ILE . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.635 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.944 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.944 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 483' ' ' GLN . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.604 ' HB2' HD13 ' A' ' 478' ' ' LEU . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 443' ' ' VAL . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' HIS . . . . . 0.523 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.6 p-80 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.864 0.364 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' A' ' 439' ' ' HIS . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 478' ' ' LEU . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' HIS . . . . . 0.793 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 46.3 t-80 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 499' ' ' ILE . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 454' ' ' LEU . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' LEU . . . . . 0.8 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' PHE . . . . . 0.702 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' ALA . . . . . 0.46 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 441' ' ' LEU . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 39.0 m-20 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 499' ' ' ILE . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' TYR . . . . . 0.542 ' CE2' HD11 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 491' ' ' SER . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' TYR . . . . . 0.793 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 95.7 p -141.27 148.59 40.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.907 0.384 . . . . 0.0 110.828 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 83.3 p -108.07 168.69 9.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 85.87 155.12 25.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.496 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.4 t -125.05 105.69 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.901 0.382 . . . . 0.0 110.852 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 p -125.34 176.75 6.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -80.16 -157.8 15.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 155.45 -95.0 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 127.58 14.83 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.669 2.246 . . . . 0.0 112.387 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -60.5 170.69 1.3 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.2 tp -101.38 140.45 35.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.933 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -94.36 143.93 27.15 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.609 0.719 . . . . 0.0 110.925 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 164.22 35.36 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.353 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -42.15 138.54 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.567 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 31.8 mtt180 -84.61 74.87 10.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -90.97 -47.01 7.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -55.91 -31.17 62.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.892 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.11 144.75 11.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 478' ' ' LEU . 7.8 mt -133.64 130.2 37.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.955 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.667 ' CD2' ' CD2' ' A' ' 505' ' ' TYR . 53.2 t-80 -87.66 108.68 19.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.836 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.701 HG22 HG12 ' A' ' 499' ' ' ILE . 46.9 t -112.74 126.47 70.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -113.99 106.79 14.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.126 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 1.033 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.6 p90 -119.07 158.25 48.6 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.917 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.82 147.5 62.63 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.639 2.226 . . . . 0.0 112.347 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -47.86 -40.33 21.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -42.85 -28.19 0.23 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -66.6 -175.31 0.37 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.886 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 9.2 ptmt -166.64 166.51 16.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.929 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.409 HG22 ' HD2' ' A' ' 455' ' ' TYR . 21.9 m -49.99 -26.81 4.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 8.1 t -71.66 -40.87 69.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.89 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -66.15 -40.62 90.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.863 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 1.033 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.4 mm? -65.38 -65.94 0.61 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.409 ' HD2' HG22 ' A' ' 451' ' ' THR . 5.1 m-85 -48.23 -53.29 17.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.486 ' O ' ' CB ' ' A' ' 459' ' ' SER . 69.5 mm-40 -54.12 -51.96 62.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.878 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.9 tp -54.03 -65.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.59 ' CE2' HG11 ' A' ' 476' ' ' VAL . 31.6 m-85 -65.98 -8.66 24.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 456' ' ' GLN . 8.3 t -45.72 -34.68 3.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.878 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.48 -40.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.093 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.424 ' CD1' ' OE1' ' A' ' 483' ' ' GLN . 20.6 m-85 -81.57 -49.56 10.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.694 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.09 -154.74 22.06 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.462 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 62.0 m-20 -52.34 126.21 18.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.06 174.47 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.145 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.9 tp60 -117.26 101.49 8.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 38.4 mt -88.37 118.59 34.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -104.29 122.61 45.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -89.16 108.46 19.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.965 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.827 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.6 -66.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.133 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -125.5 -175.0 3.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -58.96 -32.12 69.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.8 p -130.33 20.66 5.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.145 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 m -123.91 123.7 40.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.865 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.517 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.23 162.96 34.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.827 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -125.11 151.32 45.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.906 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.59 HG11 ' CE2' ' A' ' 458' ' ' PHE . 87.5 t -127.61 141.78 45.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.166 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 68.6 p -122.93 129.37 51.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.863 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.548 HD11 HD11 ' A' ' 441' ' ' LEU . 75.5 mt -116.07 171.96 7.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.946 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 22.2 t -93.19 -48.81 6.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.841 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -113.23 150.16 42.6 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.576 0.703 . . . . 0.0 110.928 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 -31.78 20.18 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.742 2.295 . . . . 0.0 112.333 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -50.12 -51.03 46.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.424 ' OE1' ' CD1' ' A' ' 461' ' ' PHE . 28.8 mm-40 -47.13 -41.3 17.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 488' ' ' VAL . 91.5 t -40.67 -53.38 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.112 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.81 -61.03 1.56 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.75 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.4 mp -53.73 -57.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -47.36 -23.52 0.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 484' ' ' VAL . 69.1 t -92.3 -35.97 7.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -69.45 -21.1 63.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.4 p -82.55 -37.49 25.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.145 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.467 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.6 p -69.86 -22.27 63.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.887 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -50.42 -62.88 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -74.11 -36.56 64.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.962 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -60.08 114.72 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -94.52 -34.99 12.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.859 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.9 m -49.87 -49.27 49.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.849 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.414 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 21.3 p90 -117.93 169.04 9.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -138.98 128.84 24.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.701 HG12 HG22 ' A' ' 443' ' ' VAL . 76.7 mt -120.03 139.13 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -152.4 163.7 38.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 40.3 p -71.85 145.95 48.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.567 ' CE2' ' HD2' ' A' ' 437' ' ' ARG . 39.9 t80 -46.5 -51.81 14.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.909 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -56.47 -45.92 80.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.102 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -57.12 -46.86 82.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.828 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.667 ' CD2' ' CD2' ' A' ' 442' ' ' HIS . 21.0 t80 -61.59 -62.82 1.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.96 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 502' ' ' TYR . 30.7 m -52.39 -42.57 38.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.135 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -36.23 -49.63 1.22 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.464 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.417 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -56.86 -55.07 39.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.86 0.362 . . . . 0.0 110.881 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.3 mtpp -54.87 -61.94 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.933 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -123.95 144.82 49.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -139.4 109.53 6.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.912 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -68.33 -129.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.503 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 25.5 ttmt -127.31 84.19 2.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.773 0.321 . . . . 0.0 110.872 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . 0.409 ' NE2' ' O ' ' A' ' 515' ' ' VAL . 22.2 tm0? -165.24 125.35 1.86 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.409 ' O ' ' NE2' ' A' ' 514' ' ' GLN . 11.0 p -39.41 141.96 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.108 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 516' ' ' LYS . 0.0 OUTLIER -110.92 152.78 26.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.6 t -145.22 145.89 31.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.853 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -122.05 83.45 0.36 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.486 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -6.75 19.35 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.33 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 60.3 p -117.41 171.48 7.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.0 p -39.21 108.32 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.495 -179.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 28.0 p -158.06 124.22 4.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.898 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 44.0 m -88.0 160.52 17.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.816 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -73.41 -123.9 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.514 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.7 m -73.25 122.96 22.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 110.893 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 45.8 t -111.75 136.69 50.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 88.96 153.13 26.85 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.507 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -145.64 87.08 0.17 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.535 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.08 32.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 0.0 112.318 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -54.32 177.21 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 30.5 mt -94.65 65.15 3.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -135.89 144.09 47.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.6 0.714 . . . . 0.0 110.9 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 145.73 57.58 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.689 2.259 . . . . 0.0 112.316 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -165.0 106.15 0.8 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.502 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 45.3 mtt180 60.68 37.93 18.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.843 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -63.85 -59.56 4.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.868 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.404 ' CD2' HG23 ' A' ' 440' ' ' VAL . 5.9 p-80 -42.48 -27.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.876 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.404 HG23 ' CD2' ' A' ' 439' ' ' HIS . 83.4 t -72.21 133.14 32.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.158 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.653 HD21 HG22 ' A' ' 484' ' ' VAL . 14.1 mt -109.76 154.17 23.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.938 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.4 ' CE1' HG23 ' A' ' 444' ' ' THR . 57.2 t-80 -123.94 108.0 11.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.726 HG22 HG12 ' A' ' 499' ' ' ILE . 15.1 t -106.37 118.66 54.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.119 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . 0.4 HG23 ' CE1' ' A' ' 442' ' ' HIS . 1.4 p -95.23 104.8 16.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.137 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.664 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.4 p90 -121.71 155.16 60.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.628 0.728 . . . . 0.0 110.923 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.52 51.35 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.702 2.268 . . . . 0.0 112.361 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.441 ' CG ' ' N ' ' A' ' 448' ' ' GLU . 43.1 pttt -42.67 -45.96 4.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' A' ' 447' ' ' LYS . 14.6 pt-20 -36.77 -37.22 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.562 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.7 m0 -55.25 172.8 0.12 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.407 ' HG2' ' C ' ' A' ' 449' ' ' TRP . 24.6 mmmt -150.35 159.88 44.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.85 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.484 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.1 m -47.07 -59.19 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.124 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 74.7 m -41.77 -42.81 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.856 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -61.87 -48.96 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.828 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.664 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.9 mm? -55.71 -58.41 7.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.0 m-85 -51.0 -53.59 31.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 47.4 mm-40 -54.13 -46.41 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.5 tp -58.33 -59.31 5.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.658 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.1 m-85 -73.83 -8.8 57.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 22.1 t -43.96 -41.03 5.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.95 -41.58 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.093 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -82.84 -54.07 5.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.88 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.865 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.76 -157.81 24.34 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -44.22 124.28 3.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.763 0.316 . . . . 0.0 110.909 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.865 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.1 pt -139.74 167.26 19.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -111.16 102.5 10.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 31.3 mt -87.77 109.66 19.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.67 115.42 28.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . 0.484 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 83.7 m95 -82.17 108.72 15.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.93 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.908 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -88.99 -67.78 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -122.89 -174.99 3.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.859 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.91 -28.41 69.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.908 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 56.8 p -128.68 21.35 5.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 4.4 t -132.92 135.09 45.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.88 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.33 172.08 13.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.908 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -131.69 142.95 49.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.912 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.658 HG21 ' CE2' ' A' ' 458' ' ' PHE . 97.0 t -133.55 104.08 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.123 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 61.9 m -94.26 128.0 40.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.535 HD13 ' HB2' ' A' ' 483' ' ' GLN . 74.5 mt -106.13 171.32 7.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.891 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 54.9 m -79.1 -48.5 14.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -120.34 148.76 48.2 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.77 -18.79 36.78 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.312 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -57.76 -57.66 11.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.535 ' HB2' HD13 ' A' ' 478' ' ' LEU . 19.3 mm-40 -39.46 -41.72 1.01 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.653 HG22 HD21 ' A' ' 441' ' ' LEU . 91.6 t -36.98 -62.23 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.168 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 484' ' ' VAL . 0.8 OUTLIER -37.33 -50.37 1.03 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.925 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.666 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.7 mp -63.78 -66.32 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.095 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.05 -42.67 0.92 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 484' ' ' VAL . 40.9 t -71.94 -46.49 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -50.07 -47.06 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.45 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.6 p -72.99 -26.31 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.186 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 52.4 p -75.67 -34.85 60.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -44.32 -63.36 0.9 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.899 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.3 p90 -65.38 -42.79 92.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.482 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -43.49 117.51 1.15 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -97.0 -43.81 7.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 18.2 t -48.49 -50.09 33.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.857 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.467 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 18.1 p90 -117.62 165.31 13.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.3 ttt180 -134.48 131.38 38.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.805 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.726 HG12 HG22 ' A' ' 443' ' ' VAL . 85.8 mt -122.94 142.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -148.65 177.51 9.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 80.7 p -85.1 157.14 20.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.087 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.696 ' CE2' HG11 ' A' ' 506' ' ' VAL . 71.0 t80 -52.41 -46.04 66.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -57.68 -43.1 84.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -55.45 -44.23 76.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -68.82 -64.54 0.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.696 HG11 ' CE2' ' A' ' 502' ' ' TYR . 30.9 m -51.24 -33.45 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.52 -63.13 1.97 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptmt -73.95 -49.19 25.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.814 0.34 . . . . 0.0 110.868 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -46.68 -68.56 0.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.865 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -64.38 116.78 6.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 35.7 pttt -150.49 122.01 7.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.884 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -144.35 -141.27 3.73 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.492 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -121.83 87.5 2.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.727 0.298 . . . . 0.0 110.892 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -174.02 132.02 0.41 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.917 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.4 m -116.17 133.33 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.068 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -54.72 141.33 32.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.916 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 74.7 p -72.66 127.71 33.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 49.98 83.13 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 178.72 4.29 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 90.9 p -163.09 115.96 1.57 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 41.2 t -98.32 130.99 44.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.257 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.495 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.345 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 83.6 p -112.37 102.76 10.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.869 0.366 . . . . 0.0 110.822 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 51.3 m -100.29 127.75 46.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -154.46 -67.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 28.3 p -156.86 117.24 3.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.92 0.39 . . . . 0.0 110.841 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 70.9 m -136.89 117.78 14.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 52.38 177.46 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.474 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 140.16 -80.94 0.26 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.484 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.49 4.4 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -77.44 171.75 14.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 23.2 mt -86.92 111.18 20.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -116.46 150.76 46.03 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.617 0.722 . . . . 0.0 110.94 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 156.57 63.0 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.755 2.303 . . . . 0.0 112.328 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -96.97 41.32 1.11 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.936 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.487 ' HD2' ' CZ ' ' A' ' 502' ' ' TYR . 61.6 mtt-85 -64.73 78.02 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.831 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -80.54 -61.51 1.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.49 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.3 p-80 -42.8 -32.21 0.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 439' ' ' HIS . 94.3 t -74.85 135.62 26.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 9.0 mt -130.26 127.44 39.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -85.19 108.06 17.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.685 HG22 HG12 ' A' ' 499' ' ' ILE . 32.0 t -113.77 121.17 65.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.133 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.0 p -98.37 104.93 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.593 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.64 153.41 69.95 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.68 0.752 . . . . 0.0 110.845 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.2 Cg_endo -69.76 145.27 56.63 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.708 2.272 . . . . 0.0 112.295 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.6 -39.14 16.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.12 -28.17 0.27 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.6 m0 -65.66 -178.08 0.51 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 3.9 pttm -159.76 175.15 13.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 10.1 m -58.03 -32.63 68.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.144 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . 0.413 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 21.0 m -68.33 -33.88 75.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -70.38 -44.32 68.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.837 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.593 HD21 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -62.57 -56.55 16.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.902 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.485 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.7 m-85 -58.74 -39.82 82.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.413 ' CG ' ' O ' ' A' ' 452' ' ' SER . 30.6 mm-40 -62.8 -53.42 54.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.977 HD11 ' CE2' ' A' ' 497' ' ' TYR . 7.9 tp -56.12 -50.0 72.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.734 ' CE2' HG11 ' A' ' 476' ' ' VAL . 40.4 m-85 -79.13 -14.5 59.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -36.16 -31.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -42.09 -46.6 4.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -80.59 -55.35 4.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.879 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.892 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 135.4 -156.14 22.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.47 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -46.48 121.81 3.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 110.912 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.892 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.1 pt -138.54 169.05 18.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -104.19 104.48 14.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 42.4 mt -93.12 103.31 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.145 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -84.08 122.79 29.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -94.05 110.86 22.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.905 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.988 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.26 -60.46 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -132.23 -174.76 3.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.74 -4.57 38.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 22.9 p -132.14 -33.02 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 54.8 p -97.38 139.73 32.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.512 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.13 -175.33 4.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.075 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.988 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -144.07 148.84 35.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.75 HG13 HD12 ' A' ' 464' ' ' ILE . 87.4 t -132.92 105.32 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 12.9 t -94.94 143.9 26.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.448 HD13 ' HB2' ' A' ' 483' ' ' GLN . 70.4 mt -111.92 171.64 7.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.2 t -85.89 -44.46 12.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -116.83 148.81 42.85 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.593 0.711 . . . . 0.0 110.931 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -29.53 23.64 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.675 2.25 . . . . 0.0 112.308 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -58.06 -48.53 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.448 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.9 mm-40 -50.87 -45.75 60.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . . . . . . . . . 76.5 t -38.52 -50.15 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.138 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -46.61 -56.81 5.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.937 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.442 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -57.28 -45.86 85.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.95 61.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 83.8 t -78.29 -45.79 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -55.82 -35.29 66.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 44.4 p -83.64 -14.97 50.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.145 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.0 p -79.66 -27.48 40.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 54.7 mttt -48.17 -58.65 4.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.515 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 9.1 p90 -72.18 -43.31 64.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.929 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.515 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.54 115.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.107 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -97.76 -42.56 7.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 73.4 m -47.08 -49.99 20.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.977 ' CE2' HD11 ' A' ' 457' ' ' LEU . 32.5 p90 -116.55 155.34 28.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -127.94 114.36 17.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.685 HG12 HG22 ' A' ' 443' ' ' VAL . 53.3 mt -102.37 144.6 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . 0.478 ' HG2' ' N ' ' A' ' 501' ' ' THR . 20.3 tt0 -145.75 162.58 37.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.478 ' N ' ' HG2' ' A' ' 500' ' ' GLN . 20.4 p -77.71 134.16 38.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.643 ' CE2' HG11 ' A' ' 506' ' ' VAL . 69.6 t80 -41.83 -53.72 3.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -50.59 -43.98 56.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.083 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . 0.429 ' HB3' ' CD ' ' A' ' 500' ' ' GLN . 2.6 mm-40 -61.66 -44.27 97.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -64.06 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 502' ' ' TYR . 24.9 m -50.26 -48.48 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.14 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.527 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -36.36 -56.63 1.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.491 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' A' ' 509' ' ' LYS . 27.7 mmtp -68.66 -50.4 51.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.833 0.349 . . . . 0.0 110.92 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 508' ' ' LYS . 37.4 tttt -36.47 -57.99 0.73 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -91.57 129.56 37.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.9 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.54 40.98 2.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 73.54 100.89 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 23.5 mtmm -121.78 41.9 3.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.752 0.31 . . . . 0.0 110.931 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 515' ' ' VAL . 39.9 tt0 -166.25 150.41 7.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.406 ' N ' ' HG2' ' A' ' 514' ' ' GLN . 34.1 m -48.45 164.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.153 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 16.0 tptp -113.12 99.09 7.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -85.63 108.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.828 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 102.48 83.31 1.71 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.514 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 145.66 57.56 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.669 2.246 . . . . 0.0 112.381 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 75.8 m -93.34 -51.06 5.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.877 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.5 m -101.91 96.97 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.504 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.4 m -127.42 171.11 11.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.888 0.375 . . . . 0.0 110.861 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 27.6 t -96.59 -60.64 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.843 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 134.72 -144.73 16.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 91.5 p -157.42 151.59 24.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.89 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 18.4 p -132.78 159.68 39.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.858 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -60.04 -166.4 0.23 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.45 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -141.78 145.64 16.16 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.5 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 1.48 4.4 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.696 2.264 . . . . 0.0 112.356 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.59 140.08 38.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -47.0 159.03 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.916 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 434' ' ' GLN . 0.0 OUTLIER -121.78 143.61 38.77 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.576 0.703 . . . . 0.0 110.923 179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.9 Cg_endo -69.73 -175.29 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.659 2.239 . . . . 0.0 112.382 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 435' ' ' PRO . 7.3 mmpt? -35.91 150.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.569 ' HD3' ' CD2' ' A' ' 502' ' ' TYR . 0.0 OUTLIER -126.26 40.23 3.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -86.06 -45.89 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -54.69 -18.62 4.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 86.5 t -68.04 126.94 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.084 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.488 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -108.47 125.29 51.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.944 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -82.8 107.97 15.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.85 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.614 HG13 HG12 ' A' ' 499' ' ' ILE . 31.4 t -111.03 113.25 43.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.074 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.7 110.35 22.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.142 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.989 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.2 p90 -122.12 155.96 60.62 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.639 0.733 . . . . 0.0 110.904 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.7 141.52 45.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.379 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.448 ' O ' ' C ' ' A' ' 448' ' ' GLU . 16.1 pttm -39.88 -48.06 2.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.8 pt-20 -34.78 -41.52 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.89 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.566 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -50.35 179.37 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.942 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -158.35 160.27 36.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.867 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 2.8 m -44.38 -55.02 5.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.134 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 2.3 m -51.41 -35.89 41.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.875 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.87 -45.35 89.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.989 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -60.15 -62.46 1.85 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.441 ' CE2' HD12 ' A' ' 466' ' ' ILE . 7.1 m-85 -49.7 -49.57 47.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.926 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -55.34 -46.59 76.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.911 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.1 tp -57.64 -67.65 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.607 ' CE2' HG11 ' A' ' 476' ' ' VAL . 28.2 m-85 -64.85 -11.7 40.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . . . . . . . . . 6.1 t -38.25 -33.3 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.2 -42.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.094 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -83.41 -55.0 4.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 138.36 -147.0 18.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.517 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 71.7 m-80 -51.75 122.1 7.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.2 pt -139.27 175.33 7.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.15 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -117.21 109.56 17.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.94 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.441 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.5 mt -93.09 118.25 38.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.128 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -103.46 125.38 50.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.5 m95 -92.61 109.13 20.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.952 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.87 -64.27 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.13 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -129.26 -175.02 3.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.46 ' OD1' HG23 ' A' ' 472' ' ' THR . 0.9 OUTLIER -58.9 -34.64 71.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.847 180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.46 HG23 ' OD1' ' A' ' 471' ' ' ASP . 58.3 p -126.02 17.56 7.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.135 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.6 m -124.03 128.16 48.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.474 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -141.18 175.66 9.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.087 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.952 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -139.28 149.23 44.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.607 HG11 ' CE2' ' A' ' 458' ' ' PHE . 72.8 t -133.46 112.32 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.15 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 6.4 t -101.53 133.31 46.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.785 HD22 ' NE2' ' A' ' 483' ' ' GLN . 45.0 mt -107.99 177.81 4.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.935 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 87.9 p -84.58 -36.91 21.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.895 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -133.88 156.6 79.18 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 484' ' ' VAL . 54.0 Cg_endo -69.76 -40.91 4.76 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.68 2.254 . . . . 0.0 112.383 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 481' ' ' PRO . 53.6 mm-40 -36.26 -45.68 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.785 ' NE2' HD22 ' A' ' 478' ' ' LEU . 22.9 mt-30 -58.14 -42.91 86.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.961 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.57 ' O ' HG23 ' A' ' 488' ' ' VAL . 75.1 t -36.68 -51.4 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.133 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 36.4 mm-40 -52.62 -57.79 8.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.695 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.1 mp -54.81 -63.97 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -39.74 -44.26 1.54 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.122 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 484' ' ' VAL . 96.0 t -70.63 -46.51 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -43.89 -57.91 3.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.518 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 82.3 p -56.71 -40.86 76.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 4.2 p -56.2 -35.14 66.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 56.1 mmtt -42.78 -62.59 0.96 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.2 p90 -68.1 -45.37 73.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.947 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.51 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -46.59 114.96 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -100.08 -38.15 8.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 26.1 t -48.74 -48.28 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.923 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -119.3 159.58 23.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.958 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -121.99 134.24 54.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.614 HG12 HG13 ' A' ' 443' ' ' VAL . 43.6 mt -132.86 135.32 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.138 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . 0.42 ' OE1' ' N ' ' A' ' 500' ' ' GLN . 18.2 pm0 -147.37 177.12 9.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.438 ' O ' ' C ' ' A' ' 502' ' ' TYR . 0.8 OUTLIER -82.44 146.34 29.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.129 -179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.569 ' CD2' ' HD3' ' A' ' 437' ' ' ARG . 2.6 t80 -35.19 -50.14 0.51 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -61.87 -52.53 63.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -43.82 -26.77 0.28 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -83.89 -75.0 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 6.9 m -48.28 -22.27 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.129 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.53 -54.95 30.25 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.484 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 8.9 mtpt -39.75 -51.76 2.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 0.0 110.877 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -55.14 -71.1 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.899 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -61.84 159.42 13.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.892 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 3.8 ttmp? -134.89 107.5 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 159.82 47.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -168.33 110.4 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -154.12 129.84 10.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.905 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.8 155.0 28.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.147 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 13.0 tptp -58.72 92.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.851 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.7 m -135.86 156.92 48.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -129.27 142.35 13.48 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.45 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 157.86 58.9 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.664 2.242 . . . . 0.0 112.347 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.6 p -173.11 113.21 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.79 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 7.7 m -143.95 175.7 9.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.808 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.52 -179.974 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 15.8 m -128.68 156.97 42.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.856 0.36 . . . . 0.0 110.849 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 43.5 p -96.18 115.04 26.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -165.75 121.84 1.03 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.532 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 2.9 t -120.85 110.28 16.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.91 0.386 . . . . 0.0 110.856 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 44.7 t -143.2 115.8 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.828 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -150.46 107.39 0.34 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -81.23 -91.24 0.54 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.477 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 118.92 5.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.667 2.245 . . . . 0.0 112.351 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.64 109.59 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 29.8 mt -145.24 166.25 26.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 -70.39 144.04 91.35 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.611 0.719 . . . . 0.0 110.92 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 153.66 68.99 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.692 2.261 . . . . 0.0 112.378 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.37 145.86 24.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.886 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.556 ' HB2' ' CD2' ' A' ' 502' ' ' TYR . 33.5 mtt180 62.83 44.46 6.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.911 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -57.27 -58.71 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.833 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.557 ' CD2' HG23 ' A' ' 440' ' ' VAL . 6.7 p-80 -43.32 -36.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.557 HG23 ' CD2' ' A' ' 439' ' ' HIS . 88.3 t -68.12 132.49 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.119 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 14.3 mt -125.57 131.37 52.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.692 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 53.1 t-80 -91.34 107.99 19.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.837 HG22 HG12 ' A' ' 499' ' ' ILE . 40.6 t -108.37 115.36 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . 0.557 HG23 ' CE1' ' A' ' 442' ' ' HIS . 6.3 p -94.51 106.17 18.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.146 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.0 p90 -125.72 155.32 72.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.665 0.745 . . . . 0.0 110.841 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.3 Cg_endo -69.8 148.31 64.52 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.331 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' C ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -50.09 -37.56 34.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -45.03 -21.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.906 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -70.86 -176.76 1.42 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.931 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.432 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 23.0 mtpp -163.84 166.26 22.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 8.3 m -46.71 -57.76 4.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 62.7 m -47.09 -31.22 3.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -71.68 -45.86 60.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.9 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.681 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -61.59 -61.28 2.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.498 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.9 m-85 -52.55 -46.49 66.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.945 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 459' ' ' SER . 8.6 mm-40 -55.78 -54.25 46.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 8.2 tp -54.82 -51.39 65.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.907 ' CE1' HG11 ' A' ' 476' ' ' VAL . 32.5 m-85 -77.53 -9.14 58.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -43.88 -34.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.906 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -39.97 -42.75 1.42 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.097 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.503 ' CD1' ' HG3' ' A' ' 483' ' ' GLN . 48.1 m-85 -83.11 -54.76 4.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.733 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.6 -153.65 22.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.51 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 39.5 t-20 -49.96 125.75 12.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.793 0.33 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.733 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.0 pt -140.04 175.4 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . 0.422 ' C ' ' CD ' ' A' ' 465' ' ' GLN . 0.9 OUTLIER -115.23 102.59 10.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.491 HD12 ' CE2' ' A' ' 455' ' ' TYR . 42.8 mt -88.14 118.36 33.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.36 118.8 35.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.19 107.84 19.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 1.04 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.3 mt -91.21 -56.22 5.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.093 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -138.63 -175.06 4.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . 0.451 ' CG ' HG23 ' A' ' 472' ' ' THR . 0.4 OUTLIER -75.69 -16.03 60.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . 0.451 HG23 ' CG ' ' A' ' 471' ' ' ASP . 72.0 p -132.06 17.15 4.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 10.4 p -146.07 128.72 16.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.499 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.12 172.23 12.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 1.04 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.4 m-85 -129.31 154.39 46.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.907 HG11 ' CE1' ' A' ' 458' ' ' PHE . 60.5 t -137.2 107.84 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 30.4 t -99.53 140.09 34.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.845 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 483' ' ' GLN . 64.0 mt -113.42 174.55 5.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.938 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 39.5 t -83.37 -45.0 14.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.89 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -116.7 153.87 49.23 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.589 0.709 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -38.84 7.3 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.692 2.262 . . . . 0.0 112.345 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -43.94 -52.79 6.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.924 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.798 ' HB3' HD13 ' A' ' 478' ' ' LEU . 6.3 mp0 -41.53 -44.44 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 488' ' ' VAL . 82.3 t -38.93 -62.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.166 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -47.45 -63.17 1.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.898 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.679 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.9 mp -43.65 -53.56 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -55.58 -51.78 65.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.059 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.6 t -55.23 -49.03 75.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.161 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -47.83 -52.29 19.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.447 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 68.8 p -70.58 -22.0 62.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.164 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 6.8 t -76.88 -25.47 53.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -54.19 -65.28 0.6 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.47 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 12.5 p90 -61.8 -44.64 96.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.47 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -42.2 117.22 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.091 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -98.54 -43.33 6.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.921 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 38.9 m -54.15 -48.69 70.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.511 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 2.6 p90 -115.55 146.45 41.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.921 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -121.68 129.53 52.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.837 HG12 HG22 ' A' ' 443' ' ' VAL . 70.5 mt -123.51 141.6 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.12 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . 0.475 ' CG ' ' HB3' ' A' ' 442' ' ' HIS . 15.3 pt20 -144.35 175.6 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.958 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -93.68 145.77 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 437' ' ' ARG . 66.8 t80 -38.02 -55.25 1.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -43.97 -48.01 8.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -59.08 -41.55 88.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.692 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 60.2 t80 -62.14 -59.84 4.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.477 ' O ' ' CG ' ' A' ' 510' ' ' GLN . 10.9 m -53.7 -38.36 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.16 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -58.06 -41.13 94.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.456 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.38 -63.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.852 0.358 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -44.2 -37.88 3.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.898 179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . 0.477 ' CG ' ' O ' ' A' ' 506' ' ' VAL . 25.7 mm-40 -60.65 151.84 28.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -135.99 106.73 6.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -114.61 -142.19 7.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.533 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -166.96 121.32 1.04 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.789 0.328 . . . . 0.0 110.924 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -171.65 134.55 0.83 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.929 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -119.96 144.92 27.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -57.53 116.76 3.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 12.7 t -60.76 120.73 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 98.62 157.07 29.52 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.497 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.82 -47.55 0.89 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.651 2.234 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 73.1 m -114.47 140.63 48.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.849 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 68.1 p -71.09 126.09 28.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.892 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.539 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 8.4 t -153.42 173.52 15.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 53.7 p -140.8 169.6 17.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 133.06 159.48 9.16 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.469 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 22.2 t -166.15 130.04 2.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.841 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 87.6 p -103.59 100.32 10.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -69.6 140.55 33.59 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.514 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -146.44 173.15 26.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.507 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 112.09 2.98 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.681 2.254 . . . . 0.0 112.365 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -164.63 164.24 21.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.871 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 7.7 mp -79.77 103.36 9.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.924 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -96.2 151.24 38.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.619 0.724 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 160.28 50.28 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.711 2.274 . . . . 0.0 112.343 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.445 ' O ' ' CE1' ' A' ' 439' ' ' HIS . 43.7 tttp -84.12 47.64 1.35 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.864 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.562 ' HB3' ' CD2' ' A' ' 502' ' ' TYR . 10.9 mmt180 -87.53 41.03 0.96 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -80.13 -58.67 3.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.677 ' CD2' HG23 ' A' ' 440' ' ' VAL . 7.1 p-80 -40.31 -39.14 0.9 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.677 HG23 ' CD2' ' A' ' 439' ' ' HIS . 58.1 t -71.6 146.75 11.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.498 HD21 HG13 ' A' ' 484' ' ' VAL . 19.1 mt -132.81 131.32 40.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.489 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 63.2 t-80 -87.2 108.96 19.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.883 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.828 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -116.7 123.43 71.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.42 111.27 22.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.179 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 454' ' ' LEU . 8.3 p90 -123.32 157.16 62.3 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.657 0.741 . . . . 0.0 110.899 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.69 148.96 66.69 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 0.0 112.343 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.476 ' O ' ' N ' ' A' ' 449' ' ' TRP . 25.2 pttm -47.35 -43.69 23.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -40.07 -25.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.57 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -68.76 -176.31 0.81 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.896 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -165.83 164.78 18.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 55.8 m -49.0 -50.48 35.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 9.7 t -50.61 -39.09 49.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -65.52 -44.23 87.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -60.85 -62.8 1.6 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.461 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.3 m-85 -48.8 -62.8 1.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 0.5 OUTLIER -48.82 -46.2 41.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.916 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 6.2 tp -57.18 -66.99 0.36 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.643 ' CE2' HG11 ' A' ' 476' ' ' VAL . 20.7 m-85 -66.88 -9.31 36.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 455' ' ' TYR . 4.8 t -41.17 -32.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.878 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.28 -36.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.12 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.518 ' CD2' ' OE1' ' A' ' 483' ' ' GLN . 64.5 m-85 -91.96 -50.31 5.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.706 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.13 -142.17 13.59 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.485 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -52.36 120.4 5.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.851 0.358 . . . . 0.0 110.854 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.0 pt -138.57 175.3 8.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.114 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -119.64 111.63 18.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.957 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 22.4 mt -96.03 119.41 44.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.103 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -104.68 119.24 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.911 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -88.71 109.06 19.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.973 HD11 ' CD2' ' A' ' 475' ' ' PHE . 6.2 mt -90.7 -64.2 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.087 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . 0.795 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.9 OUTLIER -129.18 -174.98 3.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.885 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -62.57 -29.09 70.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 79.9 p -129.3 20.36 5.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -130.49 128.8 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.2 10.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.047 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.973 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.6 m-85 -137.35 144.69 42.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.643 HG11 ' CE2' ' A' ' 458' ' ' PHE . 99.9 t -127.31 109.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 45.5 t -100.45 137.34 39.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.633 HD22 ' OE1' ' A' ' 483' ' ' GLN . 67.7 mt -114.38 177.93 4.47 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.2 m -94.9 -43.33 8.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.799 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -113.66 150.64 43.64 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 0.0 110.891 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -44.81 1.82 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.645 2.23 . . . . 0.0 112.33 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -39.27 -51.05 2.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.878 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.633 ' OE1' HD22 ' A' ' 478' ' ' LEU . 59.7 mt-30 -44.48 -49.73 9.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.498 HG13 HD21 ' A' ' 441' ' ' LEU . 95.4 t -37.0 -65.95 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.104 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -38.94 -47.24 1.42 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.92 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.557 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.6 mp -61.59 -62.54 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.154 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.87 -49.35 5.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.105 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 489' ' ' ASN . 60.5 t -65.78 -54.84 23.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.174 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 488' ' ' VAL . 17.3 t-20 -35.58 -53.91 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.485 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 49.9 p -65.42 -50.24 66.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.151 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.49 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 27.0 t -41.5 -44.02 2.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.821 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 491' ' ' SER . 3.4 mmpt? -36.94 -61.0 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.916 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 490' ' ' THR . 7.6 p90 -73.38 -38.45 65.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.49 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.17 115.77 1.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.122 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -99.95 -44.7 5.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.85 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -47.74 -42.07 24.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.488 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 3.8 p90 -122.69 167.23 13.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.918 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -132.19 135.55 46.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.828 HG12 HG22 ' A' ' 443' ' ' VAL . 69.2 mt -135.03 139.37 47.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.08 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.95 -176.93 4.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.1 p -95.08 131.03 41.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 506' ' ' VAL . 59.3 t80 -35.04 -48.65 0.43 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.938 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -54.78 -47.09 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 501' ' ' THR . 3.9 mm-40 -55.41 -41.42 72.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.489 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 18.9 t80 -68.11 -64.55 0.84 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 502' ' ' TYR . 29.6 m -49.21 -38.46 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.403 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -52.59 -40.86 55.84 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 35.4 mtmt -62.95 -59.67 4.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.827 0.346 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.468 ' HD2' ' CZ ' ' A' ' 505' ' ' TYR . 25.6 mtpt -40.87 -72.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -61.16 156.12 19.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 pttt -85.87 8.17 21.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 56.79 -95.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -173.7 110.02 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 39.7 tp60 -150.84 128.35 11.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.38 162.09 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.148 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -95.64 94.68 7.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 6.1 t -149.22 120.93 8.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 50.65 -179.28 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.519 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 166.22 28.36 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.662 2.241 . . . . 0.0 112.367 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 31.0 t -170.38 124.29 0.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.846 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 58.8 m -88.93 -59.21 2.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.851 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 91.9 p -80.23 140.48 36.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.901 0.382 . . . . 0.0 110.849 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 9.5 t -163.37 177.55 8.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 131.23 163.47 10.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.522 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.3 p -63.6 116.63 5.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.862 0.363 . . . . 0.0 110.905 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 24.5 m -89.39 102.71 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -45.67 127.71 8.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 119.74 82.78 0.77 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.505 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 143.67 51.48 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.702 2.268 . . . . 0.0 112.342 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -154.08 144.11 21.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.853 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 434' ' ' GLN . 56.9 mt -51.29 173.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.928 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . 0.427 ' CD ' ' H ' ' A' ' 434' ' ' GLN . 25.8 mp0 -35.93 144.11 0.26 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.546 0.688 . . . . 0.0 110.931 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 146.39 60.31 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.684 2.256 . . . . 0.0 112.366 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt -53.43 141.44 24.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.891 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 63.32 42.0 7.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.852 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -70.41 -51.74 27.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.472 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.0 p-80 -47.36 -20.64 0.23 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.472 HG23 ' CD2' ' A' ' 439' ' ' HIS . 94.1 t -78.67 141.16 15.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.432 HD21 HG13 ' A' ' 484' ' ' VAL . 13.4 mt -126.71 136.88 53.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.555 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 49.7 t-80 -96.5 108.57 21.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.68 HG22 HG12 ' A' ' 499' ' ' ILE . 62.7 t -114.83 127.23 72.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.123 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.8 p -112.65 104.04 12.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.102 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.996 ' CE2' HD11 ' A' ' 454' ' ' LEU . 4.5 p90 -115.19 158.34 41.36 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.671 0.748 . . . . 0.0 110.89 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.74 144.78 55.2 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.72 2.28 . . . . 0.0 112.369 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.451 ' HG2' ' N ' ' A' ' 448' ' ' GLU . 1.0 OUTLIER -48.9 -35.76 15.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.451 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 15.0 pt-20 -46.32 -24.74 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.576 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.9 m0 -69.26 -176.54 0.95 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 26.3 mtmt -158.13 166.19 33.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 20.9 m -48.9 -55.02 12.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.16 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 43.4 m -47.69 -42.64 25.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.78 -46.64 88.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.996 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.3 mm? -59.49 -59.94 4.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.481 ' CE2' HD12 ' A' ' 466' ' ' ILE . 4.7 m-85 -54.11 -63.13 1.25 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -45.81 -46.01 15.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 5.9 tp -57.11 -64.89 0.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.569 ' CE2' HG21 ' A' ' 476' ' ' VAL . 17.4 m-85 -68.73 -9.11 48.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.943 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 455' ' ' TYR . 18.8 t -43.38 -27.85 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.868 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -42.88 -39.33 2.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.107 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.48 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 59.4 m-85 -86.65 -49.27 7.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.68 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 132.1 -143.38 14.94 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.513 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -50.81 123.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.68 HG23 ' O ' ' A' ' 462' ' ' GLY . 24.7 pt -139.95 175.34 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.113 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.44 101.06 7.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.924 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.481 HD12 ' CE2' ' A' ' 455' ' ' TYR . 40.1 mt -86.01 105.62 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.3 t -94.95 120.82 35.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -86.93 110.29 19.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.746 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -90.54 -70.57 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -122.59 -174.99 3.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.856 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.8 -31.12 68.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.835 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 63.8 p -131.09 22.17 4.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.118 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 49.2 m -126.82 124.58 39.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.84 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.17 161.62 37.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.088 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.746 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -124.11 149.82 45.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.569 HG21 ' CE2' ' A' ' 458' ' ' PHE . 96.4 t -134.1 106.44 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.097 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 47.1 t -94.47 134.7 36.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.817 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 72.3 mt -111.81 179.1 4.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.3 m -88.26 -46.71 9.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -122.31 154.32 62.21 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.569 0.7 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -36.59 10.56 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.266 . . . . 0.0 112.335 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -43.69 -45.6 7.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.48 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 97.6 mt-30 -53.98 -40.55 67.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 488' ' ' VAL . 90.6 t -43.1 -47.34 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -54.9 -47.59 74.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.934 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -67.34 -39.46 82.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.159 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.26 95.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 484' ' ' VAL . 45.0 t -73.73 -52.93 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.133 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -38.53 -48.69 1.44 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.431 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 41.7 p -70.63 -32.22 69.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 488' ' ' VAL . 43.4 t -66.56 -40.62 89.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -39.52 -63.13 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.892 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 4.2 p90 -66.98 -43.05 84.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.947 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.551 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -47.3 115.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.118 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -99.2 -42.71 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 36.1 t -47.7 -47.47 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.512 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 9.3 p90 -116.55 163.18 16.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -129.04 127.37 41.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.68 HG12 HG22 ' A' ' 443' ' ' VAL . 64.2 mt -123.74 140.28 47.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.142 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -146.0 177.57 8.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 24.3 p -90.09 141.0 29.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.165 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 506' ' ' VAL . 67.0 t80 -41.29 -51.51 3.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.06 -39.6 75.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -65.27 -37.22 86.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.555 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.6 t80 -71.76 -55.63 7.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 502' ' ' TYR . 20.9 m -61.91 -36.14 72.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.105 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.16 -53.46 4.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.502 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -75.35 -49.69 18.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.891 0.377 . . . . 0.0 110.954 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -38.89 -55.29 1.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -90.8 169.15 11.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -112.43 41.16 2.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -95.37 91.77 1.39 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.537 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -168.25 116.7 0.73 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.746 0.308 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -159.78 149.35 18.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.903 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 32.8 m -145.0 145.97 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.098 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 1.3 ptpm? -109.25 160.62 15.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 45.4 p -162.94 145.17 10.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.848 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 172.29 -160.4 31.77 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.472 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -8.13 22.81 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.252 . . . . 0.0 112.361 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 10.8 t -40.01 121.71 1.36 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.89 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 2.9 t -86.13 139.09 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.842 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.488 -179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.2 m -102.8 149.76 24.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.852 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.8 t -171.87 133.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 160.8 156.74 8.36 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.2 m -87.43 173.25 9.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 0.0 110.894 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 98.6 p -99.06 -46.72 5.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -91.11 -122.48 2.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 145.86 -95.3 0.17 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.493 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.83 108.16 2.03 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.667 2.245 . . . . 0.0 112.274 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -168.41 159.47 10.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 82.4 mt -148.53 122.82 9.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -72.06 150.32 92.43 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.616 0.722 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 172.39 12.73 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.732 2.288 . . . . 0.0 112.308 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 22.0 mtpp -49.65 128.34 17.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.697 ' HD3' HG21 ' A' ' 440' ' ' VAL . 21.2 mtt180 -112.13 82.81 1.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -86.6 -52.73 5.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.494 ' CD2' HG23 ' A' ' 440' ' ' VAL . 9.0 p-80 -50.71 -36.77 37.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.697 HG21 ' HD3' ' A' ' 437' ' ' ARG . 61.6 t -69.87 145.69 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.164 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.615 HD21 HG22 ' A' ' 484' ' ' VAL . 13.8 mt -136.95 144.23 43.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.911 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.722 ' CE1' ' CE1' ' A' ' 505' ' ' TYR . 54.9 t-80 -105.91 109.58 21.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.853 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.659 HG22 HG12 ' A' ' 499' ' ' ILE . 39.6 t -111.38 121.87 64.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.121 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.3 p -95.36 107.77 19.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.601 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -127.61 153.38 77.61 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.637 0.732 . . . . 0.0 110.885 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.74 154.44 67.79 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.688 2.258 . . . . 0.0 112.356 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -56.76 -31.43 64.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -52.14 -16.66 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -75.96 -178.4 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.94 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 15.9 mtmm -162.25 164.11 27.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.458 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 7.4 m -46.16 -48.78 17.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.118 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 92.9 p -56.56 -30.88 63.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -71.37 -41.3 69.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.919 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.601 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.93 -58.44 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.4 m-85 -54.95 -43.17 73.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -61.35 -44.6 96.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.883 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.62 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -65.16 -50.98 63.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.831 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.8 m-85 -78.11 -9.57 59.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.6 t -42.55 -32.92 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.66 -36.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.103 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -90.89 -54.36 4.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.802 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.38 -152.46 21.18 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -49.6 122.33 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.884 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.05 177.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.0 tp60 -115.27 113.24 23.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 25.6 mt -102.96 106.23 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.1 m -90.51 115.47 27.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.817 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . 0.458 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 81.9 m95 -81.11 109.1 15.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.974 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.97 -66.49 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -123.43 -174.96 3.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.91 -9.42 58.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.5 p -131.97 -38.07 1.12 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.9 t -85.99 138.25 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.842 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.1 175.69 9.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.974 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.7 m-85 -131.79 146.36 52.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.831 HG11 ' CE2' ' A' ' 458' ' ' PHE . 60.1 t -133.9 107.76 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.067 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 2.1 m -97.57 139.01 34.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 483' ' ' GLN . 78.0 mt -112.92 178.33 4.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 50.7 m -80.59 -45.53 17.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.827 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -130.18 149.85 74.43 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.578 0.704 . . . . 0.0 110.934 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -19.57 36.19 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.6 -38.13 88.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.461 ' HB2' HD13 ' A' ' 478' ' ' LEU . 18.6 mm-40 -59.58 -40.5 87.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.893 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.615 HG22 HD21 ' A' ' 441' ' ' LEU . 95.9 t -36.39 -56.26 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -41.08 -58.07 1.86 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.922 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.643 ' H ' HD12 ' A' ' 486' ' ' ILE . 5.2 mp -55.15 -62.13 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -42.86 -48.72 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 484' ' ' VAL . 61.6 t -65.1 -45.36 94.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -49.9 -45.47 50.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.898 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.433 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 73.7 p -75.18 -35.85 61.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 47.3 p -65.27 -16.94 64.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -56.25 -62.2 1.87 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.547 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 14.9 p90 -63.92 -44.63 92.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.915 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.547 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -40.94 111.21 0.19 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -95.65 -39.93 9.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.889 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 10.8 t -50.92 -49.11 60.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.858 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.62 ' CE2' HD11 ' A' ' 457' ' ' LEU . 9.4 p90 -118.01 164.2 15.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.939 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -131.11 136.86 48.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.87 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 443' ' ' VAL . 82.7 mt -128.11 142.89 42.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . 0.408 ' HG3' ' C ' ' A' ' 499' ' ' ILE . 20.7 mt-30 -146.5 179.69 7.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 504' ' ' GLU . 40.8 p -96.84 140.82 30.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.117 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.618 ' O ' HG22 ' A' ' 506' ' ' VAL . 54.6 t80 -41.64 -52.99 3.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.931 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -57.41 -32.1 66.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.132 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 501' ' ' THR . 6.5 mm-40 -75.04 -53.38 9.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.722 ' CE1' ' CE1' ' A' ' 442' ' ' HIS . 40.7 t80 -56.09 -51.98 65.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.932 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 502' ' ' TYR . 34.3 m -58.27 -30.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.05 -62.78 2.55 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.499 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -50.76 14.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -37.88 -52.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -54.75 173.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -111.99 84.78 2.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -176.88 127.26 1.19 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -129.49 87.99 2.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.755 0.312 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -160.61 124.71 3.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.9 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.7 m -138.76 146.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -54.99 110.57 0.68 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 7.3 t -117.98 151.13 38.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -142.55 72.9 0.37 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 94.17 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.685 2.257 . . . . 0.0 112.376 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 33.2 t -108.22 154.14 22.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.853 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 4.3 m -92.19 153.41 19.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.863 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.457 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 3.2 t -145.91 140.95 27.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.364 . . . . 0.0 110.925 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 50.9 m -120.93 124.45 44.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.883 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -133.9 166.51 23.96 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 58.8 m -85.92 92.96 8.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.816 0.341 . . . . 0.0 110.895 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 40.9 m -52.01 176.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -163.61 -82.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 179.75 -158.17 21.67 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 113.41 3.36 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.342 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.11 166.29 11.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.923 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 59.9 mt -59.88 86.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.13 151.96 62.72 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.579 0.704 . . . . 0.0 110.92 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -178.52 2.38 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.715 2.277 . . . . 0.0 112.346 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -85.34 90.63 7.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 25.4 mtt-85 -125.82 80.49 1.91 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -92.31 -51.65 5.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.889 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.411 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.3 p-80 -48.97 -37.65 20.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.848 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.411 HG23 ' CD2' ' A' ' 439' ' ' HIS . 90.9 t -68.62 137.3 24.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.408 HD21 HG22 ' A' ' 484' ' ' VAL . 14.3 mt -129.25 136.28 49.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -92.51 107.92 19.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.677 HG22 HG12 ' A' ' 499' ' ' ILE . 49.0 t -110.13 123.66 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.098 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 7.3 p -98.15 105.66 17.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.147 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' A' ' 454' ' ' LEU . 3.9 p90 -124.68 153.42 70.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.63 0.728 . . . . 0.0 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.73 142.36 47.84 Favored 'Trans proline' 0 N--CA 1.465 -0.168 0 C-N-CA 122.733 2.289 . . . . 0.0 112.321 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 448' ' ' GLU . 17.2 ptmt -40.81 -46.03 2.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.875 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.465 ' N ' ' HG3' ' A' ' 447' ' ' LYS . 10.4 pt-20 -36.59 -40.48 0.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.554 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.1 m0 -52.43 -179.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -160.83 175.3 12.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.936 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.472 HG22 ' HD2' ' A' ' 455' ' ' TYR . 41.6 m -55.54 -55.14 35.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.166 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 80.5 p -47.84 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.62 -47.2 84.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.883 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' A' ' 445' ' ' PHE . 3.3 mm? -62.62 -55.7 24.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.493 ' O ' ' N ' ' A' ' 459' ' ' SER . 6.2 m-85 -55.34 -61.97 1.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.0 pt20 -47.28 -46.19 24.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 8.9 tp -58.08 -60.79 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.904 ' CE2' HG11 ' A' ' 476' ' ' VAL . 29.5 m-85 -71.21 -9.77 58.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 455' ' ' TYR . 9.3 t -43.37 -37.74 2.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -33.89 -39.03 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.1 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -86.52 -54.05 4.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.845 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 139.45 -154.73 23.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -47.22 123.18 5.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.735 0.302 . . . . 0.0 110.884 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 462' ' ' GLY . 17.4 pt -139.58 173.72 10.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.062 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -117.75 110.88 18.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.437 HD12 ' CE2' ' A' ' 455' ' ' TYR . 32.9 mt -98.08 109.85 24.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -93.97 116.52 28.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.853 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -81.81 109.77 16.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.956 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 1.009 HD11 ' CD2' ' A' ' 475' ' ' PHE . 7.9 mt -88.3 -63.14 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.102 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.56 -177.07 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.861 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -70.2 -6.25 33.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 81.2 p -132.2 -41.63 0.99 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.141 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 22.6 t -85.97 141.57 29.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.03 -177.59 5.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.101 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 1.009 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.2 m-85 -137.67 143.67 41.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.877 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.904 HG11 ' CE2' ' A' ' 458' ' ' PHE . 95.0 t -132.06 108.06 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.146 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 t -96.95 131.96 43.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.836 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.583 HD22 ' OE1' ' A' ' 483' ' ' GLN . 86.4 mt -108.67 177.84 4.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.891 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 75.1 m -90.16 -47.11 8.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -118.95 152.85 52.32 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.56 0.695 . . . . 0.0 110.908 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -34.91 13.59 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.698 2.265 . . . . 0.0 112.318 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -44.73 -56.62 4.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.867 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.583 ' OE1' HD22 ' A' ' 478' ' ' LEU . 45.5 mt-30 -41.19 -48.13 3.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.885 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.4 t -34.77 -54.38 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.102 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 9.8 tp60 -46.99 -53.45 12.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.849 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.55 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -58.1 -56.67 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -49.18 -44.6 43.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.099 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 484' ' ' VAL . 48.0 t -67.55 -46.78 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.109 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -51.39 -52.22 47.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.413 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 76.2 p -64.9 -40.2 94.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.132 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.469 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 53.7 p -61.46 -40.96 96.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 491' ' ' SER . 54.6 mmtt -36.16 -65.13 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.917 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 11.3 p90 -70.44 -43.55 69.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.92 111.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.137 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -90.22 -40.47 12.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.2 t -51.07 -50.33 58.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.851 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.446 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.6 p90 -121.98 154.38 37.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -125.02 131.66 53.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.677 HG12 HG22 ' A' ' 443' ' ' VAL . 87.1 mt -117.91 138.48 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.115 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -145.17 172.62 12.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.6 p -92.09 143.24 26.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.14 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.938 ' CE2' HG11 ' A' ' 506' ' ' VAL . 64.8 t80 -42.82 -46.44 5.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -53.12 -40.12 63.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.108 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -65.76 -48.38 72.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.857 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.16 -57.79 11.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.938 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.5 m -59.17 -41.0 82.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -54.01 -47.14 67.61 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.515 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -70.04 -56.87 5.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.349 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 26.8 tttm -44.21 -48.33 9.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.849 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -73.28 171.89 12.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -150.01 123.2 8.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.869 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -60.6 -143.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.459 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -123.46 42.58 3.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.723 0.297 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -162.58 146.27 11.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 11.2 p -75.42 144.19 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.117 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 12.1 mmmt -44.4 135.19 4.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.2 t -160.17 140.83 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 131.45 84.99 0.31 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.459 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 145.51 57.65 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.737 2.292 . . . . 0.0 112.344 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 3.8 m -140.37 113.55 8.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . 0.416 ' O ' ' C ' ' A' ' 522' ' ' GLY . 58.2 m -122.78 155.09 37.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.827 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 521' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 32.0 t -97.14 100.25 11.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.861 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 84.8 p -133.7 130.27 37.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -126.51 -173.39 13.54 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.476 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 26.1 t -91.37 141.14 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.374 . . . . 0.0 110.849 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 52.6 p -87.88 120.88 29.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.835 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -116.46 90.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.475 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 86.08 83.32 1.1 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.496 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.82 102.15 1.0 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.701 2.268 . . . . 0.0 112.348 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.4 168.52 5.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -58.62 89.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -51.45 142.97 20.35 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.584 0.707 . . . . 0.0 110.919 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -174.85 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.674 2.249 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.54 33.46 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.56 ' HD2' ' CE2' ' A' ' 502' ' ' TYR . 29.7 mtt180 -78.42 84.43 4.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -100.39 -45.23 5.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -54.36 -30.09 50.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.5 HG21 ' HD3' ' A' ' 437' ' ' ARG . 89.5 t -73.1 132.64 33.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.105 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 478' ' ' LEU . 9.0 mt -121.09 147.08 46.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.641 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 49.5 t-80 -108.03 109.34 20.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.827 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 499' ' ' ILE . 12.1 t -114.26 118.11 57.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.116 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -98.53 104.1 16.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.564 ' CE2' HD11 ' A' ' 454' ' ' LEU . 12.6 p90 -115.66 154.94 47.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.637 0.732 . . . . 0.0 110.891 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.8 146.21 59.25 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.665 2.243 . . . . 0.0 112.333 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 10.0 ptmm? -47.88 -39.06 17.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.93 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -43.68 -28.15 0.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.3 m0 -66.54 -174.87 0.33 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt -161.78 165.06 28.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 86.7 m -46.89 -55.15 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.13 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.8 t -47.91 -49.31 30.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.884 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -52.99 -44.49 67.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.83 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.564 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.7 mm? -62.38 -61.06 2.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.911 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -49.89 -65.48 0.56 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.912 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.463 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 4.4 pt20 -43.69 -45.51 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.907 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.463 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 12.2 tp -59.04 -61.31 2.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.917 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.8 m-85 -70.85 -8.94 56.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.869 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 5.4 t -45.39 -25.5 0.42 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -49.46 -38.94 31.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 52.8 m-85 -85.36 -46.47 10.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.859 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.863 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 124.11 -144.57 15.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.515 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -44.86 120.73 2.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.863 HG23 ' O ' ' A' ' 462' ' ' GLY . 37.0 pt -140.16 171.8 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -125.43 101.01 6.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.924 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 37.8 mt -83.65 109.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.116 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -98.69 109.85 22.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -76.71 109.36 10.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.953 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.948 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -90.46 -70.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.128 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . 0.465 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.7 m-20 -120.09 -174.85 2.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -63.23 -33.14 74.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 24.8 p -124.91 19.54 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.108 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -129.47 133.41 47.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.891 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.23 173.86 11.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.948 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -134.04 149.96 51.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.0 t -137.49 109.51 6.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.146 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 13.9 t -97.76 134.0 41.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.535 HD11 HD11 ' A' ' 441' ' ' LEU . 65.0 mt -109.6 177.67 4.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -88.43 -47.9 8.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.812 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -118.24 149.16 45.26 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.662 0.744 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -18.49 37.24 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.693 2.262 . . . . 0.0 112.38 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -60.37 -55.41 33.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.466 ' HB2' HD13 ' A' ' 478' ' ' LEU . 55.1 mm-40 -45.36 -45.54 12.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 483' ' ' GLN . 84.0 t -34.79 -56.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.093 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -46.22 -55.33 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.614 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -54.17 -54.45 20.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.124 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.2 -54.87 25.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.087 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 65.5 t -59.33 -39.53 79.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.078 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -52.08 -63.82 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 62.1 p -55.23 -37.43 67.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . . . . . . . . . 17.3 t -55.94 -31.15 62.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.914 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -52.96 -64.74 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 6.1 p90 -66.82 -41.84 86.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.464 ' N ' ' CD1' ' A' ' 493' ' ' TYR . . . -52.52 118.58 3.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.113 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -98.31 -38.23 9.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 78.8 p -47.31 -48.5 25.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.832 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -118.75 165.83 13.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -134.18 125.31 27.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.553 HG12 HG22 ' A' ' 443' ' ' VAL . 50.2 mt -117.4 142.64 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -143.76 -179.12 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 20.9 p -95.15 140.08 30.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.15 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.962 ' O ' HG22 ' A' ' 506' ' ' VAL . 85.7 t80 -45.88 -39.08 8.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.937 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 506' ' ' VAL . . . -68.54 -31.72 71.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.12 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -71.5 -38.29 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.942 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.641 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 42.3 t80 -75.05 -54.17 7.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.895 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.962 HG22 ' O ' ' A' ' 502' ' ' TYR . 12.6 m -56.05 -23.19 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.133 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -81.28 -34.76 25.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 9.0 ptpt -89.65 -18.02 27.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.883 0.373 . . . . 0.0 110.913 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.456 ' CG ' ' HA ' ' A' ' 506' ' ' VAL . 0.0 OUTLIER -91.65 -33.86 14.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.887 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -71.36 139.56 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -158.3 113.71 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -100.94 -143.85 14.63 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.478 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -131.5 80.35 1.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.736 0.303 . . . . 0.0 110.932 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 40.0 tp60 -164.05 130.82 3.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.932 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 6.3 p -55.44 138.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 3.9 mmmm -60.63 137.35 58.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.902 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 30.7 p -101.83 172.74 6.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -103.07 146.21 16.5 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.458 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 137.32 35.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.72 2.28 . . . . 0.0 112.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 80.7 p -46.84 124.12 5.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 3.4 t -58.17 157.46 8.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.516 179.98 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 67.9 m -146.25 164.6 31.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.94 0.4 . . . . 0.0 110.811 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.1 t -147.59 156.55 42.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -58.06 149.23 34.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 70.3 m -91.65 173.64 7.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.851 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 16.4 m -109.0 98.53 7.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.828 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -79.61 54.58 4.38 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.465 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 110.77 83.45 1.39 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 141.63 45.66 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.688 2.259 . . . . 0.0 112.338 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.421 ' O ' ' NE2' ' A' ' 434' ' ' GLN . 3.3 p30 -56.73 166.42 0.96 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 5.4 mp -51.94 97.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . 0.421 ' NE2' ' O ' ' A' ' 432' ' ' ASP . 7.3 mp0 -41.33 151.55 0.29 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.563 0.697 . . . . 0.0 110.952 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.81 -179.19 2.76 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.668 2.245 . . . . 0.0 112.303 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -101.33 42.37 1.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.866 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.548 ' CB ' ' CD2' ' A' ' 502' ' ' TYR . 24.0 mmt180 -110.29 74.89 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -106.11 -43.47 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.837 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.407 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.2 p-80 -60.8 -36.82 80.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.407 HG23 ' CD2' ' A' ' 439' ' ' HIS . 57.5 t -73.34 132.07 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.418 HD21 HG13 ' A' ' 484' ' ' VAL . 9.5 mt -115.05 142.19 46.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.582 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 66.1 t-80 -105.44 108.02 19.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.687 HG22 HG23 ' A' ' 499' ' ' ILE . 31.2 t -108.89 131.26 60.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.126 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.3 p -109.57 104.03 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.156 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.696 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.1 p90 -121.75 156.59 58.78 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.502 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.8 Cg_endo -69.75 142.0 46.8 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.422 ' C ' ' HD3' ' A' ' 447' ' ' LYS . 0.0 OUTLIER -48.55 -33.24 9.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -46.71 -22.98 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.502 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.2 m0 -69.61 -175.3 0.83 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 22.0 mtmm -157.36 163.19 38.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 22.9 m -48.93 -41.0 32.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.208 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 31.5 m -59.79 -43.29 94.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.61 -41.01 93.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.696 HD11 ' CE2' ' A' ' 445' ' ' PHE . 3.6 mm? -65.61 -68.64 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 2.9 m-85 -45.09 -60.35 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 6.0 pt20 -48.17 -46.18 34.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 10.5 tp -58.22 -62.11 2.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.895 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.451 ' CE2' HG11 ' A' ' 476' ' ' VAL . 22.9 m-85 -70.63 -9.11 56.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.853 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.6 t -42.2 -24.25 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 458' ' ' PHE . . . -47.84 -48.68 30.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.078 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -77.94 -45.61 23.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.92 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.55 -150.87 19.98 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.456 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -57.23 126.93 29.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.339 . . . . 0.0 110.903 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.3 pt -136.9 172.35 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.17 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -110.04 99.92 8.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.958 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.45 HD12 ' CE2' ' A' ' 455' ' ' TYR . 43.8 mt -85.13 107.57 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.137 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 2.4 m -96.65 113.61 25.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -79.92 109.85 14.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.896 HD11 ' CD2' ' A' ' 475' ' ' PHE . 4.9 mt -90.83 -59.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -132.25 -174.76 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -68.67 -24.8 64.56 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 64.7 p -129.75 19.62 5.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.151 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 7.0 t -137.17 135.94 37.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.855 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.447 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.31 175.35 9.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.123 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.896 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -132.78 145.53 51.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.877 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.451 HG11 ' CE2' ' A' ' 458' ' ' PHE . 53.9 t -126.01 135.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 5.5 p -122.96 138.34 54.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 61.5 mt -119.87 177.34 5.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.941 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 98.1 p -92.49 -44.31 8.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -119.36 148.91 46.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.945 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -36.85 9.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.275 . . . . 0.0 112.338 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -44.8 -46.14 10.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 484' ' ' VAL . 16.1 mm-40 -53.79 -44.94 70.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.892 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.426 ' C ' ' O ' ' A' ' 483' ' ' GLN . 78.3 t -36.05 -57.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -46.67 -55.67 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.53 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.5 mp -53.51 -56.76 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.17 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -46.97 -49.24 21.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.098 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 74.6 t -64.59 -42.1 94.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.421 ' ND2' ' HA ' ' A' ' 486' ' ' ILE . 22.2 m-20 -51.71 -50.62 60.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.892 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.443 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 42.2 p -64.06 -33.89 76.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.146 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.439 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 19.2 p -68.15 -40.53 82.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.836 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 491' ' ' SER . 87.0 mttt -36.53 -58.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.907 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.443 ' CE2' ' O ' ' A' ' 490' ' ' THR . 9.4 p90 -75.73 -41.11 54.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.973 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -41.38 119.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.069 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -99.56 -47.78 4.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.848 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 69.6 m -48.3 -47.65 36.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.416 ' CZ ' ' CB ' ' A' ' 494' ' ' ALA . 27.0 p90 -117.43 162.41 17.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -131.99 132.13 43.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.833 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.687 HG23 HG22 ' A' ' 443' ' ' VAL . 23.1 mt -125.6 137.78 56.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -139.43 -179.27 5.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.907 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 6.9 p -92.0 146.1 24.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.548 ' CD2' ' CB ' ' A' ' 437' ' ' ARG . 55.4 t80 -45.75 -48.1 15.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.53 -45.27 77.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.081 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -56.68 -31.58 64.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.582 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 46.3 t80 -76.37 -67.53 0.68 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 502' ' ' TYR . 5.7 m -51.93 -26.79 8.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.122 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -62.94 -44.28 97.65 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.527 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.36 -41.79 69.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -56.47 -58.31 8.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -80.97 121.99 26.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 17.6 mtmm -81.26 42.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.86 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . 72.37 125.51 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -132.18 89.7 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.724 0.297 . . . . 0.0 110.927 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -168.07 125.17 1.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.57 159.28 41.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.149 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -102.43 102.81 13.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.894 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 26.2 t -59.55 137.67 57.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 121.69 85.31 0.8 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.481 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . 0.452 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.9 Cg_endo -69.77 136.57 33.32 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.674 2.249 . . . . 0.0 112.339 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 519' ' ' PRO . 53.9 p -34.66 138.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.841 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 67.0 p -81.46 147.05 29.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.834 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.504 -179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 20.9 m -118.47 92.15 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.878 0.371 . . . . 0.0 110.862 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 2.4 t -138.05 143.16 40.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 166.48 -115.2 0.62 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.475 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 68.4 m -160.28 142.45 12.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.89 0.376 . . . . 0.0 110.841 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 1.9 m -113.04 169.93 8.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 121.22 42.61 0.46 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.486 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -54.73 164.17 3.49 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.523 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 1.47 4.4 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.706 2.271 . . . . 0.0 112.37 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -80.0 165.42 22.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 18.1 mt -93.79 102.94 15.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.928 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -80.99 149.86 67.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.621 0.724 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.83 154.54 67.35 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 0.0 112.336 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -74.67 110.76 9.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.423 ' HB3' ' CD2' ' A' ' 502' ' ' TYR . 16.2 mmt85 -124.11 43.84 2.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.839 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.59 -60.3 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.863 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.425 ' CD2' HG23 ' A' ' 440' ' ' VAL . 3.0 p-80 -41.47 -32.91 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.425 HG23 ' CD2' ' A' ' 439' ' ' HIS . 73.2 t -73.91 131.74 34.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.148 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.49 HD21 HG13 ' A' ' 484' ' ' VAL . 13.7 mt -121.64 130.8 53.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.494 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 48.4 t-80 -93.07 107.92 19.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.526 HG22 HG12 ' A' ' 499' ' ' ILE . 47.9 t -108.9 119.79 59.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.128 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.9 p -102.06 104.51 15.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.587 ' CD2' HD11 ' A' ' 454' ' ' LEU . 11.1 p90 -120.85 154.52 57.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.665 0.745 . . . . 0.0 110.824 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.81 157.07 61.56 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.339 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -56.59 -38.38 71.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -44.6 -26.76 0.4 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.572 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -67.19 173.93 3.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -146.82 164.85 31.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 33.2 m -52.76 -49.85 64.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.145 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 45.0 m -54.34 -41.05 68.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -59.25 -46.78 87.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.587 HD11 ' CD2' ' A' ' 445' ' ' PHE . 2.0 mm? -59.07 -57.25 13.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.908 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.526 ' CE2' HD12 ' A' ' 466' ' ' ILE . 6.3 m-85 -53.38 -52.72 58.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -53.16 -46.55 68.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.959 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.3 tp -58.84 -58.99 6.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 476' ' ' VAL . 15.5 m-85 -73.47 -8.81 57.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 455' ' ' TYR . 10.5 t -45.76 -28.86 1.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -43.18 -40.77 3.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.052 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 483' ' ' GLN . 44.9 m-85 -84.93 -51.89 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.852 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.791 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 133.85 -147.68 19.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -48.15 123.51 6.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.855 0.36 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.791 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.6 pt -139.28 179.91 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -125.7 100.0 6.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.921 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.526 HD12 ' CE2' ' A' ' 455' ' ' TYR . 36.7 mt -84.78 106.63 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.139 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.13 117.67 33.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -83.04 110.99 18.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.955 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.912 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.4 mt -89.91 -64.03 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.17 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -128.09 -177.03 3.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -55.67 -40.39 72.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 40.4 p -120.96 20.36 11.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.164 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.2 t -125.13 134.45 52.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.833 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.49 177.78 8.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.07 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.912 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.0 m-85 -138.74 148.6 44.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.938 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 458' ' ' PHE . 84.8 t -138.16 107.04 3.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 50.6 m -98.95 129.66 45.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.834 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . . . . . . . . . 57.1 mt -107.27 175.0 5.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.901 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 53.9 m -86.21 -44.57 12.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.822 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 9.4 mm100 -120.35 152.48 55.03 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.544 0.688 . . . . 0.0 110.885 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 482' ' ' GLU . 53.8 Cg_endo -69.75 -42.92 2.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.7 2.267 . . . . 0.0 112.378 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 481' ' ' PRO . 3.3 mp0 -35.82 -51.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.473 ' HB3' ' CE1' ' A' ' 461' ' ' PHE . 88.8 mt-30 -50.37 -46.01 55.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.49 HG13 HD21 ' A' ' 441' ' ' LEU . 94.0 t -34.4 -53.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.57 4.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.895 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.536 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.1 mp -53.3 -45.33 55.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.08 -43.08 70.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.092 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 98.1 t -73.53 -49.72 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.092 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -40.55 -41.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 28.4 p -71.0 -43.28 68.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.12 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 60.3 p -60.02 -35.01 74.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.836 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -43.3 -64.54 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.412 ' CG ' ' N ' ' A' ' 494' ' ' ALA . 10.5 p90 -71.32 -40.81 70.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.92 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.476 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -52.26 121.25 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -99.37 -42.29 7.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 9.6 t -47.18 -48.53 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.484 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 38.2 p90 -116.05 160.41 20.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -132.93 122.01 23.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.526 HG12 HG22 ' A' ' 443' ' ' VAL . 73.2 mt -112.97 138.12 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -143.36 168.09 20.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 21.4 p -81.76 147.08 29.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.874 ' CE2' HG11 ' A' ' 506' ' ' VAL . 76.7 t80 -52.3 -48.17 65.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.959 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.63 -35.6 66.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.111 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -71.19 -52.45 19.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.856 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.494 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 23.7 t80 -60.06 -58.64 7.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.921 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.874 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.4 m -52.27 -29.75 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.137 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -43.43 -63.18 2.21 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.464 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -74.47 -47.94 30.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.841 0.353 . . . . 0.0 110.914 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 505' ' ' TYR . 28.2 tttm -41.48 -46.35 3.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.917 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -77.21 179.06 6.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.949 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -144.28 110.25 5.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.94 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -120.14 -141.78 6.44 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -174.91 116.89 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.726 0.298 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -164.77 123.77 1.81 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.923 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 93.6 t -127.13 140.68 48.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -171.42 120.43 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 13.3 t -88.84 92.86 9.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -126.72 88.96 0.35 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -174.11 0.85 Allowed 'Trans proline' 0 N--CA 1.466 -0.146 0 C-N-CA 122.687 2.258 . . . . 0.0 112.336 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 71.7 m -106.04 116.04 31.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 42.1 t -101.76 165.04 11.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.488 -179.988 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 46.5 p -53.05 152.98 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 56.9 p -165.02 139.76 5.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 149.39 159.17 8.47 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.499 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 77.4 p -148.2 137.53 22.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.888 0.375 . . . . 0.0 110.823 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 22.9 t -86.41 97.62 10.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 50.57 -126.2 24.07 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.478 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 124.49 74.5 0.25 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 1.55 4.35 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.687 2.258 . . . . 0.0 112.322 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -78.33 154.07 31.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 10.5 mt -106.79 147.71 29.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -119.03 150.92 49.73 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.439 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.6 Cg_endo -69.77 -174.51 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.642 2.228 . . . . 0.0 112.358 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 435' ' ' PRO . 20.3 mmtt -34.93 146.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 48.3 mtt-85 -108.61 80.0 1.3 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.18 -55.76 3.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -43.78 -36.85 2.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.95 145.48 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.137 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.62 HD21 HG22 ' A' ' 484' ' ' VAL . 7.5 mt -130.27 144.16 51.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.723 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 54.7 t-80 -99.46 108.64 21.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.679 HG22 HG12 ' A' ' 499' ' ' ILE . 86.9 t -111.41 123.17 67.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.137 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.2 p -104.68 103.96 13.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.166 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.663 ' CD2' HD11 ' A' ' 454' ' ' LEU . 9.1 p90 -119.63 153.1 54.14 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.637 0.732 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 54.0 Cg_endo -69.71 143.75 52.11 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 0.0 112.38 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 44.4 pttt -48.12 -35.87 12.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.888 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -45.6 -28.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.4 m0 -65.61 178.02 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 452' ' ' SER . 2.3 ttmm -153.38 152.22 30.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.897 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.403 ' C ' ' O ' ' A' ' 450' ' ' LYS . 93.8 m -37.51 -28.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.095 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . 0.49 ' N ' ' O ' ' A' ' 450' ' ' LYS . 35.2 t -71.11 -48.77 50.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 450' ' ' LYS . 40.9 m-20 -59.07 -37.06 76.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.663 HD11 ' CD2' ' A' ' 445' ' ' PHE . 3.8 mm? -65.33 -56.43 12.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.666 ' CE2' HD12 ' A' ' 466' ' ' ILE . 8.0 m-85 -57.59 -53.78 54.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.92 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 -52.37 -44.84 65.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.934 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 10.8 tp -58.87 -58.98 6.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.852 ' CE2' HG21 ' A' ' 476' ' ' VAL . 15.4 m-85 -74.69 -8.7 57.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.877 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.8 t -43.07 -38.82 2.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.836 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.03 -39.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -86.9 -54.22 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.47 -145.03 17.15 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.468 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 37.7 m-20 -50.14 121.24 5.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 0.0 110.884 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.784 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.8 pt -138.37 176.39 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -119.51 99.88 6.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.666 HD12 ' CE2' ' A' ' 455' ' ' TYR . 50.3 mt -84.16 102.52 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.117 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -92.38 111.82 23.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -79.07 109.53 13.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.895 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.1 mt -89.95 -70.61 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.065 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -117.89 -174.87 2.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.843 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -63.7 -29.54 70.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 67.1 p -128.79 16.77 6.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.085 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.4 t -125.37 135.12 52.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -142.27 170.64 15.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.895 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -131.0 146.16 52.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.852 HG21 ' CE2' ' A' ' 458' ' ' PHE . 90.9 t -133.9 115.88 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.101 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 40.0 t -107.04 143.16 35.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.858 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.552 HD13 ' CB ' ' A' ' 483' ' ' GLN . 81.8 mt -123.44 179.18 4.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.5 m -94.52 -41.23 9.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -117.15 143.93 32.73 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.563 0.697 . . . . 0.0 110.906 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -22.51 32.33 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.731 2.287 . . . . 0.0 112.355 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.54 -46.38 73.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.552 ' CB ' HD13 ' A' ' 478' ' ' LEU . 40.6 mt-30 -52.0 -40.0 60.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.935 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.715 ' O ' HG23 ' A' ' 488' ' ' VAL . 93.7 t -47.35 -41.61 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.117 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -56.5 -34.15 66.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 4.9 mp -81.17 -51.45 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.152 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -50.68 -33.67 23.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 484' ' ' VAL . 36.0 t -81.92 -51.83 14.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -48.38 -44.25 34.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.417 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 41.1 p -68.86 -42.44 77.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.459 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 82.0 p -62.53 -35.79 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.855 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.23 -60.28 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 494' ' ' ALA . 11.2 p90 -74.26 -43.55 56.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -47.1 121.27 3.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.077 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.91 -43.06 6.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 19.8 m -47.8 -50.19 26.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.833 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -118.05 152.56 35.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 3.2 tpp85 -123.95 129.06 50.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.84 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.679 HG12 HG22 ' A' ' 443' ' ' VAL . 69.8 mt -119.43 140.88 41.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -152.01 173.41 14.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 35.5 p -82.66 145.97 29.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.604 ' O ' HG22 ' A' ' 506' ' ' VAL . 46.6 t80 -45.48 -40.39 8.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.885 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.58 78.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -67.37 -36.91 82.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.723 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 17.8 t80 -71.61 -54.5 10.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.965 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 502' ' ' TYR . 19.8 m -65.83 -38.11 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.094 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.19 -48.01 0.79 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.496 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 0.0 OUTLIER -82.55 -48.66 10.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.852 0.358 . . . . 0.0 110.905 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 11.4 tptp -35.75 -58.22 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.908 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . 0.401 ' O ' ' CG ' ' A' ' 510' ' ' GLN . 11.9 pt20 -80.07 90.52 5.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -65.73 86.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.888 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -91.54 -134.23 6.18 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.459 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 14.9 mtpp -125.47 45.56 2.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.712 0.291 . . . . 0.0 110.885 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -160.42 156.05 25.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 46.5 t -120.47 143.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -38.18 126.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 3.9 m -101.19 131.34 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 139.18 70.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 120.25 7.06 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.76 2.307 . . . . 0.0 112.358 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 65.7 p -137.89 111.72 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.829 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 6.0 t -44.47 148.65 0.45 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.857 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.515 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 50.0 m -119.09 167.78 11.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.348 . . . . 0.0 110.865 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.5 t -117.18 115.92 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 132.09 69.18 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.471 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 9.0 t -56.29 145.14 27.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.879 0.371 . . . . 0.0 110.845 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.3 p -88.85 84.27 6.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.885 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 54.1 -114.03 3.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.475 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 148.4 83.5 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.475 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 1.53 4.37 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.657 2.238 . . . . 0.0 112.331 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -91.88 150.96 20.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.12 92.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -73.88 143.99 82.0 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.584 0.707 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 165.45 30.88 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.66 2.24 . . . . 0.0 112.382 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 33.4 tttt -94.45 38.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.503 ' NH1' ' CE2' ' A' ' 502' ' ' TYR . 37.3 mtt85 -84.18 79.15 9.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.857 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -92.31 -46.95 7.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.454 ' CD2' HG23 ' A' ' 440' ' ' VAL . 5.1 p-80 -54.82 -33.72 61.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.858 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.454 HG23 ' CD2' ' A' ' 439' ' ' HIS . 92.4 t -69.22 144.67 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.103 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 484' ' ' VAL . 10.2 mt -137.07 124.77 22.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.63 ' NE2' ' CD1' ' A' ' 505' ' ' TYR . 56.8 t-80 -91.65 108.03 19.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.897 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.643 HG22 HG23 ' A' ' 499' ' ' ILE . 45.0 t -111.89 125.52 69.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.085 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.7 p -105.64 107.49 18.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.592 ' CE2' HD11 ' A' ' 454' ' ' LEU . 5.4 p90 -121.43 158.17 54.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.654 0.74 . . . . 0.0 110.862 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.505 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.6 Cg_endo -69.83 145.4 56.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.711 2.274 . . . . 0.0 112.327 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -45.03 -43.1 9.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -38.72 -32.28 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.892 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.559 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 10.4 m0 -61.66 -179.31 0.18 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 450' ' ' LYS . 7.4 mtpm? -163.45 168.33 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.884 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 15.0 m -49.91 -50.18 47.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.175 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.4 m -49.59 -41.86 43.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.48 -48.85 77.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.592 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.9 -58.62 7.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -53.44 -62.05 1.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.924 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.476 ' CG ' ' N ' ' A' ' 457' ' ' LEU . 3.8 pt20 -50.19 -46.26 54.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.476 ' N ' ' CG ' ' A' ' 456' ' ' GLN . 7.5 tp -57.82 -65.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.905 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.463 ' CE2' HG11 ' A' ' 476' ' ' VAL . 21.4 m-85 -69.19 -8.73 48.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 28.0 t -40.29 -38.93 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.39 -40.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 45.3 m-85 -82.29 -52.26 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.771 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 128.83 -144.48 15.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.478 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -48.93 120.26 3.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 0.0 110.9 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 462' ' ' GLY . 19.7 pt -138.83 168.75 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -115.19 100.88 8.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 50.7 mt -88.95 106.85 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.155 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -99.77 118.37 36.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -82.35 111.25 18.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.808 HG22 ' OD1' ' A' ' 470' ' ' ASP . 4.1 mt -90.25 -70.34 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.146 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . 0.808 ' OD1' HG22 ' A' ' 469' ' ' ILE . 0.6 OUTLIER -118.51 -174.78 2.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.848 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.8 -27.62 69.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 43.6 p -132.18 20.66 4.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.132 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 2.3 t -127.58 132.6 49.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.412 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.46 163.36 33.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.076 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.691 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.1 m-85 -122.86 142.66 50.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.818 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.463 HG11 ' CE2' ' A' ' 458' ' ' PHE . 48.9 t -133.33 107.85 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.096 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 27.6 t -99.72 137.09 38.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.833 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.612 HD13 ' CB ' ' A' ' 483' ' ' GLN . 83.4 mt -113.62 177.56 4.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.892 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 29.4 m -93.9 -49.89 5.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . 0.418 ' H ' ' NE2' ' A' ' 483' ' ' GLN . 75.2 mt-30 -106.45 145.68 31.5 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.582 0.706 . . . . 0.0 110.903 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -21.99 32.66 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.727 2.285 . . . . 0.0 112.364 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -59.56 -49.43 77.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.612 ' CB ' HD13 ' A' ' 478' ' ' LEU . 21.6 mt-30 -49.0 -46.89 44.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 488' ' ' VAL . 85.5 t -35.1 -56.31 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.125 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . 0.424 ' HA ' ' NE2' ' A' ' 485' ' ' GLN . 7.9 tp60 -48.66 -70.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.919 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.636 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.8 mp -42.81 -47.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.141 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.09 -45.46 71.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.103 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 491' ' ' SER . 57.2 t -71.83 -57.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.164 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 1.1 t30 -35.85 -40.22 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.862 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -72.2 -42.5 65.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.113 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 79.1 p -65.32 -29.23 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -41.02 -65.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.892 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.404 ' CE2' ' HA ' ' A' ' 490' ' ' THR . 35.2 p90 -75.88 -38.32 57.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.557 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -43.61 117.27 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.81 -44.68 7.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 53.8 m -48.43 -45.99 36.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.876 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.559 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 27.8 p90 -122.07 157.69 30.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 23.5 ttm180 -129.05 130.42 46.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.643 HG23 HG22 ' A' ' 443' ' ' VAL . 34.8 mt -121.76 137.16 56.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.141 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -144.16 176.45 9.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 60.8 p -93.7 147.46 23.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.15 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.503 ' CE2' ' NH1' ' A' ' 437' ' ' ARG . 37.8 t80 -39.64 -46.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.31 75.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.109 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -63.5 -34.67 78.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.63 ' CD1' ' NE2' ' A' ' 442' ' ' HIS . 21.7 t80 -71.5 -54.54 10.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' A' ' 507' ' ' GLY . 31.4 m -63.82 -38.99 83.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.157 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 506' ' ' VAL . . . -35.11 -65.05 0.43 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.424 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 7.4 ptmt -65.72 -42.62 90.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.828 0.347 . . . . 0.0 110.918 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 13.2 tptm -46.16 -64.16 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.06 110.92 22.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -173.48 128.51 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -125.96 -85.13 0.57 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.538 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -171.92 109.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.763 0.316 . . . . 0.0 110.875 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . 0.406 ' O ' ' C ' ' A' ' 515' ' ' VAL . 21.1 tt0 -149.04 126.36 11.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 514' ' ' GLN . 15.0 p -37.52 142.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.127 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -92.8 136.44 33.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -166.09 166.15 17.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.847 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 145.56 -162.9 28.26 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.467 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 2.28 3.63 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.676 2.25 . . . . 0.0 112.363 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 68.5 m -73.04 142.98 47.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.83 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 11.2 t -164.28 164.66 22.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.858 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.455 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.3 t -46.6 -58.96 3.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.839 0.352 . . . . 0.0 110.876 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 79.8 p -56.19 156.42 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.84 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -164.81 50.37 0.29 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.467 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 71.9 p -166.3 161.37 16.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.894 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 56.1 p -93.81 169.12 10.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.824 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -111.45 42.82 1.86 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -135.57 -158.71 8.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.504 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 117.32 5.02 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.719 2.28 . . . . 0.0 112.342 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -143.22 170.45 15.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 25.2 tp -104.4 93.28 4.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.71 152.4 45.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.605 0.717 . . . . 0.0 110.904 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 175.91 7.52 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -92.29 42.39 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 23.9 mtt85 -112.89 52.53 0.78 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.832 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -90.09 -48.97 6.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.894 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.421 ' CD2' HG23 ' A' ' 440' ' ' VAL . 7.8 p-80 -50.25 -27.37 5.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.84 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.421 HG23 ' CD2' ' A' ' 439' ' ' HIS . 41.0 t -76.19 137.74 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.077 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 478' ' ' LEU . 7.5 mt -128.79 125.43 37.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.417 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 47.9 t-80 -90.16 107.94 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.584 HG22 HG12 ' A' ' 499' ' ' ILE . 33.7 t -109.54 117.18 53.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.6 p -94.1 104.05 16.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.143 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 454' ' ' LEU . 14.4 p90 -122.7 156.09 62.19 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.651 0.739 . . . . 0.0 110.872 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.497 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.76 141.85 46.36 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 449' ' ' TRP . 0.0 OUTLIER -46.33 -36.76 6.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.445 ' N ' ' HG2' ' A' ' 447' ' ' LYS . 7.3 pt-20 -41.77 -24.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.497 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -71.14 -176.2 1.37 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -157.54 160.24 37.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.925 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 88.9 m -40.15 -53.56 2.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . 0.434 ' O ' ' CG ' ' A' ' 456' ' ' GLN . 24.4 p -51.48 -62.3 1.71 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.85 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . 0.428 ' HA ' ' CD ' ' A' ' 456' ' ' GLN . 18.9 t0 -38.75 -44.06 0.98 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 445' ' ' PHE . 2.9 mm? -64.24 -57.51 9.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.496 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.2 m-85 -49.81 -71.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.434 ' CG ' ' O ' ' A' ' 452' ' ' SER . 0.0 OUTLIER -40.08 -55.5 2.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.881 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 6.1 tp -51.86 -40.78 61.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.918 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 1.001 ' CE2' HG11 ' A' ' 476' ' ' VAL . 15.0 m-85 -88.69 -8.99 53.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 455' ' ' TYR . 38.0 t -48.05 -21.8 0.51 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.858 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -47.45 -40.81 19.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 483' ' ' GLN . 23.8 m-85 -89.14 -54.38 4.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.856 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 140.65 -151.02 22.1 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.507 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -49.39 125.43 11.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.791 0.329 . . . . 0.0 110.857 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.5 pt -139.78 173.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.112 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -117.61 103.74 10.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.901 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 53.0 mt -85.84 101.16 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.148 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -89.56 114.98 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.82 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -81.76 108.38 15.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.969 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.6 mt -90.94 -70.65 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.133 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -122.34 -174.96 3.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.892 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -62.57 -36.6 83.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 20.7 p -121.89 19.85 10.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.122 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 1.7 m -131.53 129.82 41.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.505 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.88 174.53 10.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.969 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -134.27 146.6 50.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 1.001 HG11 ' CE2' ' A' ' 458' ' ' PHE . 57.7 t -130.88 119.8 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.154 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.3 p -106.04 140.86 38.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.792 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.537 HD11 HD11 ' A' ' 441' ' ' LEU . 70.6 mt -114.73 179.69 3.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.903 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 60.2 p -99.84 -24.9 14.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -128.66 143.09 47.13 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.638 0.732 . . . . 0.0 110.858 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.436 ' O ' HG23 ' A' ' 484' ' ' VAL . 53.7 Cg_endo -69.74 -36.53 10.7 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.93 -49.53 62.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.865 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.474 ' HB3' ' CE2' ' A' ' 461' ' ' PHE . 15.6 mm100 -48.89 -33.48 10.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.491 HG13 HD21 ' A' ' 441' ' ' LEU . 94.3 t -46.04 -62.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.141 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -48.64 -51.66 27.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.965 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 486' ' ' ILE . 3.0 mp -51.28 -52.46 19.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -53.85 -43.1 69.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.02 -45.0 88.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -52.54 -41.88 63.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 60.8 p -73.95 -32.03 63.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.098 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.462 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 87.5 p -71.76 -14.0 61.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -59.66 -55.92 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.913 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -81.07 -39.66 25.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.928 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -44.01 116.67 1.03 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.119 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -98.36 -38.54 9.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 63.5 p -48.34 -44.76 34.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.417 ' C ' ' CD1' ' A' ' 497' ' ' TYR . 5.2 p90 -125.06 170.73 10.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -136.58 116.33 13.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.584 HG12 HG22 ' A' ' 443' ' ' VAL . 54.4 mt -111.63 142.21 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -150.62 160.3 43.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 33.7 p -72.04 145.22 48.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.137 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.447 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.2 t80 -47.54 -52.55 17.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.939 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.15 -41.56 71.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.078 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -61.39 -44.88 96.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.879 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.417 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 21.5 t80 -63.31 -57.51 10.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 502' ' ' TYR . 27.5 m -59.09 -39.27 78.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -41.14 -58.18 2.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.477 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -47.74 -41.29 22.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.82 -64.84 0.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -73.37 111.21 8.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 5.6 ttpm? -173.22 112.23 0.21 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -119.65 -107.44 2.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.515 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -121.29 40.77 3.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.717 0.294 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -149.23 127.94 12.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.893 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 35.0 m -135.6 176.64 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.144 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -79.54 111.6 15.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.933 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 1.6 t -114.38 161.89 17.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -149.1 146.81 16.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.471 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 520' ' ' SER . 53.7 Cg_endo -69.78 -49.31 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.669 2.246 . . . . 0.0 112.321 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . 0.45 ' C ' ' O ' ' A' ' 519' ' ' PRO . 83.8 p -34.74 146.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.843 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 13.5 p -50.92 -179.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.495 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 34.1 t -103.98 137.06 42.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.867 0.365 . . . . 0.0 110.87 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 1.2 t -151.19 175.46 12.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.841 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . -128.16 176.19 18.21 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.467 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 1.5 t -126.32 85.59 2.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.891 0.377 . . . . 0.0 110.856 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 19.9 m 50.69 42.52 27.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -177.14 -156.4 15.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.487 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 143.41 -161.59 27.66 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.51 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 432' ' ' ASP . 53.7 Cg_endo -69.77 174.46 9.48 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.677 2.252 . . . . 0.0 112.358 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 431' ' ' PRO . 30.9 t0 -36.22 125.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 24.6 tp -113.06 92.26 3.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.1 143.96 86.85 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.604 0.716 . . . . 0.0 110.875 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 147.34 62.48 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 0.0 112.355 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.1 tptm -173.33 129.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . . . . . . . . . 37.5 mtt-85 53.52 45.5 28.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.917 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -62.87 -54.78 33.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.881 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.537 ' CD2' HG23 ' A' ' 440' ' ' VAL . 3.2 p-80 -45.13 -30.37 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.852 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.537 HG23 ' CD2' ' A' ' 439' ' ' HIS . 92.8 t -71.6 138.63 21.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 478' ' ' LEU . 13.3 mt -118.48 153.41 34.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -120.75 112.7 19.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.422 HG22 HG12 ' A' ' 499' ' ' ILE . 9.3 t -113.89 127.91 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.7 p -108.26 104.03 13.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.171 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.6 p90 -115.36 156.5 45.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.663 0.744 . . . . 0.0 110.868 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 448' ' ' GLU . 54.0 Cg_endo -69.7 141.76 46.36 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.75 2.3 . . . . 0.0 112.326 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 446' ' ' PRO . 6.7 ptpp? -37.82 -27.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.901 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 446' ' ' PRO . 54.3 mm-40 -54.67 -47.83 73.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.531 ' CH2' ' HB3' ' A' ' 497' ' ' TYR . 12.7 m0 -55.17 154.31 5.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -133.39 175.77 9.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.886 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.464 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 99.4 m -51.69 -53.18 41.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 49.5 m -53.54 -45.19 69.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.843 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -53.72 -44.93 70.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -64.3 -59.48 4.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.483 ' O ' ' N ' ' A' ' 459' ' ' SER . 11.5 m-85 -47.5 -49.03 26.89 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -57.45 -52.26 66.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.923 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 7.6 tp -56.07 -52.06 65.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.739 ' CE2' HG21 ' A' ' 476' ' ' VAL . 22.2 m-85 -77.0 -10.69 59.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.908 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 455' ' ' TYR . 6.4 t -42.52 -40.25 2.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.914 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -36.59 -46.65 0.59 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -76.61 -51.69 11.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.89 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 134.24 -151.32 20.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.48 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -51.07 125.29 13.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.79 0.329 . . . . 0.0 110.936 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.693 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -140.22 173.53 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -118.15 106.71 13.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.464 HD12 ' CE2' ' A' ' 455' ' ' TYR . 57.2 mt -92.11 109.29 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.12 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.2 t -101.8 115.31 30.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.877 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . 0.464 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 78.1 m95 -79.09 109.53 13.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.5 mt -88.78 -69.04 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.093 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -119.6 -174.87 2.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -61.55 -33.08 73.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.857 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 51.3 p -127.02 17.98 7.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.156 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.85 132.13 53.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.28 163.12 33.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.045 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.905 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -123.29 143.11 50.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 458' ' ' PHE . 59.6 t -134.23 105.49 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.157 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 23.8 t -94.54 136.72 34.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.872 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.717 HD11 HD11 ' A' ' 441' ' ' LEU . 85.7 mt -110.77 175.02 5.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 67.5 m -86.94 -48.62 7.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.845 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -120.79 150.49 52.88 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.609 0.718 . . . . 0.0 110.905 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.503 ' HA ' HG23 ' A' ' 484' ' ' VAL . 53.9 Cg_endo -69.79 -32.35 18.59 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.363 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -44.58 -37.72 3.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.504 ' HB2' HD13 ' A' ' 478' ' ' LEU . 10.4 mm100 -69.65 -42.5 74.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 488' ' ' VAL . 73.0 t -35.08 -52.88 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.9 -60.85 2.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.719 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -48.87 -49.59 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -54.47 -41.33 69.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.092 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 484' ' ' VAL . 93.0 t -72.88 -38.53 57.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.135 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.81 -43.11 80.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.546 ' O ' ' CE2' ' A' ' 493' ' ' TYR . 45.6 p -69.0 -37.57 78.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.104 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.463 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 4.8 p -67.98 -34.71 77.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.82 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 491' ' ' SER . 17.2 mmtm -37.61 -58.13 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.912 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.546 ' CE2' ' O ' ' A' ' 490' ' ' THR . 15.7 p90 -75.44 -42.9 52.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.514 ' CB ' ' CZ ' ' A' ' 497' ' ' TYR . . . -41.03 116.45 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.073 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -96.63 -44.62 7.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 32.3 t -51.82 -48.18 64.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.531 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 47.6 p90 -115.77 159.34 21.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -131.11 127.5 38.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.463 ' HB ' ' CB ' ' A' ' 491' ' ' SER . 75.5 mt -117.33 145.32 23.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.111 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -149.51 -175.12 4.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.929 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 3.2 t -105.36 152.03 23.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.165 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.691 ' CE1' HG11 ' A' ' 506' ' ' VAL . 41.7 t80 -50.14 -18.21 0.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.882 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -75.68 -34.48 60.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.068 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.1 -50.21 24.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.895 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -55.03 -46.37 75.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.929 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.691 HG11 ' CE1' ' A' ' 502' ' ' TYR . 26.8 m -69.93 -44.02 79.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.142 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.458 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -42.23 -49.69 5.49 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.445 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -58.38 -52.42 65.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.806 0.336 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.25 -36.95 71.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.853 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -66.38 128.17 35.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -132.72 98.67 4.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -111.4 -133.17 6.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -170.37 112.11 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.72 0.295 . . . . 0.0 110.923 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -155.09 134.34 12.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.8 m -73.29 171.08 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.4 ttpp -174.14 141.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.87 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 33.8 m -70.48 172.96 7.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.835 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -82.72 141.37 21.0 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.503 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -42.16 3.71 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.692 2.262 . . . . 0.0 112.349 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 43.8 p -109.11 146.58 33.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.0 m -125.33 -47.12 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.465 -179.984 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 63.2 p -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.873 0.368 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 8.4 t -65.05 -45.7 84.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.888 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 88.95 -98.62 2.46 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.51 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 4.0 m 52.79 44.66 30.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.841 0.353 . . . . 0.0 110.843 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 82.7 p -70.07 -44.4 69.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -108.35 -150.48 14.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.505 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 52.89 83.45 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.479 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 131.77 21.95 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.692 2.261 . . . . 0.0 112.35 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.34 156.14 16.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.874 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 15.8 mt -101.18 39.46 1.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -80.64 154.02 73.47 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 0.0 110.923 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . 0.424 ' O ' ' C ' ' A' ' 436' ' ' LYS . 53.8 Cg_endo -69.66 153.27 69.62 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.709 2.272 . . . . 0.0 112.354 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.73 ' HD2' ' HB2' ' A' ' 503' ' ' ALA . 17.7 pttp -35.8 145.59 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.458 ' HB3' ' CG2' ' A' ' 440' ' ' VAL . 1.0 OUTLIER -67.63 90.16 0.26 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.905 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -72.27 -58.32 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.402 ' CD2' HG23 ' A' ' 440' ' ' VAL . 2.3 p-80 -47.15 -34.77 6.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 437' ' ' ARG . 83.5 t -69.09 147.5 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 484' ' ' VAL . 11.4 mt -130.41 145.32 51.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.94 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.713 ' CD2' ' CG ' ' A' ' 505' ' ' TYR . 50.7 t-80 -107.1 110.41 22.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.862 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.656 HG22 HG12 ' A' ' 499' ' ' ILE . 44.0 t -112.44 122.92 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.112 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.4 p -102.64 104.0 14.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.118 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.87 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.3 p90 -120.23 155.09 56.25 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.633 0.73 . . . . 0.0 110.862 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.575 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.9 Cg_endo -69.72 142.6 48.54 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.667 2.245 . . . . 0.0 112.372 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.413 ' O ' ' C ' ' A' ' 448' ' ' GLU . 15.1 ptmt -42.81 -44.58 4.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.1 pt-20 -37.67 -37.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.575 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 11.0 m0 -54.53 -176.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.884 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt -161.96 165.53 27.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . 0.454 ' HG1' ' HZ2' ' A' ' 468' ' ' TRP . 92.7 m -48.98 -57.89 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.153 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.1 m -45.08 -41.61 7.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.65 -49.56 77.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.87 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.5 mm? -57.03 -55.15 38.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 459' ' ' SER . 5.9 m-85 -57.21 -43.94 83.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.907 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -65.17 -30.97 71.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 11.9 tp -75.08 -43.61 52.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.784 ' CE1' HG11 ' A' ' 476' ' ' VAL . 23.2 m-85 -88.41 -13.15 41.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.88 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 455' ' ' TYR . 44.5 t -39.24 -34.97 0.21 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.82 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.29 -44.01 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -82.34 -49.07 10.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.835 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.64 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 136.93 -151.21 20.89 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.479 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -54.78 126.46 24.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.5 pt -139.58 166.52 21.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -106.86 100.88 10.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.423 HD13 ' CB ' ' A' ' 454' ' ' LEU . 68.1 mt -86.37 106.52 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.8 m -95.79 116.29 28.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . 0.454 ' HZ2' ' HG1' ' A' ' 451' ' ' THR . 85.1 m95 -81.79 109.08 15.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.93 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.891 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -89.45 -66.55 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.133 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.61 -176.56 3.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -63.48 -27.56 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 77.4 p -129.64 21.3 5.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.5 t -133.17 135.75 45.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.845 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 445' ' ' PHE . . . -142.26 173.43 11.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.891 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -132.61 142.96 49.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.784 HG11 ' CE1' ' A' ' 458' ' ' PHE . 58.8 t -125.69 136.53 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.164 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 4.5 p -118.61 139.0 52.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.558 HD13 ' CB ' ' A' ' 483' ' ' GLN . 42.5 mt -126.05 168.18 14.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 4.6 t -82.06 -49.22 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -122.71 158.66 56.16 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.567 0.698 . . . . 0.0 110.936 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -35.08 13.44 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.736 2.291 . . . . 0.0 112.309 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -38.72 -59.35 0.95 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.558 ' CB ' HD13 ' A' ' 478' ' ' LEU . 26.4 mp0 -41.43 -49.35 3.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.82 ' O ' HG23 ' A' ' 488' ' ' VAL . 64.5 t -37.5 -45.41 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.102 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . . . . . . . . . 42.8 mm-40 -58.86 -44.75 91.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.419 ' N ' ' O ' ' A' ' 483' ' ' GLN . 3.9 mp -70.17 -51.32 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.122 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -52.93 -42.24 65.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 484' ' ' VAL . 42.6 t -73.46 -43.0 56.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.111 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -48.3 -37.74 17.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 80.5 p -78.26 -40.83 35.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.173 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.451 ' CB ' ' HB ' ' A' ' 499' ' ' ILE . 26.2 p -64.81 -11.25 35.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -62.51 -59.66 4.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -76.88 -38.37 53.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.892 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -51.45 121.09 5.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.096 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -100.11 -39.95 7.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.843 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 8.4 m -48.06 -46.91 33.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.444 ' HB3' ' CH2' ' A' ' 449' ' ' TRP . 10.4 p90 -120.51 150.8 40.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . 0.4 ' HB2' ' NH1' ' A' ' 498' ' ' ARG . 18.5 ttm105 -122.65 123.9 42.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.656 HG12 HG22 ' A' ' 443' ' ' VAL . 69.3 mt -119.08 138.52 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.14 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -144.27 -175.31 4.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.938 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.43 ' O ' ' C ' ' A' ' 502' ' ' TYR . 23.3 p -95.82 143.16 27.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.189 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.431 ' O ' HG22 ' A' ' 506' ' ' VAL . 49.3 t80 -35.31 -46.52 0.37 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.948 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.73 ' HB2' ' HD2' ' A' ' 436' ' ' LYS . . . -55.2 -52.85 62.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.111 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -52.09 -33.39 39.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.713 ' CG ' ' CD2' ' A' ' 442' ' ' HIS . 15.6 t80 -72.21 -67.41 0.55 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 502' ' ' TYR . 11.1 m -49.8 -42.51 18.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -48.32 -44.49 27.69 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 508' ' ' LYS . 0.0 OUTLIER -49.95 -58.72 4.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 110.881 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 12.4 mtpp -52.7 -61.67 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -63.91 169.96 3.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -170.45 116.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -150.95 -56.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 55.0 pttt -159.24 116.84 2.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.74 0.305 . . . . 0.0 110.879 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -173.49 136.46 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.9 139.25 19.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.101 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 21.8 ttpt -121.65 149.52 43.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.929 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 4.5 m -47.04 137.65 7.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.868 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . -156.12 70.99 0.27 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.458 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 166.1 28.82 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.653 2.235 . . . . 0.0 112.317 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 62.4 p -94.22 -46.5 7.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.858 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 88.9 p -87.93 98.06 11.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.82 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.476 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 4.0 m -104.03 114.03 27.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 26.1 p -158.09 150.63 22.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.822 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 136.27 92.08 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 15.9 m -143.15 111.88 6.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.866 0.365 . . . . 0.0 110.895 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 43.3 t -98.9 147.83 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.89 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -46.87 112.31 0.9 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.522 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . 48.62 79.67 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 122.06 8.72 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.684 2.256 . . . . 0.0 112.318 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -121.76 155.44 35.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 20.9 tp -98.68 142.68 29.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -108.4 150.89 41.19 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.6 0.714 . . . . 0.0 110.901 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 163.84 36.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.659 2.24 . . . . 0.0 112.344 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -77.26 143.28 39.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.463 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 31.7 mtt-85 -106.12 78.58 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -84.58 -61.84 1.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.83 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -41.8 -36.72 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 91.6 t -70.36 141.56 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.155 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.505 HD21 HG13 ' A' ' 484' ' ' VAL . 32.0 mt -129.71 127.79 41.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.9 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . . . . . . . . . 45.8 t-80 -93.74 114.14 26.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.623 HG22 HG12 ' A' ' 499' ' ' ILE . 11.9 t -114.26 125.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.113 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 3.1 p -99.48 105.66 17.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.668 ' CE2' HD11 ' A' ' 454' ' ' LEU . 3.9 p90 -125.35 154.88 72.24 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.7 Cg_endo -69.78 146.1 59.08 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.68 2.253 . . . . 0.0 112.357 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.464 ' O ' ' N ' ' A' ' 449' ' ' TRP . 14.2 ptmt -45.29 -44.6 11.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.914 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 447' ' ' LYS . 10.9 pt-20 -37.48 -30.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.898 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.543 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 9.8 m0 -63.71 -176.11 0.16 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . 0.405 ' CG ' ' O ' ' A' ' 449' ' ' TRP . 17.1 mtmm -167.15 172.16 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.89 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 30.5 m -50.54 -56.78 10.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.125 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 3.9 m -48.19 -32.09 6.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.806 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -71.36 -42.12 68.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.668 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.1 mm? -66.11 -56.03 13.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.494 ' O ' ' N ' ' A' ' 459' ' ' SER . 3.8 m-85 -56.83 -49.27 75.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.897 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.468 ' O ' ' CB ' ' A' ' 459' ' ' SER . 28.2 mm-40 -54.27 -56.99 13.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.608 HD11 ' CE2' ' A' ' 497' ' ' TYR . 6.7 tp -53.98 -57.64 10.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.931 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.903 ' CE2' HG21 ' A' ' 476' ' ' VAL . 20.8 m-85 -71.1 -8.69 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 455' ' ' TYR . 8.2 t -46.4 -32.0 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -40.85 -46.33 2.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.108 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -79.4 -53.28 7.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.888 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.794 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 137.57 -155.33 23.0 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -49.14 124.66 9.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 0.0 110.912 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 462' ' ' GLY . 18.9 pt -139.05 176.55 6.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.142 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -115.5 107.54 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 28.2 mt -93.45 113.5 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.7 m -98.01 117.54 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.4 m95 -85.48 108.0 17.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.865 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 1.003 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.07 -52.11 10.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.071 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -144.74 -174.95 4.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.907 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -74.75 -16.67 60.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 21.4 p -132.06 17.78 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 27.0 p -145.98 130.72 18.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.912 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.407 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -142.11 173.21 11.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 1.003 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.3 m-85 -129.83 149.88 51.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.903 HG21 ' CE2' ' A' ' 458' ' ' PHE . 70.7 t -132.36 103.75 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.147 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 15.1 m -98.22 128.88 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.435 HD13 ' HB3' ' A' ' 483' ' ' GLN . 50.7 mt -102.54 176.19 5.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.3 t -77.91 -43.92 28.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -127.05 155.62 75.62 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.561 0.696 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 482' ' ' GLU . 54.0 Cg_endo -69.74 -45.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.697 2.265 . . . . 0.0 112.36 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 481' ' ' PRO . 1.5 pp20? -33.58 -53.36 0.42 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.44 ' O ' ' C ' ' A' ' 484' ' ' VAL . 9.3 mt-30 -45.73 -48.49 15.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.505 HG13 HD21 ' A' ' 441' ' ' LEU . 92.1 t -34.87 -53.48 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.13 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' ND2' ' A' ' 489' ' ' ASN . 10.1 mm-40 -48.2 -48.59 34.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.915 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 2.6 mp -64.56 -60.16 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.149 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.21 -48.97 6.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.085 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 484' ' ' VAL . 58.0 t -64.68 -43.71 96.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 485' ' ' GLN . 87.2 m-20 -53.99 -43.48 70.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.548 ' O ' ' CD2' ' A' ' 493' ' ' TYR . 70.1 p -75.53 -36.72 60.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.112 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 58.3 p -60.09 -34.43 73.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -40.84 -58.01 1.79 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' A' ' 490' ' ' THR . 11.5 p90 -75.35 -42.22 54.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.943 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.421 ' N ' ' CG ' ' A' ' 493' ' ' TYR . . . -42.73 118.82 1.31 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.088 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -99.38 -39.95 8.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 1.8 m -49.17 -44.39 42.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.608 ' CE2' HD11 ' A' ' 457' ' ' LEU . 35.2 p90 -126.13 158.65 34.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.937 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 17.7 ttm-85 -128.05 117.8 22.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 443' ' ' VAL . 25.2 mt -110.74 140.47 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . 0.585 HE22 ' N ' ' A' ' 505' ' ' TYR . 0.0 OUTLIER -147.77 175.4 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.927 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 504' ' ' GLU . 18.6 p -78.12 132.36 37.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.463 ' CE1' ' HD2' ' A' ' 437' ' ' ARG . 65.2 t80 -35.53 -42.44 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.927 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -58.31 -44.9 88.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 501' ' ' THR . 5.2 mm-40 -53.15 -23.61 8.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.889 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.585 ' N ' HE22 ' A' ' 500' ' ' GLN . 23.8 t80 -84.02 -69.33 0.65 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.93 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . . . . . . . . . 4.9 m -48.58 -35.82 6.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -44.69 -48.18 9.01 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.498 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . . . . . . . . . 4.1 mmpt? -50.28 -54.09 23.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.823 0.344 . . . . 0.0 110.886 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 21.3 mtpt -47.08 -63.72 0.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.92 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 43.8 mm-40 -55.32 176.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . 0.48 ' HE2' ' N ' ' A' ' 512' ' ' GLY . 0.0 OUTLIER -128.64 110.44 12.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . 0.48 ' N ' ' HE2' ' A' ' 511' ' ' LYS . . . 99.09 79.1 1.43 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.516 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.83 42.52 3.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 0.0 110.924 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -153.89 135.33 14.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 33.4 m -109.39 143.71 19.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 15.2 tptp -72.34 155.2 40.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.865 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 5.4 t -103.06 114.45 28.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.881 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 78.72 146.13 3.14 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -17.3 37.92 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.722 2.282 . . . . 0.0 112.352 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 63.3 m -106.62 87.69 2.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.844 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 15.5 t -70.75 94.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.859 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.521 -179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 58.8 m -143.71 156.37 44.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.379 . . . . 0.0 110.886 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 3.0 t -153.23 164.89 37.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.827 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 144.24 -174.04 24.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.522 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 48.8 m -108.29 96.74 6.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 110.828 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 33.0 t -44.79 138.6 3.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . -99.37 118.64 6.24 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.47 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -161.8 145.88 11.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.497 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 1.1 4.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.686 2.258 . . . . 0.0 112.342 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.55 168.94 11.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.0 104.49 17.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -46.86 139.83 6.47 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.575 0.702 . . . . 0.0 110.899 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 153.79 68.28 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.674 2.25 . . . . 0.0 112.377 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.6 mmtm -87.34 103.63 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.448 ' HG3' ' CE2' ' A' ' 502' ' ' TYR . 2.3 mmp_? -118.14 83.11 1.95 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -110.4 -47.75 3.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -61.08 -24.1 65.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.01 138.72 19.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . . . . . . . . . 12.5 mt -130.72 135.5 47.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.625 ' CD2' ' CD1' ' A' ' 505' ' ' TYR . 64.5 t-80 -94.43 107.98 19.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.865 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.581 HG13 HG12 ' A' ' 499' ' ' ILE . 9.3 t -111.22 124.67 68.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.129 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 1.4 p -106.72 104.49 14.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.174 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.555 ' CE2' HD11 ' A' ' 454' ' ' LEU . 9.7 p90 -117.83 154.62 51.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.675 0.75 . . . . 0.0 110.885 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.76 149.67 67.19 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.681 2.254 . . . . 0.0 112.371 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 449' ' ' TRP . 10.8 ptpt -47.42 -43.26 23.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -41.24 -26.74 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.889 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.574 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.2 m0 -68.81 168.23 13.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -147.86 166.7 26.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.7 m -48.11 -57.3 6.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.183 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 26.9 m -48.55 -39.97 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.83 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.81 -47.28 86.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.856 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.555 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.0 mm? -61.17 -64.73 0.85 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.458 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.6 m-85 -45.52 -51.76 11.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.934 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -57.68 -39.95 78.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.858 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . . . . . . . . . 12.6 tp -65.22 -52.28 55.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.635 ' CE2' HG11 ' A' ' 476' ' ' VAL . 19.5 m-85 -79.15 -8.8 59.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.879 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 455' ' ' TYR . 3.3 t -40.15 -40.43 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 459' ' ' SER . . . -34.1 -39.41 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.07 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . 0.54 ' CD1' ' HG2' ' A' ' 483' ' ' GLN . 29.3 m-85 -86.58 -50.68 6.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.888 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.779 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 130.79 -151.16 19.5 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.498 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -48.64 123.15 6.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.811 0.339 . . . . 0.0 110.877 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 462' ' ' GLY . 20.1 pt -140.07 172.44 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.137 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -115.37 101.02 8.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . . . . . . . . . 75.7 mt -84.56 106.41 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.096 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.9 m -91.12 118.22 30.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -85.77 108.62 18.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.944 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.8 mt -90.34 -70.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 469' ' ' ILE . 4.3 m-20 -121.99 -175.0 3.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.832 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.88 -32.1 73.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 75.6 p -126.78 21.33 6.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.144 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 41.1 m -132.58 129.46 39.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . . . . . . . . . . . -140.69 172.44 12.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.944 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.8 m-85 -132.8 153.11 51.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.635 HG11 ' CE2' ' A' ' 458' ' ' PHE . 98.9 t -138.04 111.6 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 28.0 t -98.14 133.61 42.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.815 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 483' ' ' GLN . 80.8 mt -113.62 175.49 5.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.967 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 58.0 m -90.88 -46.19 8.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.857 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -128.06 157.48 73.91 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.592 0.711 . . . . 0.0 110.92 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -24.03 30.08 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.675 2.25 . . . . 0.0 112.34 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -46.14 -35.17 4.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.604 ' HB2' HD13 ' A' ' 478' ' ' LEU . 51.6 mt-30 -75.67 -47.48 26.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 485' ' ' GLN . 72.4 t -36.82 -65.31 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . 0.438 ' C ' ' O ' ' A' ' 484' ' ' VAL . 23.7 mm-40 -35.42 -56.46 0.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 486' ' ' ILE . 4.2 mp -59.76 -57.38 11.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.49 -30.29 0.55 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.117 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 490' ' ' THR . 47.9 t -86.25 -66.91 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 488' ' ' VAL . 9.8 t30 -35.48 -32.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 488' ' ' VAL . 42.8 p -76.58 -59.56 2.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.123 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 494' ' ' ALA . 6.1 p -53.74 -23.92 13.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -47.23 -52.67 15.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.915 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . 0.455 ' CD2' ' O ' ' A' ' 490' ' ' THR . 25.0 p90 -84.28 -39.21 19.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.93 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 491' ' ' SER . . . -46.1 116.2 1.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -95.61 -23.23 17.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 13.7 t -67.66 -42.43 82.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.841 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -125.57 155.74 40.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.904 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -124.67 129.09 49.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.581 HG12 HG13 ' A' ' 443' ' ' VAL . 66.3 mt -126.46 137.77 56.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.136 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -145.78 173.75 11.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 23.0 p -84.23 144.94 28.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 506' ' ' VAL . 70.1 t80 -47.64 -52.04 19.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 506' ' ' VAL . . . -52.44 -35.39 52.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.107 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -71.85 -35.5 69.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.911 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 442' ' ' HIS . 37.2 t80 -72.38 -40.19 67.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.928 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 502' ' ' TYR . 34.2 m -79.06 -32.23 15.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.181 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . . . . . . . . . . . -42.21 -61.15 2.47 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 509' ' ' LYS . 8.8 ptmt -60.83 -53.62 55.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 508' ' ' LYS . 21.2 mttt -35.27 -55.4 0.63 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.91 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -83.7 126.57 33.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -116.8 104.86 11.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.899 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -135.89 -64.84 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 10.6 pttp -159.34 126.24 4.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.869 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -171.24 131.53 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.48 131.81 14.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.62 124.35 51.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 60.1 p -98.02 114.69 26.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.812 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 81.72 66.57 1.58 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 130.12 18.78 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.669 2.246 . . . . 0.0 112.374 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 26.8 t -92.15 -56.71 2.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 70.3 m -46.8 119.65 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.499 -179.972 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' SER . . . . . . . . . . . . . 1.5 t -155.09 132.67 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 110.851 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' SER . . . . . . . . . . . . . 30.9 t -58.45 -56.8 17.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.81 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' GLY . . . . . . . . . . . . . . . 168.24 -78.92 0.1 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.508 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' SER . . . . . . . . . . . . . 46.3 t -119.28 154.69 33.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' SER . . . . . . . . . . . . . 51.5 p -80.12 114.17 18.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' GLY . . . . . . . . . . . . . . . 65.12 119.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.521 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -67.5 125.6 23.68 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.459 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 1.42 4.48 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.312 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.9 155.41 40.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.879 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' LEU . . . . . . . . . . . . . 53.3 mt -51.86 172.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.975 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -48.64 142.69 8.54 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.56 0.695 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 146.52 60.14 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.658 2.239 . . . . 0.0 112.32 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 23.2 mttm -112.81 177.48 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' ARG . . . . . 0.572 ' HD2' ' CE1' ' A' ' 502' ' ' TYR . 55.1 mtt-85 60.82 47.59 7.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -55.08 7.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.831 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' HIS . . . . . 0.523 ' CD2' HG23 ' A' ' 440' ' ' VAL . 4.6 p-80 -44.98 -30.9 1.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' A' ' 439' ' ' HIS . 96.2 t -75.08 134.26 29.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.166 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 478' ' ' LEU . 7.9 mt -123.78 139.37 54.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' HIS . . . . . 0.793 ' CE1' ' CD1' ' A' ' 505' ' ' TYR . 46.3 t-80 -100.35 108.03 19.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' VAL . . . . . 0.431 HG22 HG12 ' A' ' 499' ' ' ILE . 6.5 t -109.43 130.54 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' THR . . . . . . . . . . . . . 2.1 p -111.97 104.03 12.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.168 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 454' ' ' LEU . 10.1 p90 -119.37 156.0 53.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.658 0.742 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 449' ' ' TRP . 53.4 Cg_endo -69.8 152.86 69.2 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 0.0 112.31 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' LYS . . . . . . . . . . . . . 8.1 pttm -58.69 -23.22 59.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -60.36 -12.48 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 446' ' ' PRO . 10.0 m0 -82.36 -175.03 5.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -160.05 163.31 34.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' THR . . . . . . . . . . . . . 26.1 m -46.18 -56.4 5.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.179 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' SER . . . . . . . . . . . . . 12.3 t -47.64 -36.85 11.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -65.78 -44.84 84.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LEU . . . . . 0.8 HD11 ' CE2' ' A' ' 445' ' ' PHE . 4.2 mm? -61.95 -61.94 2.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' TYR . . . . . 0.48 ' O ' ' N ' ' A' ' 459' ' ' SER . 4.7 m-85 -50.15 -44.24 52.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -62.07 -43.29 99.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 497' ' ' TYR . 11.9 tp -63.91 -48.4 76.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' PHE . . . . . 0.702 ' CE2' HG21 ' A' ' 476' ' ' VAL . 16.3 m-85 -82.14 -12.05 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 455' ' ' TYR . 1.1 t -37.86 -37.05 0.22 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.82 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -38.34 -46.6 1.13 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.075 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -78.5 -50.81 10.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 464' ' ' ILE . . . 131.25 -144.29 15.83 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.461 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -56.51 123.46 14.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 0.0 110.908 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 462' ' ' GLY . 21.0 pt -138.44 177.28 5.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.12 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -118.95 103.19 9.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' ILE . . . . . 0.44 HD12 ' CE2' ' A' ' 455' ' ' TYR . 33.0 mt -89.07 106.43 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' SER . . . . . . . . . . . . . 1.1 t -94.27 109.02 20.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.853 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -75.83 109.46 9.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' ILE . . . . . 0.998 HD11 ' CD2' ' A' ' 475' ' ' PHE . 5.7 mt -91.02 -70.56 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.146 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.91 -174.98 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -66.96 -23.75 65.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' THR . . . . . . . . . . . . . 11.4 p -131.82 18.0 4.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' SER . . . . . . . . . . . . . 3.9 m -131.7 130.23 41.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.884 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' ALA . . . . . 0.46 ' HB3' ' CE2' ' A' ' 445' ' ' PHE . . . -141.96 171.52 13.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.096 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' PHE . . . . . 0.998 ' CD2' HD11 ' A' ' 469' ' ' ILE . 2.5 m-85 -135.61 153.23 51.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' VAL . . . . . 0.702 HG21 ' CE2' ' A' ' 458' ' ' PHE . 99.3 t -139.65 111.57 5.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.133 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 8.2 m -99.45 123.99 44.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 441' ' ' LEU . 64.1 mt -96.71 176.78 5.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.5 m -90.43 -47.36 7.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -111.85 144.17 30.13 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -31.69 20.14 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.721 2.281 . . . . 0.0 112.29 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -50.35 -49.91 52.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 484' ' ' VAL . 61.4 mm-40 -47.89 -46.88 32.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' VAL . . . . . 0.443 ' C ' ' O ' ' A' ' 483' ' ' GLN . 92.2 t -34.74 -60.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.111 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' GLN . . . . . 0.434 ' O ' ' CG ' ' A' ' 489' ' ' ASN . 26.8 mm-40 -40.51 -53.38 2.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ILE . . . . . . . . . . . . . 3.2 mp -59.93 -57.82 9.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.129 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' ALA . . . . . . . . . . . . . . . -43.0 -42.81 3.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' VAL . . . . . . . . . . . . . 61.1 t -73.81 -45.55 49.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' ASN . . . . . 0.434 ' CG ' ' O ' ' A' ' 485' ' ' GLN . 39.0 m-20 -56.6 -33.82 66.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.894 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' THR . . . . . . . . . . . . . 71.5 p -79.01 -42.3 26.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' SER . . . . . 0.451 ' HB3' HD12 ' A' ' 499' ' ' ILE . 53.6 p -61.36 -15.03 32.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' LYS . . . . . . . . . . . . . 5.7 mtmp? -56.55 -54.77 42.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' TYR . . . . . . . . . . . . . 32.2 p90 -80.8 -37.73 29.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.919 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' ALA . . . . . . . . . . . . . . . -49.28 111.73 0.53 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.129 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.2 -40.06 10.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' SER . . . . . . . . . . . . . 4.5 t -47.69 -40.89 21.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' TYR . . . . . 0.542 ' CE2' HD11 ' A' ' 457' ' ' LEU . 10.8 p90 -127.33 169.79 13.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.899 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -139.74 131.59 27.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.878 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 491' ' ' SER . 43.8 mt -120.69 137.75 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.186 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -142.04 132.76 25.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' THR . . . . . . . . . . . . . 22.9 p -50.68 138.76 17.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 506' ' ' VAL . 46.7 t80 -39.19 -51.61 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.904 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.35 75.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -62.99 -40.4 97.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.917 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' TYR . . . . . 0.793 ' CD1' ' CE1' ' A' ' 442' ' ' HIS . 18.5 t80 -68.44 -57.25 6.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.942 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 502' ' ' TYR . 30.4 m -56.83 -40.44 71.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.131 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 506' ' ' VAL . . . -37.01 -44.48 1.0 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.448 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 508' ' ' LYS . 2.7 mptp? -65.83 -68.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.896 0.379 . . . . 0.0 110.907 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -39.98 -57.74 1.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -64.11 97.12 0.17 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -169.34 117.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.952 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' GLY . . . . . . . . . . . . . . . -102.83 -134.68 8.44 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.467 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' LYS . . . . . . . . . . . . . 13.8 ttpp -120.9 84.12 2.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.0 110.888 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -173.49 124.1 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.929 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' VAL . . . . . . . . . . . . . 84.3 t -127.52 137.87 56.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.17 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' LYS . . . . . . . . . . . . . 24.3 mmtp -81.55 127.4 32.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' SER . . . . . . . . . . . . . 48.8 m -118.9 151.83 37.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' GLY . . . . . . . . . . . . . . . 130.47 144.96 5.63 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 114.55 3.74 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' SER . . . . . . . . . . . . . 2.5 t -115.86 170.41 8.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.826 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' SER . . . . . . . . . . . . . 1.2 t -173.76 177.45 2.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.838 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.477 -179.995 . . . . . . . . 0 0 . 1 stop_ save_